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Introduction 
The increase in longevity, the growing number of older people and the decreasing number 
of newborns, denotes that the populations of most countries in the world are aging rapidly. 
To date, Europe has the highest proportion of older people in the world. In 2011, the 
Netherlands had a total population of 16.5 million inhabitants of whom 15.6% were aged 
65 years or older1. It has been projected that by the year 2050, 24.5% of the Dutch 
population will be aged 65 or older1. This increase is primarily due to changes in health 
indicators including improved nutrition and increasing hygiene2. Moreover, with advances 
in preventive and curative medicine, an increasingly large number of patients survive 
medical conditions that used to be fatal. Because of these developments, the percentage of 
individuals who are suffering from a chronic disease, a disease of long duration and 
generally slow progression3, has increased substantially. The prevalence of multimorbidity, 
the occurrence of two or more chronic diseases within a single individual4, has also 
increased significantly the past few decades. Prevalence estimates of multimorbidity ranging 
from 23%5 to over 50%6 of the population under study have been reported. Hence, general 
practitioners (GPs), being the gatekeepers to other health care facilities, are increasingly 
confronted with individuals who suffer from multiple pathology. In a qualitative study 
aimed at exploring the views and attitudes of GPs managing patients with multimorbidity, 
GPs reported to have difficulties with the often complex health situations of patients with 
multimorbidity7. They also reported that they lacked confidence or clinical competence, 
when confronted with multimorbidity. 
Multiple pathology may lead to faster disease progression, to problems in diagnosing 
new medical conditions and may require more complex therapy and health care8. For 
example, the number of different physicians seen annually by the average patient ranges 
from 4 physicians to 14 physicians when suffering from one medical condition to 
respectively five or more medical conditions. These results indicate the significant impact of 
multimorbidity on the daily practice of health care. Multimorbidity is also well known for 
its profound effects on patients. Previous research claims that multimorbidity is associated 
with various adverse health outcomes including activity limitations and decrease in quality 
of life. These adverse health effects appear to increase with the number of chronic medical 
conditions. Having multiple medical conditions makes it more challenging for patients to 
participate effectively in the process of their own care. Multimorbidity might also affects 
the patient’s family, friends and other caretakers since caring may take a lot of time and 
effort and may require considerable changes in lifestyle. 
To properly assess multimorbidity and it’s impact on patients, valid general-practice 
based data regarding multimorbidity and related health factors are indispensable. Increasing 
our understanding of multimorbidity may not only result in improved health care delivery 
for patients with multimorbidity but may also give direction to future intervention 
programs aimed at ameliorating the adverse health effects of multimorbidity. This thesis 
reports on multimorbidity and several of its adverse health effects and related constructs. In 
addition, innovative research strategies to detect prevalent patterns of multimorbidity are 
introduced and applied. 
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MULTIMORBIDITY: DEFINITION AND OPERATIONALZIATION 
A major obstacle in studying multimorbidity is the absence of a universally accepted 
consensus regarding the use of the term multimorbidity. Although there is still an ongoing 
debate about the terminology and definition of multimorbidity, in this thesis the definition 
as proposed by van den Akker and colleagues, which has been widely used and referred to 
will be used. This definition of multimorbidity, i.e. the co-occurrence of two ore more 
chronic conditions in one individual4, views all medical conditions from an overall 
perspective. This definition differs from co-morbidity, which is defined as the presence of 
one ore more medical conditions in addition to an index condition9. 
 
Based on a bibliometric study in 2005, Fortin and colleagues concluded that despite the 
high prevalence of multimorbidity, relatively few articles in the medical literature have been 
devoted to multimorbidity or co-morbidity10. Since then multimorbidity has become more 
prominent in observational scientific research. However, most research is still focused on 
specific, single diseases, hereby excluding patients with multiple medical conditions. 
Research on multimorbidity may be scarce because the term multimorbidity comes 
with a range of methodological problems11. As stated previously, the definition of 
multimorbidity is the first problem that arises. Secondly, the number and set of diseases on 
which multimorbidity will be based, is decisive for the prevalence of multimorbidity. In 
general, a high number of diseases under study will result in a high prevalence of 
multimorbidity. When only a small number of diseases will be evaluated, a non-realistic 
picture of the prevalence of multimorbidity is presented. Thirdly, diagnostic criteria and 
diagnostic procedures that are used for the definition of a chronic medical condition 
strongly influence the prevalence of multimorbidity. For example, a disease will be 
identified more frequently if the diagnostic criteria are less strict or when active case-finding 
is used. Moreover, when a disease symptom (e.g. hypertension) is considered as a chronic 
medical condition, the prevalence of multiple pathology is also expected to rise. Fourthly, 
previous studies on multimorbidity are conducted in restricted populations such as nursing 
home patients or geriatric patients. Research in these subpopulations may provide results 
that are less representative for the general population. Fifthly, multimorbidity is often 
assessed by means of self-reported medical status. However, self-reports encompass 
individual interpretations and expectations and may reflect various underlying causes. 
Moreover, since the agreement between self-reports and medical records tends to weaken in 
older age groups and in people with multiple pathology12, results from studies using self-
reported multimorbidity may be less adequate. 
Perhaps the most important methodological issue that arise is the conceptualization of 
multimorbidity. One of the most widely used methods for the assessment of 
multimorbidity is a simple disease count; a count of the number of chronic medical 
conditions in a single individual13, 14. A variant of the simple disease count is the 
conditional count, also known as comorbidity; the number of chronic diseases in addition 
to an index disease. Although both a simple disease count and a conditional count are 
straightforward and parsimonious, counting the number of diseases within a single 
individual might be overly simplistic since disease severity is not accounted for. Moreover, 
Chapter 1 
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in a simple disease count as well as in a conditional count a potential strong association 
between a single disease and a particular outcome may become diluted when intermingled 
with diseases which do not have an effect on the outcome at hand. Another method that is 
often used to assess multimorbidity is an index score in which all chronic conditions within 
an individual are weighted according to their severity (e.g. the Charlson index15)16. 
Although this method does account for disease severity, it requires the use of medical 
records and trained reviewers. Multimorbidity can also be assessed by the relative 
association between diseases. This method assesses the degree to which a specific 
combination of diseases (e.g. diabetes mellitus and depression) exceeds a level expected by 
chance alone (i.e. as if they were independent)8. In part, our understanding regarding 
multimorbidity is limited because studies have used a variety of approaches that all have to 
be considered in regard to the research aim, study design and study population. Therefore, 
it is difficult if not unfeasible to compare the results of various studies on multimorbidity. 
 
Another problem that rises when studying multimorbidity is the use of other gerontological 
constructs such as frailty (i.e. a state of increased vulnerability that may result from 
decreased physiological reserve17) and disability (i.e. according to the WHO any restriction 
or lack of the ability to perform an activity in the manner or within the range considered 
normal for the individual18), which are often used interchangeably with multimorbidity to 
identify the weakest and most vulnerable subset of older adults. The relationship between 
multimorbidity and these other construct is complex and still poorly understood. 
INNOVATIVE RESEARCH STRATEGIES 
The introduction of personal computers in health care has rapidly increased the acquisition 
and storage of medical information which in turn has resulted in vast amounts of medical 
data and published medical text (e.g. published research articles stored in Medline). Large 
medical datasets as well as the large body of medical literature can be potentially relevant in 
the context of dedicated medical research questions. As a result of the lack of ability to 
extract new information and insight from these enormous amounts of medical data, 
medical researchers may be missing out on a significant portion of relevant medical 
information and knowledge. Therefore, new methods are needed in order to accurately 
transform these vast amounts of data and text into usable information. 
Piatetsky-Shapiro was the first to introduce the term Knowledge Discovery in 
Databases (KDD) when referring to the process of inferring implicit and hidden patterns 
into well-grounded and testable hypotheses19, 20. The primary goal of KDD is to find the 
unexpected, that is, to discover associations and patterns that may not logically follow from 
earlier research21. KDD can be divided into two different, but related domains: data mining 
and text mining. Data mining is the process of discovering patterns in large databases in an 
automatic or semiautomatic manner which can result in new classification schemes, newly 
generated hypotheses or new predictive models which were previously unknown22–25. Text 
mining refers to the process of analyzing large collections of documents to discover 
promising new hypotheses26, 27. Since KDD methods are able to identify meaningful 
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patterns in large databases, KDD could be an efficient approach in exploring medical 
databases for novel patterns of multimorbidity. 
Patterns of Multimorbidity 
Knowledge of the patterns of multimorbidity in a given population has important 
implications for medical research, health care delivery and daily practice. More specifically, 
a thorough understanding of frequently co-occurring medical conditions might improve 
our ability to predict future occurring medical conditions and mat provide insight to 
underlying pathological mechanism. Moreover, health care for and quality of life of 
patients with multimorbidity might also be improved. 
Given the large spectrum of chronic medical conditions one would expect many 
patterns of multimorbidity (i.e. combinations of co-occurring diseases) which can either 
have a non-causal association or can share a common pathophysiological cause. However, if 
we want to investigate all possible existing combinations of co-occurring medical conditions 
we are confronted with a colossal amount of possible multimorbidity patterns. Therefore, 
data approaches that can identify meaningful patterns and relations in massive amounts of 
medical data are required in order to identify novel, potentially relevant medical 
information. 
SUCCESFUL AGING 
The worldwide increase in longevity does not necessarily reflect improvement of health of 
individuals. If this increase in longevity solely occurs because individuals, instead of dying, 
become disabled or ill for a longer period of time, then the health of a population has not 
improved2. If a longer life is due to a lower occurrence of ill individuals, the health of a 
population will improve. Consequently, in the last decades, the focus of medical research 
and daily practice is on “successful aging”28. Successful aging has been defined as a 
summary of three main components: 1) low probability of disease and disease-related 
susceptibility, 2) high cognitive and physical functioning, and 3) active engagement with 
life. As this definition indicates, successful aging is a multidimensional concept, of which 
the included concepts are all highly intertwined. Several studies included in this thesis 
focuses on the association between two of the three components of successful aging namely 
diseases on one side and cognitive and physical functioning on the other. 
RESEARCH AIMS AND OBJECTIVES 
The primary aim of this thesis is to advance our knowledge regarding multimorbidity. 
Expanding our knowledge regarding multimorbidity may improve heath care delivery for 
individuals with multimorbidity and can facilitate the development of future intervention 
programs aimed at reducing the adverse health consequences associated with 
multimorbidity. Gaining knowledge on multimorbidity may be acquired by the use of 
innovative research strategies. With this specific aim in mind, the following primary aims, 
with corresponding research questions, were formulated: 
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1) to report on several adverse health-related factors and related constructs. 
 Is multimorbidity associated with subjective memory complaints? 
 What is the longitudinal effect of multimorbidity on cognitive functioning? 
 Are the mental and physical problems that accompany multimorbidity temporary 
or persistent? 
 What is the relation between frailty, multimorbidity and disability? 
 Is diabetes mellitus type II related to subsequent depression in a general practice 
based population? 
 
2) to introduce and apply innovative research strategies useful for analyzing large amounts 
of medical data. 
 Can Knowledge Discovery in Databases (KDD) be of use in medical research? 
 Which patterns of multimorbidity frequently occur in patients above a chance 
level? 
OUTLINE 
Chapter 2 describes the association between multimorbidity and subjective memory 
performance in a large community-dwelling population of older adults. Chapter 3 
evaluates the association between multimorbidity and objective cognitive performance by 
making use of the Registration Network family Practice (RNH) and the Maastricht Aging 
Study (MAAS). Chapter 4 focuses on the association between multimorbidity and 
functional health. The objective of this study was to evaluate if the changes in mental and 
physical functioning, caused by multimorbidity, are permanent or temporal. Chapter 5 
discusses the relation between frailty, multimorbidity and disability by evaluating their 
association with several biological markers, nursing home admission and mortality. This 
study was conducted by means of the Age, Gene/Environment Susceptibility study. 
Chapter 6 describes the influence of diabetes mellitus type II on subsequent depression in a 
longitudinal study based on a general practice-based population. Chapter 7 presents a 
methodological outline of Knowledge Discovery in Databases which can aid the medical 
research in the process of hypothesis generation. Chapter 8 describes an exploratory 
analyzing approach in which two selection criteria were combined with an expert evaluation 
phase in order to identify undiscovered, potential relevant disease combinations in a large 
general practice-based data set. The general discussion is presented in the last chapter, 
chapter 9. This chapter recaptures the main findings of the abovementioned studies and 
discusses the methodological issues. Finally, implications of the findings for clinical practice 
are presented even as recommendations for future research. 
 
 
General introduction 
 - 15 -
REFERENCES 
1. Sociale Monitor, Centraal Bureau voor de Statistiek, 2010; Available from: http://statline.cbs.nl/-
StatWeb/publication/. 
2. R.G. Evans, M.L. Barer, and T.R. Marmor. Why are some people healthy and other not? The deter-
minants of health of populations. 1994, New York: Walter de Gruyter, Inc. 
3. http://www.who.int/topics/chronic_diseases/en/. 
4. M. van den Akker, F. Buntinx, J.F. Metsemakers, S. Roos, and J.A. Knottnerus. Multimorbidity in 
general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent dis-
eases. J. Clin. Epidemiol., 1998;51(5):367–375. 
5. F.G. Schellevis, J. van der Velden, E. van de Lisdonk, J.T. van Eijk, and C. van Weel. Comorbidity of 
chronic diseases in general practice. J. Clin. Epidemiol., 1993;46(5):469–473. 
6. M. Fortin, G. Bravo, C. Hudon, A. Vanasse, and L. Lapointe. Prevalence of multimorbidity among 
adults seen in family practice. Ann. Fam. Med., 2005;3(3):223–228. 
7. S.M. Smith, S. O’Kelly, and T. O’Dowd. GPs’ and pharmacists’ experiences of managing multimor-
bidity: a ‘Pandora’s box’. Br. J. Gen. Pract., 2010;60(576):285–294. 
8. L.G. Glynn, J.M. Valderas, P. Healy, E. Burke, J. Newell, P. Gillespie, and A.W. Murphy. The preva-
lence of multimorbidity in primary care and its effect on health care utilization and cost. Fam. Pract., 
2011;28(5):516–523. 
9. A.R. Feinstein and M. Levitt. The role of tonsils in predisposing to streptococcal infections and recur-
rences of rheumatic fever. N. Engl. J. Med., 1970;282(6):285–291. 
10. M. Fortin, L. Lapointe, C. Hudon, and A. Vanasse. Multimorbidity is common to family practice: is it 
commonly researched? Can. Fam. Physician, 2005;51:244–245. 
11. M. van den Akker, F. Buntinx, S. Roos, and J.A. Knottnerus. Problems in determining occurrence 
rates of multimorbidity. J. Clin. Epidemiol., 2001;54(7):675–679. 
12. S. Goebeler, M. Jylha, and A. Hervonen. Self-reported medical history and self-rated health at age 90. 
Agreement with medical records. Aging clinical and experimental research, 2007;19(3):213–219. 
13. R. John, D.S. Kerby, and C.H. Hennessy. Patterns and impact of comorbidity and multimorbidity 
among community-resident American Indian elders. Gerontologist, 2003;43(5):649–660. 
14. J.M. Guralnik. Assessing the impact of comorbidity in the older population. Ann. Epidemiol., 
1996;6(5):376–380. 
15. D.M. Needham, D.C. Scales, A. Laupacis, and P.J. Pronovost. A systematic review of the Charlson 
comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical 
care research. J. Crit. Care, 2005;20(1):12–19. 
16. N.I. Martinez-Velilla and I. Gaminde Inda. Comorbidity and multimorbidity indexes in the elderly 
patients. Med. Clin. (Barc). 2011;136(10):441–446. 
17. L.P. Fried, C.M. Tangen, J. Walston, A.B. Newman, C. Hirsch, J. Gottdiener, T. Seeman, R. Tracy, 
W.J. Kop, G. Burke, and M.A. McBurnie. Frailty in older adults: evidence for a phenotype. J. Geron-
tol. A. Biol. Sci. Med. Sci., 2001;56(3):146–156. 
18. Disabilities, World Health Organization; Available from: http://www.who.int/topics/disabilities/en/. 
19. C. Piatetsky-Shapiro. Knowledge Discovery in Real Databases: A Report on the IJCAI-89 Workshop. 
Artificial Intelligence Magazine, 1991;11(5):68–70. 
20. G. Piatetsky-Shapiro. Data mining and knowledge discovery 1996 to 2005: overcoming the hype and 
moving from “university” to “business” and “analytics”. Data Mining and Knowledge Discovery, 
2007;15(1):99–105. 
21. R. Agrawal, T. Imielinski, and A. Swami. Database mining: A Performance Perspective. IEEE Transac-
tions on Knowledge and Data Engineering, 1993;5(6):914–925. 
22. J.D. Hand. Data mining: statistics and more? The American Statistician, 1998;52:112–118. 
23. A.M. Berger and C.R. Berger. Data mining as a tool for research and knowledge development in 
nursing. Computers, Informatics, Nursing, 2004;22(3):123–131. 
Chapter 1 
 - 16 -
24. J.H. van Bemmel, E.M. van Mulligen, B. Mons, M. van Wijk, J.A. Kors, and J. van der Lei. Databases 
for knowledge discovery. Examples from biomedicine and health care. Int. J. Med. Inf., 2006;75(3–
4):257–267. 
25. I.H. Witten and E. Frank. Data mining: practical machine learning tools and techniques. 2nd. ed. 
2005, San Francisco: Elsevier. 
26. I. Spasic, S. Ananiadou, J. McNaught, and A. Kumar. Text mining and ontologies in biomedicine: 
making sense of raw text. Briefings in Bioinformatics, 2005;6(3):239–251. 
27. N. Uramoto, H. Matsuzawa, T. Nagano, A. Murakami, H. Takeuchi, and K. Takeda. A text-mining 
system for knowledge discovery from biomedical documents. IBM Systems Journals, 2004;43(3). 
28. J.W. Rowe and R.L. Kahn. Successful aging. Gerontologist, 1997;37(4):433–440. 
 
 - 17 -
CHAPTER 2 
Multimorbidity is associated with subjective memory 
complaints in a large general population of older adults 
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ABSTRACT 
Background 
Multimorbidity has been suggested to be predictive of a variety of negative health-related 
outcomes. The present study was designed to assess the validity of multimorbidity as a 
predictor of subjective memory complaints. 
Methods 
This cross-sectional study was based on data obtained from a postal survey designed by the 
Public Health Service (Gemeentelijke Gezondheidsdienst, GGD) involving 15,188 persons 
aged 55 and over living independently in Limburg, the Netherlands. Multivariate logistic 
regression analyses, adjusted for potentially important covariates, were performed to 
evaluate the predictive value of self-reported multimorbidity on three outcomes related to 
subjective memory complaints. 
Results 
Multimorbidity was predictive of subjective memory complaints. The ability of 
multimorbidity to predict subjective memory complaints was positively influenced by age. 
Moreover, multimorbidity predicted the degree of worrying about memory complaints in 
people who perceived themselves as forgetful. Multimorbidity was also an important 
predictor for reporting a larger increase in these subjective memory complaints during the 
last year. In this latter case, multimorbidity had more prognostic capability in men than in 
women. Psychological distress was a significant predictor for all three subjective memory-
related outcome measures. 
Conclusions 
In our sample, which was representative of the Dutch population, multimorbidity was 
predictive of subjective memory complaints. The prognostic value of multimorbidity 
differed between men and women and between age groups. 
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INTRODUCTION 
Subjective memory complaints, or the feeling that one’s ability to remember and to retrieve 
information is not as good as it used to be, are common complaints among middle-aged 
and elderly persons. One study using a large sample of almost 2000 participants aged 24 to 
86 years indicated that nearly 40 percent considered themselves to be forgetful1. In a sample 
of 500 older people between 50 and 90 years of age, 57 percent of the respondents were 
slightly concerned about their forgetfulness, and over 32 percent were very concerned2. 
Whether subjective memory complaints are indicative of Mild Cognitive Impairment 
(MCI) or dementia has been studied extensively, but no clear-cut conclusions have emerged 
so far3. Some studies have demonstrated that self-perceived forgetfulness is indeed 
predictive of cognitive decline and dementia4, 5. It has been argued that a person’s belief 
about his or her own memory performance is an important moderator of changing memory 
functioning because it can affect memory performance through cognitive, affective, and 
motivational routes6. Other studies have found no association between subjective memory 
complaints and objective memory decline and argued that these complaints are merely 
related to depressive feelings and anxiety7, 8. Moreover, earlier research suggested that 
subjective feelings of memory impairment are more closely related to personality traits (i.e., 
feelings of inferior personal competence and capacities as well as tendencies toward phobic 
or obsessive/compulsive reactions) than to actual memory performance in normal elderly 
people9. 
Although subjective memory complaints are not necessarily directly related to objective 
memory decline 7, the extent and impact of these self-perceived memory problems could in 
any case be significant. Previous research has demonstrated that, in older individuals, 
subjective memory complaints were associated with a lower quality of life10. Moreover, in a 
study conducted in a general practice-based population, results indicated that the presence 
of subjective memory complaints increased the cost of health care utilization by 60% over 
three years11. These findings underscore the impact of subjective memory complaints on a 
person’s daily life and on society as a whole. Hence, it is important to gain more insight 
into the predictive factors contributing to subjective memory complaints. Investigating 
these potential contributing factors may contribute to the development of a risk profile for 
elderly patients with self-perceived forgetfulness. 
Multimorbidity, a term that describes the co-occurrence of two or more chronic 
medical conditions within one person12, has been indicated as one factor that might 
contribute to the presence of subjective memory complaints. Prior research has suggested 
that morbidity status (i.e., morbidity and multimorbidity) might be predictive of objective 
memory decline13. A variety of medical conditions, including diabetes mellitus14 and 
cardiovascular diseases15 have already been associated with decreased memory performance. 
Given that multimorbidity is the rule rather than the exception among older individuals 
and that patients suffering from multimorbidity use health care services more frequently 
than patients suffering from a single chronic condition16, the impact of multimorbidity on 
society is substantial. 
Although subjective memory complaints have been an important topic in recent 
gerontological and neuropsychological research, multimorbidity as a predictive factor for 
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subjective memory complaints has, to our knowledge, never been evaluated. The first aim 
of the current study was to evaluate the ability of multimorbidity to predict the presence of 
subjective memory complaints. The second aim was to investigate whether multimorbidity 
was prognostic for the degree of worrying about these memory complaints. The final aim 
was to determine if multimorbidity was predictive of an increase in memory complaints 
during the previous year. The results of the present study could help clinicians to identify 
subgroups of older people who are at risk of developing subjective memory complaints, which 
may be mediated by poor morbidity status. 
METHODS 
Study Design 
This study was based on data from a cross-sectional postal survey designed by the Public 
Health Service (Geneeskundige Gezondheidsdienst, GGD Zuid Limburg and GGD 
Limburg-Noord) and was sent to a representative sample (of the municipal registrar’s 
office) of people aged 55 and over living in the province of Limburg, the Netherlands. This 
questionnaire was comprised of questions concerning health status, lifestyle and special care 
needs. 
Study Population 
In 2008, more than 21,000 community-dwelling persons aged 55 and over were sent a 
questionnaire, which was completed and returned by 15,188 persons (response rate of 72.3 
percent). All participants were living in the province of Limburg, the Netherlands. 
Measures 
Independent variables 
Morbidity (i.e., the occurrence of one disease within a patient) and multimorbidity (i.e., 
the co-occurrence of two or more diseases within one patient) were conceptualized by a 
simple disease count17. This count incorporated self-reported medical conditions that had 
been diagnosed by a medical doctor (see Appendix). Based on these medical conditions, 
four distinct groups of respondents were formed: 1) people without any of the medical 
conditions of interest, 2) people who suffered from one medical condition (i.e., morbidity), 
3) people who suffered from two medical conditions (i.e., multimorbidity 2), and 4) people 
who suffered from three or more medical conditions (i.e., multimorbidity ≥ 3). The latter 
group was formed to determine if the degree of multimorbidity mattered. 
 
Dependent variables 
Memory complaints were probed using three questions. The first question was, ‘Do you 
perceive yourself as forgetful?’ and required a yes or no answer. Participants who replied 
affirmatively (n=3,976) also rated the degree of worrying about their subjective memory 
complaints on a 5-point scale ranging from 1 (‘not at all’) to 5 (‘a great deal’). Based on this 
question, two groups were identified, those who perceived themselves as forgetful but did 
not worry about it (a rating of 1, 2 or 3 on the 5-point scale was required; n=3,527) and 
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those who considered themselves as forgetful and were also worried about their 
forgetfulness (a rating of 4 or 5 on the 5-point scale was required; n=446). The third 
question asked the respondent if his or her memory complaints had increased during the 
last year. Again, five answers were possible, ranging from 1 (‘not at all’) to 5 (‘a great deal’). 
Again, two groups were created. The first group contained participants who perceived 
themselves as forgetful and whose forgetfulness had not increased much during the last year 
(a rating of 1, 2 or 3 on the 5-point scale was required; n= 3,586). The other group 
consisted of participants who perceived themselves as forgetful and whose forgetfulness had 
increased during the last year (a rating of 4 or 5 on the 5-point scale was required; n=254). 
 
Confounders 
Potential confounders that were taken into account included sex, age (grouped in two 
categories: people aged 55 to 69 and people aged 70 and over), education level (low, 
medium or high), current smoking status (smoker/nonsmoker), alcohol intake (excessive 
drinker: yes/no; excessive was defined as more than 21 glasses per week for men and more 
than 14 glasses per week for women), living arrangements (living alone: yes/no), exercise 
(persons who meet the Dutch Healthy Exercise Standard (Nederlandse Norm Gezond 
Bewegen) versus persons who did not meet this standard)18, healthy eating habits (persons 
who meet al of the standards regarding fruit, vegetable and breakfast consumption versus 
persons who did not meet any of these three standards). 
Because psychological distress is known to have a profound association with memory 
complaints, psychological distress was used in all statistical analyses to adjust for the effects 
of mood on subjective memory complaints. The questionnaire included ten questions that 
were based on the depression and anxiety subscales of the Kessler Psychological Distress 
Scale (K10)19. Its brevity, strong psychometric properties and ability to discriminate DSM-
IV psychological distress cases from non-cases make the K10 appropriate for use in health 
surveys. The K10 consists of ten items that were answered on a five-point Likert scale 
(where 5 = “all of the time” and 1 = “none of the time”). The possible total score ranges 
from 10 (no distress) to 50 (severe distress). Two groups were formed based on this score: 
namely, people with low/medium psychological distress and people with high psychological 
distress (i.e., a score of 30 or more). If responses to one or two questions were missing, 
imputation based on all participants’ average score on that particular question was 
conducted. Persons with three or more missing values on this questionnaire were excluded 
from the analyses. 
Statistical Analyses 
Multivariate logistic regression analysis was conducted to determine the capability of 
multimorbidity to predict subjective memory complaints. Next, two in-depth analyses were 
performed to obtain a more detailed view of the predictive capability of multimorbidity in 
participants who perceived themselves as forgetful. First, among people who perceived 
themselves as forgetful, multimorbidity as a prognostic factor for the degree of worrying 
about these memory complaints was evaluated. Second, among people who perceived 
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themselves as forgetful, multimorbidity as a predictor for increased subjective memory 
complaints perceived during the last year was investigated. 
Multimorbidity was conceptualized by a simple disease count. First, simple logistic 
regression models (unadjusted models), using only multimorbidity as a predictor, were 
separately conducted for all three outcome measures. Second, three multivariate analyses 
were conducted, including all confounders. Third, the model was expanded by including 
the relevant interaction terms. In all three analyses, interaction terms of (multi)morbidity 
with age and (multi)morbidity with sex were included because the predictive capability of 
multimorbidity for memory complaints was expected to differ between men and women 
and between age groups. Only the interaction terms that appeared significant are reported 
here. The multivariate analyses were conducted with corrections for sex, age, educational 
level, smoking status, alcohol intake, living arrangements, exercise, eating habits and 
psychological distress. Categorical confounders were coded into dummy variables. Potential 
confounders that were not significantly related to memory complaints were excluded from 
the final analyses (P-values > 0.05). The confounders of gender, age and education always 
remained in the final analyses, irrespective of significance. A stepwise backward method was 
employed using the statistical software package SPSS version 17. Only persons with no 
missing data were included in the analyses. Odds ratios (OR) and 95% confidence intervals 
(CI) are reported. P-values of 0.05 or less were considered statistically significant. 
RESULTS 
Descriptive characteristics of the 15,188 participants are shown in Table 1. More than 26% 
of the participants considered themselves forgetful, and more than 50% suffered from 
multimorbidity.  
In the unadjusted analyses, multimorbidity appeared to be a significant predictor of 
subjective memory complaints (see Table 2). In the interaction analyses, there was a 
significant two-way interaction between multimorbidity and age, indicating that the 
predictive capability of multimorbidity for subjective memory complaints was stronger in 
people aged 55 to 69 (OR: 2.08) than in people aged 70 and over (OR: 1.48) (see Table 3).  
The two-way interaction between multimorbidity with three or more diseases present 
and age was also significant (OR: 3.09 for people aged 55 to 69 and OR: 2.11 for people 
aged 70 and over). Interactions between morbidity and age and between multimorbidity 
and sex were not significantly related to the presence of subjective memory complaints. 
Psychological distress and healthy eating habits both appeared to be significant prognostic 
factors of subjective memory complaints. 
Among participants who perceived themselves as forgetful, suffering from 
multimorbidity appeared to be a significant predictor of a higher degree of worrying about 
subjective memory complaints (see Table 2). After adjustment for significant confounders, 
multimorbidity remained a significant predictor (see Table 3). In interaction analyses, no 
significant interactions with multimorbidity were detected. Psychological distress was 
indicative of a higher degree of worrying about subjective memory complaints (see table 5). 
 
Multimorbidity and subjective memory complaints 
 - 23 -
Table 1. Descriptive characteristics of the study population (N = 15,188) 
Characteristics  
People aged 55 to 69 (%) 7556 (49.7) 
Gender (% females)  8063 (33.1) 
Perceived forgetfulness (% yes) 3976 (26.2) 
Educational level   
 Low 3893 (25.7) 
 Medium 8194 (53.9) 
 High 2047 (13.5) 
(Multi)morbidity score diagnosed by a medical doctor (%)  
    0 4067 (26.8) 
    1 3392 (22.3) 
    2 2502 (16.5) 
    ≥ 3 5227 (34.4) 
Excessive alcohol drinker (% yes)  1176 (7.7) 
Smoking (% yes) 2567 (16.9) 
Exercise (% meet the norm)  8595 (56.6) 
Eating habits (% meet all 3 norms)  2296 (15.1) 
Living arrangement (% living alone) 3882 (25.6) 
Psychological distress (% high risk)  983 (6.5) 
Mean age was 70 (age ranged from 55 to 90 years) │Educational level: wow is defined as primary school, 
lower medium or lower vocational education; medium as secondary school and/or medium level vocational 
education; high as higher vocational education or university degree. For 6.9% of individuals this 
information was missing. │ Excessive alcohol drinker: >21 glasses per week (men) or > 14 glasses per week 
(women) │ Eating habits: meeting all three norms for fruit, vegetable and breakfast consumption.  
 
Table 2. Uncorrected relations between (multi)morbidity and memory complaints, degree of worry 
about memory complaints and the increase of memory complaints perceived during the last year 
(odds ratio and 95% CI). 
 Memory complaints 
 
Degree of worry about 
memory complaints  
Memory complaints 
during the last year  
(Multi)morbidity     
 1 disease 1.29 (1.12 – 1.47)** 1.42 (0.94 – 2.17) 1.48 (0.87 – 2.52) 
 2 diseases 1.78 (1.55 – 2.05)** 1.00 (0.63 – 1.59) 1.13 (0.64 – 2.01) 
 ≥ 3 diseases 3.02 (2.68 – 3.39)** 2.65 (1.87 – 3.74)** 2.28 (1.46 – 3.54)** 
* p < .05; ** p < .01 │The reference group consisted of people with none of the included medical 
conditions 
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Table 3. Corrected relations between (multi)morbidity and memory complaints, degree of worry 
about memory complaints and the increase in memory complaints perceived during the last year 
(odds ratio and 95% CI corrected for age, sex, education and psychological stress). 
 Memory complaints 
 
Degree of worry about 
memory complaints  
Memory complaints 
during last year  
(Multi)morbidity    
 1 disease 1.2 (1.05 – 1.38)** 1.35 (0.88 – 2.07) 1.32 (0.77 – 2.281) 
 2 diseases 1.65 (1.43 – 1.90)** 0.97 (0.61 – 1.56) 1.04 (0.58 – 1.87) 
 ≥ 3 diseases 2.34 (2.07 – 2.64)** 1.93 (1.35 – 2.76)** 1.33 (0.84 – 2.11) 
* p < .05; ** p < .01 │ The reference group consisted of people with none of the included medical 
conditions 
 
Table 4. Relation between (multi)morbidity and memory complaints in the full study sample 
(corrected odds ratio and 95% CI resulting from logistic regression analyses) 
 Memory complaints (yes vs. no) 
Age  1.04 (1.03 – 1.04)** 
Sex 0.84 (0.76 – 0.91)** 
(Multi)morbiditya  
    1 disease 1.19 (1.04 – 1.37)* 
    2 diseases 1.61 (1.39 – 1.86)** 
    ≥ 3 diseases 2.28 (2.01 – 2.58)** 
Educational levelb  
 Medium 0.87 (0.78 – 0.97)** 
 High 0.86 (0.738– 0.99)* 
Excessive alcohol drinker  0.99 (0.84 – 1.18) 
Smoking  1.01 (0.88 – 1.15) 
Exercise  1.02 ( 0.93 – 1.12) 
Eating habits 0.68 (0.60 – 0.77)** 
Living arrangement 1.10 (0.99 – 1.23) 
Psychological distress 2.67 (2.24 – 3.17)** 
Interactiona   
    Age * multimorbidity (2 diseases) 0.71 (0.53 – 0.95)* 
    Age * multimorbidity (> 3 diseases) 0.68 (0.54 – 0.87)** 
* p < .05; ** p < .01 │ Note: 0= no memory complaints 1= memory complaints; 1= male, 2= female a 
reference group consisted of people with none of the included medical conditions │ b Reference group 
consisted of people with low education 
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Table 5. Relations between (multi)morbidity and the degree of worry about memory complaints and 
the increase of memory complaints during the last year among participants who perceived themselves 
as forgetful (corrected OR and 95% CI resulting from logistic regression analyses) 
 Degree of worry about memory 
complaints 
(n=3,598) 
Increase memory complaints 
during last year 
(n=3,441) 
Age 1.28 (1.01 – 1.62)* 0.66 (0.48 – 0.91)* 
Sex 1.22 (0.98 – 1.53) 3.13 (1.14 – 8.62)* 
(Multi)morbiditya   
   1 disease 1.35 (0.88 – 2.07) 2.37 (0.84 – 6.65) 
   2 diseases 0.97 (0.61 – 1.56) 2.72 (0.97 – 7.66) 
   ≥ 3 diseases 1.93 (1.35 – 2.76)** 2.96 (1.16 – 8.62)* 
Educational levelb   
   Medium 0.79 (0.62 – 1.01) 1.03 (0.76 – 1.40) 
   High 1.05 (0.72 – 1.54) 0.90 (0.52 – 1.56) 
Excessive alcohol drinker  0.77 (0.42 – 1.40) 1.16 (0.96 – 1.42) 
Smoking  1.05 (0.73 – 1.52) 0.88 (0.56 – 1.38) 
Exercise  0.86 (0.67 – 1.13) 0.51 (0.38 – 0.70)** 
Eating habits 0.60 (0.350- 1.02) 0.58 (0.32 – 1.02) 
Living arrangement 1.20 (0.91 – 1.59) 1.13 (0.80 – 1.60) 
Psychological distress 4.89 (3.82 – 6.24)** 5.17 (3.81 – 7.02)** 
Interactiona    
    Sex * multimorbidity 
    (2 diseases) 
NS 0.21 (0.06 – 0.76)* 
   Sex * multimorbidity 
    (3 diseases) 
NS 0.301 (0.10 – 0.88)* 
NS= not significant and therefore omitted │ Note: 0= low degree of memory complaints, 1= high degree of 
memory complaints │ │ 0= small increase last year, 1= large increase last year  1= male, 2= female. * p < .05; 
** p < .01 │a Reference group consisted of people with none of the included medical conditions │b 
Reference group consisted of people with low education 
 
Among participants who perceived themselves as forgetful, multimorbidity appeared to be a 
significant predictor for reporting increased memory complaints during the last year (see 
Table 2). However, when corrected for the presence of depressive symptoms, 
multimorbidity did not remain a significant predictor of the degree of increase in memory 
complaints during the last year (see Table 3). There was a significant two-way interaction 
between multimorbidity and sex, indicating that the predictive capability of multimorbidity 
(i.e., multimorbidity 2) was higher among men (OR: 2.72) than among women (OR: 1.79) 
(see Table 5). Moreover, there was a significant two-way interaction between 
multimorbidity (i.e., multimorbidity 3 or higher) and sex (OR: 2.96 for men and OR: 1.12 
for women). Interaction terms between morbidity and sex and between multimorbidity and 
age were not significantly related to an increase in memory complaints during the last year.  
Psychological distress and exercise both appeared to be significant prognostic factors of 
subjective memory complaints. Living arrangements, alcohol consumption, smoking 
behavior, and exercise did not significantly contribute to any of the three outcome measures 
and were therefore removed from all statistical analyses. 
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DISCUSSION 
The primary aim of the study was to assess the predictive capability of multimorbidity for 
subjective memory complaints in community-dwelling older adults aged 55 and over living 
independently in Limburg, the Netherlands. The results indicate that multimorbidity can 
indeed act as a predictive factor for subjective memory complaints. The predictive 
capability of multimorbidity for self-perceived forgetfulness was higher among people aged 
55 to 69 than among people aged 70 and above. 
In participants who suffered from three or more co-occurring chronic diseases and who 
perceived themselves as forgetful, multimorbidity was a significant predictor of the degree 
of worrying about subjective memory complaints. This finding indicates that 
multimorbidity was indeed indicative of a higher degree of worrying about one’s self-
perceived forgetfulness. 
Among participants who perceived themselves as forgetful, multimorbidity appeared to 
be a significant predictor of the degree of increase in memory complaints during the last 
year. However, when corrected for psychological distress, this association disappeared. Men 
who perceived themselves as forgetful and who suffered from multimorbidity reported a 
larger increase of their memory problems during the last year than did women who 
perceived themselves as forgetful and suffered from multimorbidity. 
This is the first study that aimed to assess the predictive capability of multimorbidity 
for subjective memory complaints. Several explanations for the predictive capability of 
multimorbidity could be brought forward. First, in patients suffering from multimorbidity, 
self-reported memory complaints may reflect a real decline in objective memory 
performance, which may be mediated by poor health status. Unexpected common 
pathogenetic mechanisms, such as autoimmune responses, genetics, inflammation and/or 
immunological mechanisms, might contribute to this association. Some studies did find an 
association between the total number of morbid conditions and poor performance on 
memory tests13,20. Second, a patient’s knowledge that he or she is suffering from multiple 
medical conditions may change his or her subjective assessment of other health-related 
problems. People who are suffering from multimorbidity may tend to overestimate the risk 
of acquiring more health-related conditions, which may, among other consequences, result 
in more complaints and a higher degree of worrying about their self-perceived 
forgetfulness21. Third, it could be argued that memory complaints are completely secondary 
to psychological distress, which may influence a person’s evaluation of their memory 
functions. However, after controlling for psychological distress, multimorbidity remained a 
significant predictor of subjective memory complaints. 
The question remains of why the predictive capability of multimorbidity for subjective 
memory complaints is stronger among people aged 55 to 69 than among people aged 69 
and over. Younger people may still be active in professional activities and managing a 
workload and may therefore perceive more direct hindrance due to their forgetfulness in 
daily life. Hence, older individuals might evaluate their memory complaints as being more 
common than do younger individuals who are confronted with age-related memory 
complaints at an earlier stage in life22. 
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In short, attention should be paid to the physical as well as the cognitive consequences of 
multimorbidity. Early identification and monitoring of people with multimorbidity could 
provide opportunities for controlling the negative health-related consequences of 
multimorbidity, including subjective memory complaints. Older patients with an increased 
probability of subjective memory problems, possibly mediated by a poor morbidity status, 
may be identified by routinely inquiring about memory complaints. Early inquiry is 
especially important in those patients suffering from three or more diseases and those in 
whom memory complaints are indeed a consequence of objective memory decline. These 
patients can then be monitored appropriately, including by a general practitioner3. If 
objective memory performance is found to be normal, patients need to be reassured that 
their worry is unfounded and that their forgetfulness can be ascribed to normal 
forgetfulness, which tends to increase with age. Psychosocial interventions aimed at 
reducing psychological distress related to these complaints may be beneficial for people 
with subjective memory complaints23. 
Another finding of the current study was that participants who perceived themselves as 
forgetful and who suffered from high psychological distress worried more about their 
reported memory problems and reported a larger increase in these problems during the last 
year as compared to persons with lower psychological distress. These findings are in line 
with previous research that claims that anxiety and psychosocial stress may affect both 
patients’ perception of their own memory performance and their objective memory 
performance 7, 24. Because self-observations of memory decline may also lead to depressive 
feelings, the relationship between depressive feelings and subjective memory complaints 
may be a reciprocal one 25. 
Two other intriguing findings were present in this study. First, persons who met the 
norm for healthy eating (i.e., the norm for vegetables, fruit or breakfast consumption) had a 
lower risk of reporting memory complaints. Moreover, people who met the standard for 
exercise had a lower risk of reporting increased memory complaints during the last year. 
This result is in accordance with previous research indicating that a healthy eating pattern 
and sufficient exercise are related to a variety of profitable health-related outcomes, 
including a lower risk for diabetes mellitus type II26 and cancer27. 
One of the strong points of this study was its use of data based on a large number of 
participants aged 55 years and over living in the community. Consequently, the results are 
representative for community-dwelling older individuals and are therefore more 
generalisable than results of studies conducted in more homogeneous populations28. 
Furthermore, several relevant health-related factors have been used to control for possible 
confounding. 
Despite these strengths, our findings must be interpreted in light of some possible 
limitations. First, multimorbidity was conceptualized based on participants’ self-reports, 
which could have compromised the validity of these data. Although self-reported morbidity 
status has been shown to correlate reasonably well with medical records, the oldest old (i.e., 
people aged 90 and over) tend to under-report certain diagnosed medical conditions29. 
Secondly, the present study did not control for the presence of Mild Cognitive Disorder or 
dementia in participants. Because participants were required to be cognitively intact to fill 
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in the questionnaire, the percentage of participants with sincere objective memory 
problems is expected to be small. Third, the present study is of a cross-sectional nature, 
which means that no conclusions can be drawn regarding the longitudinal effects of 
multimorbidity on subjective memory complaints. Because memory complaints due to 
health status are likely to develop over the course of many years, ideally the underlying 
process should be investigated longitudinally. Hence, a well-conducted longitudinal study 
with adequate control for confounding factors is warranted to evaluate the effects of 
multimorbidity on the evolution of subjective memory complaints. Future research should 
also explore the role of multimorbidity as assessed by using a more objective approach, such 
as a general practice database that incorporates all medical diseases diagnosed by a general 
practitioner. It might be argued that the predictive capability of multimorbidity as assessed 
by a more objective approach is less strong than that found in the present study. 
In conclusion, our findings indicate that multimorbidity and subjective memory 
complaints are both common in a population of older adults and appear to be related. 
Taking into account previous research that suggested that subjective memory complaints 
may be related to future memory decline, the present results may have implications for 
clinical practice in an aging population. To protect people’s quality of life and to save a 
considerable amount in health care expenditures, adequate early intervention programs to 
ameliorate the negative health-related consequences of multimorbidity are called for. 
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ABSTRACT 
Background 
Multimorbidity has risen considerably because of the increase in longevity and the rapidly 
growing number of older individuals. Today, only little is known about the influence of 
multimorbidity on cognitive decline in a normal healthy aging population. The primary 
aim of the present study was to investigate the effect of multimorbidity on cognitive 
functioning over a 12 year period in an adult population with a large age range. 
Methods 
Data were collected as part of the Maastricht Aging Study (MAAS), a prospective study 
into the determinants of cognitive aging. Eligible MAAS participants (N=1.763), aged 24–
81 years, were recruited from the Registration Network Family Practices which enabled the 
use of medical records. The association between 96 chronic diseases, grouped into 23 
clusters, and cognitive functioning on baseline and at 6 and 12 years of follow-up were 
analyzed. Cognitive performance was measured in two domains: verbal memory and 
psychomotor speed. A multilevel statistical analysis, a method that respects the hierarchical 
data structure, was used. 
Results 
Multiple clusters of chronic medical conditions were associated with cognitive decline 
during a 12-year follow-up period in a healthy adult population. Apart from the disease 
combination malignancies and movement disorders multimorbidity appeared not to 
significantly affect cognition. 
Conclusions 
The current results indicate that morbidity status adversely affects cognitive functioning. 
However, the effects of morbidity and multimorbidity status on cognitive decline appear to 
be small in a normal healthy aging population. 
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INTRODUCTION 
In today’s society, the occurrence of (multiple) chronic medical conditions has risen 
considerably because of the increase in longevity and the rapidly growing number of older 
individuals. Various prevalence estimates of multimorbidity, a term used to describe the co-
occurrence of two or more chronic conditions within one person1, have been reported, 
ranging from 30%2, 62%3 to over 68%4 of the population under study. (Multi)morbidity is 
associated with several poor outcomes such as: activity limitations5, decreased health related 
quality of life 6 and impaired cognitive functioning7. Several studies have suggested that 
impaired health status may enhance cognitive decline in normal aging but may also 
enhance pathological cognitive aging 7, 8. 
Various single disease entities have already been related to a decrease in cognitive 
performance. Evidence to date suggests that disorders such as diabetes mellitus type I and 
II9, cardiovascular diseases10, stroke11 and peripheral atherosclerosis12 may all be associated 
with decreased cognitive functioning. In addition, several diseases are also known to 
enhance the development of dementia8. For example, after a ischemic stroke, dementia 
develops in approximately 25% of patients13. Moreover, another study concluded that the 
attributable risk of diabetes for dementia is 8.8 percent14. 
Several studies focused on the relationship between a specific chronic medical 
condition and cognition, which most often implies the exclusion of persons with co-
morbid diseases12. Since research suggests that up to 68 percent of persons in a hospital 
setting suffer from multimorbidity15, studies limited to persons with only one single disease 
entity may therefore be less representative. Moreover, it has been suggested that in a 
geriatric population cumulative illness is associated with more enhanced cognitive decline 
compared to elderly with one single diseases15. The majority of the studies that focussed on 
the relationship between morbidity and cognition have been cross-sectional9,15. However, 
since cognitive decrements due to health status are likely to develop over the course of 
many years, ideally the underlying process should be investigated longitudinally. In most 
cases, longitudinal studies included only a small number of participants7 or were limited to 
specific population samples, such as older persons12 or patients admitted for clinical 
rehabilitation12, 15. Therefore, it is unclear how multimorbidity affects cognitive functioning 
in a normal aging adult population. Furthermore, since most studies did not include 
younger participants, it is unclear to what extent these people experience cognitive decline 
which may be mediated by their health status. 
So far, research involving the association between morbidity and cognition was mainly 
restricted to evaluate only a few chronic medical conditions. In a longitudinal study with 
six years of follow-up, the influence of seven somatic chronic diseases on changes in 
cognitive functioning was studied in persons aged 62 to 85 years12. However, in order to 
specify the differential effects of various medical conditions on cognitive functioning, it is 
necessary to evaluate a greater variety of medical conditions. Furthermore, most studies 
reporting on the association between morbidity and cognition were based on self-reported 
morbidity status12. As the agreement between self-reports as medical records tends to 
weaken in older age groups16, this is highly problematic when studying the effects of 
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multimorbidity in older persons. Moreover, in patients suffering from multiple medical 
conditions, the agreement between self-reports and medical records also tends to be lower17. 
Hence, medical records from general practitioners (GPs) may provide more valid data on 
prevalent morbidity, especially in countries such as the Netherlands, were GPs are the 
gatekeepers to other health care facilities, thus having a comprehensive view of their 
patient’s health status. 
The primary aim of the present study was to investigate the effect of (multi)morbidity 
on cognitive functioning, measured by established neurocognitive tests, in an adult 
population with a wide age range. A longitudinal study was conducted over a 12-year 
period, in order to evaluate the effect of 96 chronic medical conditions, grouped into 
clusters, on cognitive functioning. 
METHODS 
The present study was conducted on data gathered in two projects: The Registration 
Network Family Practices (RNH) and the Maastricht Aging Study (MAAS). MAAS is a 
prospective study of determinants of usual cognitive aging18. Participants of MAAS were 
recruited from the Registration Network Family Practices (Registratie Netwerk 
Huisartspraktijken, RNH), which contains demographic and health information of over 
120.000 patients inhabited in the South of Limburg, the Netherlands19. 
Maastricht Aging Study (MAAS) 
In 1992, 10.396 people were recruited from the RNH database of whom 4.490 were 
willing to participate (43.2%), 3.531 refused participation (34%), and 2.375 did not 
respond (22.8%). Since MAAS’ primary aim was to investigate healthy aging, participants 
were excluded from baseline participation when medical records from the RNH database 
contained the following conditions known to interfere with cognition: history of coma, 
cerebrovasculair disorder, tumour of the nervous system, congenital malformation of the 
nervous system, multiple sclerosis, Parkinsonism, epilepsy, dementia, organic psychosis, 
schizophrenia, affective psychosis or mental retardation. The 4,490 eligible participants 
were screened by telephone for medical conditions not documented in the RNH database 
(history of transient ischemic attack, brain surgery, haemodialysis for renal failure, 
electroconvulsive therapy or daily psychotropic drug use). Of the remaining 4,189 
participants (301 were excluded based on the telephone screening), 1,823 (aged 24 to 81 
years at baseline) were randomly selected, stratified for age (12 discrete groups between 24 
and 81 years of age at baseline), sex and occupational achievement (2 levels). 
Registration Network Family Practices (RNH) 
The morbidity status of all MAAS participants at baseline, 6- and 12-year follow-up was 
retrieved from the RNH database. The RNH is a continuously updated database, which 
contains the medical records of patients from 21 family practices in which 65 general 
practitioners (GPs) working in the south of the Netherlands are participating. This 
database includes all relevant current and past health problems. A health problem was 
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defined as ‘anything that has required, does or may require health care management and 
has affected or could significantly affect a person’s physical or emotional well-being 20. A 
diagnosis is made by the GP or by a medical specialist to whom a patient may be referred. 
Especially in complex medical conditions, registration is often based on a specialist 
diagnosis reported to the GP. The RNH database contains health problems which are only 
coded by the GP when they are permanent (no recovery expected), chronic (duration 
longer than 6 months) or recurrent (more than three recurrences within 6 months), or 
when they have lasting consequences for the functional status or prognosis of the patient. 
Problems are coded in a standardized fashion, according to the International Classification 
of Primary Care (ICPC)21, using the criteria of the International Classification of health in 
Primary Care (ICHPPC-2) and other more current guidelines of the Dutch College of 
GP’s. The database also contains background information about the patient’s sex, date of 
birth, marital status, living arrangement and level of education. Membership of the RNH 
registry ends by migration or death. All patients included in the RNH database have been 
informed about the potential anonymous use of their health information. If a patient does 
not agree with the use of his/her health information, the inclusion of this patient in the 
RNH database can be stopped. The quality of the data is ascertained by ample instruction 
and training sessions, regular regional consensus groups, quality control audits, an online 
thesaurus available during data-entry and systematic control for erroneous or missing 
entries. Sociodemographical characteristics of samples in other studies which made use of 
the RNH database have been shown to be comparable to the Dutch population22. 
Outcome Measures 
Two representative neuropsychological tests were used to assess the cognitive domains of 
memory and processing speed at all three measurements points. 
 
Visual Verbal Learning test 
The Visual Verbal Learning test (VVLT) is the Dutch version of the Rey VVLT, which 
measures the ability to learn new verbal information and retrieve information from memory 
23. Fifteen monosyllabic words were visually presented one at a time on five consecutive 
trials. Participants were asked to recall as many words as possible, with no restriction 
concerning the order of recall (immediate recall). After a 20 minutes delay, participants 
were again asked to recall as many correct words as possible (delayed recall). This was 
followed immediately by a recognition test, involving the previous seen fifteen words 
intermixed with fifteen new words23. The latter score (ranging from 0 to 15) was used as 
outcome measure. Parallel versions of the memory tasks were used for each assessment. 
 
Letter Digit Substitution Task 
The Letter Digit Substitution Task (LDST) is used to measure complex information 
processing under time pressure 24, 25. A sheet with letters, each matched to its own number 
(1 to 9) was presented to the participant. Participants were asked to match as much letters 
and numbers as possible in 90 seconds, by filling in the right numbers belonging to the 
right letters. The total number of filled in numbers was used as outcome measure. 
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Independent Variables 
Based on either previously conducted studies or from clinical experience, 96 chronic 
medical conditions with (possible) high prevalence and/or potential to impact brain 
functioning were included in the analyses, namely: malignancies, movement disorders, 
chronic respiratory diseases, cardiovascular diseases (heart failure, ischemic diseases, 
arrhythmias and cerebrovascular diseases), endocrine diseases, neurological disturbances and 
psychological disorders. The medical conditions on which exclusion for MAAS 
participation was based were also included in order to monitor possible occurrences after 
baseline. 
Beforehand, single morbidity codes were combined into clusters of morbidities by 
three experts (MvdA, MvB, JM), including 2 medical doctors (MvB, JM), to limit the 
number of independent variables. Some morbidity codes were not clustered because they 
were highly prevalent and/or because their effect on cognition has been well documented 
(diabetes mellitus, dementia and Parkinsonism). A list of all ICPC codes and the clustering 
of these ICPC codes is presented in Appendix I. Note that one person can belong to two or 
more clusters when diagnosed with multiple medical conditions. Moreover, a person can be 
diagnosed with more than one disease in one cluster. Instead of coding each cluster as either 
being present or absent in a participant, time in years since diagnosis was incorporated in 
order to take disease duration into account. If a person was diagnosed with more than one 
disease within one cluster, the cluster was coded with the first date of a diagnosis. The 
reference group consisted of all participants without any of the 96 diseases. The overall 
morbidity status of all MAAS participants was assessed by looking at the (present and past) 
medical records retrieved from the Registration Network Family Practices providing info at 
baseline and at 6 and 12 year follow-up. 
Possible Confounders 
Potential confounders were taken into account: gender, age, education level measured on a 
8-point ordinal scale (ranging from primary education to university degree)26, smoking 
behaviour at baseline (yes or no), alcohol intake at baseline (number of alcoholic units 
consumed per week) and living arrangements in three categories (living with family, living 
alone, living in a home for the elderly). Self-reported depression as assessed by the SCL-90 
was inserted as a possible confounding factor27.  
Total morbidity score (in 6 categories, ranging from no disease present to 6 or more 
diseases present) was assessed by calculating the total number of chronic diseases per 
individual in the RNH database. Total cluster score (in 6 categories, ranging from no 
cluster of diseases present to 6 or more clusters present) was assessed by looking at the total 
number of clusters in which patients had at least one disease. 
Statistical Analyses 
As the independent variables (20 clusters and 3 separate chronic medical conditions) and 
the outcome measures (cognitive functioning at two neuropsychological tests) were 
measured three times during 12 years, data were analyzed with Linear Mixed Models. This 
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procedure respects the hierarchical structure of longitudinal data28. Since measurements 
within subjects of this study are more alike than measurements between subjects, there is 
correlation between the repeated measurements. This within-subjects variation that 
accounts for changes within each subject through repeated measurements in time and the 
between-subjects variation accounting for differences between the subjects performance, 
can be established by a multilevel approach 28. Moreover, in a multilevel approach, 
participants with missing observations are retained in the analysis.  
The missing observations are supposed to be Missing At Random. The interpretation 
of the regression parameters obtained in a multilevel approach is comparable to that of the 
(one-level) multiple linear regression. As previously stated the dependent variables were 
measured three times during 12 years (baseline, 6 year follow-up and 12 year follow-up). At 
baseline, 6 and 12 years follow-up the independent variables (i.e. medical status) were 
retrieved from the RNH database. However, since reporting the results of the 6 year follow-
up will decrease the comprehension of the present study, only the results at 12 year follow-
up will be reported. 
The multilevel models included fixed terms for follow-up (time of measurement), age, 
gender, education, smoking behaviour, alcohol intake, living arrangements, total morbidity 
score and total cluster score. Total morbidity score and total cluster score were always tested 
in separate models. A covariate was included in the model if it significantly influenced the 
cognitive domain under study (p < 0.05). In order to limit the number of variables in a 
multilevel model, each cluster (and the 3 separate medical conditions) was evaluated 
separately using a univariate analysis, resulting in 23 analyses for each cognitive domain. 
The effect of multimorbidity on cognitive function was investigated by studying cluster 
interactions. Seven clusters of chronic diseases were selected, based on prevalence and their 
significant effect on cognition. First, these seven clusters were evaluated using a multivariate 
analysis using a backward-method. Next, clusters that appeared significant in this 
multivariate analysis were used in order to analyze two-way interactions, in order to 
evaluate the effects of multimorbidity on cognition. All analyses were conducted with the 
SPSS statistical software package version 16.0 for Windows (SPSS Inc., Chicago, IL, USA). 
P-values of 0.05 or less were considered statistically significant. 
RESULTS 
Descriptive characteristics of the study sample are reported in Table 1. The data set 
contained 4196 measurements among 1763 participants. The sample size differed between 
the three measurements which is due to drop out (i.e. migration, death). At baseline, the 
average age was 55.4 years with slightly more women (50.4) than men. Multimorbidity was 
present in 55.9% of the participants.  
Higher education was associated with a significant better performance of memory 
(P<.001) and processing speed. Higher age negatively influenced memory and processing 
speed (P<.001) and women scored significantly higher than men in both cognitive domains 
(respectively, P<.001 for memory and P<.002 for processing speed). Depressive complaints, 
as measured with the Symptom checklist, were associated with impaired memory (P=.013) 
and speed (P<.001). Smoking and alcohol consumption, living arrangements, total 
Chapter 3 
 - 38 -
morbidity score and total cluster score appeared not to affect cognition significantly, and 
were therefore dropped from all the analyses. 
Multiple clusters appeared to be significantly related to cognition (Table 2). 
Malignancies were related to a lower performance on both cognitive measures as was the 
ischemic diseases cluster and arrhythmias/heart failure. A lower performance on both 
cognitive measures was also found among persons with asthma/Chronic Obstructive 
Pulmonary Disease (COPD)/bronchitis and among persons with gastro-intestinal diseases. 
Peptic ulcers, diseases of the ear, other cardiovascular diseases, movement disorders, mood 
disorders, other mental disorders, endocrine diseases or diseases of the urinary tract 
significantly decreased performance on the processing speed task but not on the verbal 
memory task. In contrast, Parkinsonism and eczema/psoriasis/chronic skin ulcer was 
negatively associated with verbal memory, but not with processing speed. Migraine and 
headache, other diseases of the nervous system and other chronic respiratory diseases were 
not associated with neither of the two cognitive functions. 
The following seven clusters were selected in order to investigate the influence of cluster 
combinations (i.e. multimorbidity) on cognitive decline: cerebrovasculair diseases, cardiac 
diseases, malignancies, movement disorders, asthma/COPD/ bronchitis, endocrine diseases 
and diabetes mellitus. Since the medical conditions in the cluster ischemic diseases and in 
the cluster other cardiovascular diseases are rather comparable these two clusters were 
regrouped into one cardiac disease cluster. Consequently, the prevalence of the cardiac 
cluster was larger than the prevalence of the two individual clusters which resulted in a 
more robust cardiac cluster.  
In the multivariate analyses only the cardiac cluster and malignancies were associated 
with a significant lower verbal memory performance (see Table 3). Cerebrovascular 
diseases, cardiac diseases, malignancies and movement disorders were all significantly 
related to a decrease in processing speed. Hence, these four clusters, namely 
cerebrovasculair diseases, malignancies, movement disorders and cardiac disease, were 
selected in order to evaluate the effects of combinations of clusters, and thus of 
multimorbidity, on cognition in univariate models. 
Since only two disease clusters were related to verbal memory in the multivariate 
model, only one cluster combination, cardiac diseases and malignancies, was evaluated for 
verbal memory in a univariate model. The interaction of these two disease clusters appeared 
not to be significantly associated with cognitive decline. Since four disease clusters appeared 
to significantly affect processing speed in the multivariate model, six cluster combinations 
were separately investigated in univariate analyses. As displayed in Table 4, only the cluster 
combination malignancies and movement disorders was related to a faster decline in 
processing speed. 
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Table 1. Descriptive characteristics of the study population (N=1763)  
Characteristics (baseline) 
Follow-up (# of participants)  
    Baseline 1,763 
    6 year 1,310 
    12 year 1,123 
Mean age in years (SD)a  55.4 (15.9) 
Gender (% females)  886 (50.3) 
Total morbidity score (%)  
    0 404 (22.9) 
    1 374 (21.2) 
    2 ≥  985 (55.9) 
Total cluster score (%)  
    0 404 (22.9) 
    1 427 (24.2) 
    2 ≥ 932 (52.9) 
Days per week of alcohol intake (%)b  
    1 467 (26.5) 
    2 543 (30.8) 
    3 180 (10.2) 
    4 78 (4.4) 
    5–7 172(9.8) 
Educational Levelc  
   Low (%) 650 (36.9) 
   Medium (%) 712 (40.4) 
   High (%) 399 (22.6) 
Living arrangement  
   Living with family (%) 1490 (84.5) 
   Living alone (%)  235 (13.3) 
   Home for the elderly/commune (%)  8 (0.5) 
   Unknown/others  30 (1.7) 
SCL-90 Depressive symptom score (SD)d  23.1 (8.6) 
Smoking (% NO) 1250 (70.9) 
a Mean age on June 15, 1993 │ b For 323 (18.3%) people this information was missing │ c For 2 people 
this information was missing; low is defined as primary school and/or lower vocational education, medium 
as secondary school and/or medium level vocational education, high as higher vocational education or 
university degree. │ d Mean score on the SCL-90 subscale depressive complaints 
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Table 2. Regression coefficients describing the relation between morbidity clusters and cognitive 
function (corrected for age, sex, education and depressive complaints)  
 Verbal memory Processing speed N 
All malignancies -0.047** -0.341** 135 
Peptic ulcers -0.233 -0.210** 35 
Other gastro-intestinal diseases -0.037* -0.226** 94 
Diseases of the eye -0.067* -0.330** 34 
Diseases of the ear -0.024 -0.123* 65 
Ischemic diseases -0.061** -0.370** 130 
Pulmonary embolism and phlebitis -0.036 -0.246** 43 
Cerebrovascular diseases -0.074* -0.467** 66 
Arrhythmias & heart failure -0.052** -0.261** 108 
Other cardiovascular disease -0.054 -0.227* 96 
Movement disorders -0.017 -0.087** 318 
Parkinsonism -0.536* -0.698 5 
Migraine & Headache 0.004 -0.065 41 
Other diseases of nervous system -0.021 -0.078 12 
Mood disorders -0.220 -0.234** 57 
Alzheimer -6.220** -7.021** 5 
Other mental disorders -0.005 -0.144** 53 
Asthma, COPD and bronchitis -0.020* -0.078** 114 
Other chronic respiratory diseases -0.010 -0.052 125 
Eczema, psoriasis chronic skin ulcer  -0.028** -0.065 82 
Endocrine diseases -0.018 -0.160** 169 
Diabetes mellitus (Type I and II) -0.052** -0.341** 101 
Diseases of the urinary tract -0.230 -0.117* 44 
 * p │≤ 0.05 ** p ≤ 0.01 N refers to the number of participants at 12 years follow-up 
 
Table 3. Regression coefficients of clusters in multivariate analyses (corrected for age, sex, education 
and depressive complaints) 
 Verbal 
memory 
Processing 
speed 
N 
 
Cerebrovascular diseases NS -0.262** 66 
Cardiac diseases -0.047** -0.183** 180 
Malignancies  -0.038** -0.213** 135 
Movement disorders NS -0.062* 318 
Asthma/COPD/bronchitis NS NS 114 
Endocrine diseases NS NS 169 
Diabetes Mellitus NS NS 101 
 * p │ │≤ 0.05 ** p ≤ 0.01  NS = not significant N refers to the umber of participants at 12 years follow-up 
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Table 4. Regression coefficients of cluster combinations in univariate analyses (corrected for age, sex, 
education and depressive complaints) 
 Verbal 
memory 
Processing 
speed 
N 
 
Cardiac diseases * malignancies NS NS 40 
Malignancies * movement disorders NA -0.012* 53 
Malignancies * cerebrovascular diseases NA NS 16 
Cerebrovascular diseases * movement disorders NA NS 32 
Cerebrovascular diseases * cardiac diseases NA NS 29 
Movement disorders * cardiac diseases NA NS 84 
* p │ │≤ 0.05 ** p ≤ 0.01  NA = non applicable v NS = not significant  N refers to the number of 
participants at 12 years follow-up 
DISCUSSION 
This study was conducted to evaluate the differential longitudinal effects of 96 chronic 
diseases, grouped into clusters, on cognition in a healthy aging population. The present 
results indicate that specific clusters of chronic diseases indeed were associated with a 
decline in one or both tested domains of cognitive functioning during a 12 year follow-up 
period. 
The rate of decline on verbal memory and processing speed during the 12 years follow-
up period was higher among diabetes patients, which is in line with previous studies9, 12. 
Although the RNH database does not make a clear distinction between type I and type II 
diabetes mellitus, only 11 out of 101 (10.9%) diabetes patients (at 12 year follow-up) were 
diagnosed with diabetes before the age of forty. Hence, it can be stated that the conclusion 
drawn about the association between diabetes mellitus and cognition is primarily based on 
people diagnosed with diabetes mellitus type II. Other endocrine diseases appeared to be 
negatively related to processing speed, but not to verbal memory. 
Ischemic heart disease and arrhythmias/heart failure were both negatively related to the 
two domains of cognitive functioning. Previous studies on the relationship between 
cardiovascular diseases and cognition have shown mixed results; some studies found no 
association9, while others found a negative association10,29. Other cardiovascular diseases, 
including hypertension and other peripheral vascular diseases, were only negatively 
associated with processing speed, which is in accordance with previous cross-sectional 
research9. Our findings also support the evidence for a negative association between 
cerebrovasculair disease and cognitive performance11. We found evidence of a decline on 
both cognitive domains among persons with malignancies. Previous research regarding this 
association is inconclusive. While some studies reported a negative association30, Comijs et 
al (2009) even reported a positive association between cancer and memory (delayed 
recall)12. 
Interestingly, the rate of memory and speed decline was higher among persons with 
gastro-intestinal diseases. A negative association between asthma/COPD/bronchitis and 
both cognitive domains was also found, which is in accordance with previous study on the 
association between COPD31/chronic bronchitis9 and cognitive decline. Persons with 
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peptic ulcers were more prone to show a decline in processing speed as compared to healthy 
controls. Diseases of the urinary tract were also significantly related to processing speed. In 
contrast, being diagnosed with eczema/psoriasis/chronic skin ulcer only decreased one’s 
performance on verbal memory. 
Mood disorders as well as other mental disorders (including anxiety and schizophrenia) 
were only related to speed of processing. Contradictory, previous studies illustrated mood 
disorders to be related to numerous cognitive domains, including memory, speed, executive 
functioning and verbal fluency32. The lack of an association between mood disorders as well 
as other mental disorders and memory might be due to the fact that persons in the present 
study were a relatively healthy group, with no overt clinical signs of mental disorders (at 
baseline). It could be agued that since all statistical analyses were controlled for depressive 
complaints, this could have given an underestimation of the true effects of mood disorder. 
However, the same results were obtained when depressive complaints were not 
incorporated as a confounding variable. 
Although Parkinson patients were expected to show a decreased performance in both 
cognitive domains, only a decrease in verbal memory performance was found. Since 
Parkinsonism was excluded at baseline and only 25 persons developed Parkinson in the 12-
years of follow-up, the current study might have lacked the power to detect a significant 
effect. Furthermore, persons who developed Parkinson in the course of the study were a 
relative healthy group as they needed to be in order to keep participating in the study 
notwithstanding their disease. Persons diagnosed with other movement disorders also 
showed a decline in processing speed. Since the LDST is a task that requires proper upper 
limb coordination, a worse performance of persons with movement disorders as compared 
to healthy control was expected. 
Diseases of the eye were related to verbal memory as well as to processing speed since 
both tasks required proper vision. Diseases of the ear were also related to a decrease in 
processing speed. However, in a cross-sectional study by van Boxtel and colleagues diseases 
of the ear were only related to a decrease in verbal memory (1998) 9. Migraine/headache, 
other diseases of the nervous system and other chronic respiratory diseases were not 
associated with either of the two cognitive functions. 
To summarize, several disease clusters appear to be related to cognitive decline. Due to 
the explorative nature of this study, it is difficult at this stage to explain these associations. 
However, we believe that our research may help in finding unexpected common 
pathogenetic mechanisms, such as autoimmune responses, genetics, inflammation, 
immunological mechanisms or depressogenic actions. This unbiased approach may raise 
new hypotheses which may result in a better understanding of general concepts of 
comorbidity and frailty, in contrast to a disease-specific approach. Hence, the present 
results indicate that a standard classification of diseases based on overt sign and symptoms 
might be inconclusive. 
Multimorbidity, or the co-occurrence of two ore more chronic diseases within one 
person, is common in general practice as evidenced through a prevalence of 55.2% in our 
study population. Previous research reported lower prevalence estimates3,33, which might be 
due to the limited number of medical conditions included in those studies2. Investigating 
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the influence of disease combinations, on cognition showed that only the combination 
malignancies and movement disorders was significantly related to cognitive decline. Hence, 
persons suffering from a movement disorder as well as a malignancy perceive more 
cognitive decline than persons who are suffering from only one of these two disease clusters. 
Multimorbidity appeared to be less associated to cognitive decline than expected based on 
the negative influence of multimorbidity on other health-related outcomes. Hence, the 
present results indicate that specific disease clusters have a much more profound effect on 
cognition than multimorbidity. 
All presented results were controlled for age, sex, depressive complaints and education 
which all appeared to be significantly related to cognitive functioning. In contrast to 
previous research, which suggested that the total number of morbid conditions was 
significantly related to memory, but not to speed of processing34, no association between 
total morbidity score and cognition was found in the present study. This dissimilarity 
might be the result of the inclusion of as much as 96 medical conditions, as compared with 
previous conducted studies, which in general included only a small selection of medical 
conditions. Since so many medical conditions were included, not all conditions will have 
the same profound effect on cognition. For example, a person diagnosed with only one 
chronic condition (e.g. dementia) can encounter much more cognitive decrements than a 
person diagnosed with multiple chronic conditions. Moreover, total cluster score was also 
considered as a possible confounder. The number of morbid clusters appeared not to be 
significantly related to memory or processing speed. 
Since two neuropsychological tests were used as two distinct outcome measures (i.e. 
Visual Verbal Learning Test and Letter Digit Substitution Task), it might be argued that 
compound scores (several raw test scores being grouped into one score) would improve the 
robustness of the underlying cognitive construct. However, for reasons of parsimony the 
authors decided to only use the two abovementioned tests as a selection of all possible 
cognitive tests. Both tests are relatively robust, rather sensitive to age effects and are among 
the most widely used tests in clinical practice as well as in cognitive research24, which makes 
comparison the previously conducted studies rather straightforward. 
The current study has several advantages over previous studies. First of all, this is the 
first study that incorporated as many as 96 chronic medical conditions grouped into 
different clusters. By doing so, a more complete inventory of the relation between medical 
conditions and cognition is studied. Second, this study provided longitudinal data with a 
follow-up of 12 years in a large population-based sample. Since cognitive decrements due 
to morbidity status are expected to develop in the course of many years, a realistic picture of 
the influence of morbidity status on cognitive decline emerges from the present study. 
Thirdly, we have evaluated the causal relationship between morbidity and cognition in a 
general practice based setting. Consequently, the results are more representative for the 
general population than results of studies conducted in smaller and less healthy 
homogeneous samples35. Moreover, in contrast to previous studies, the current study 
assessed medical status by using a general practice database instead of using self-reported 
medical status. Fourthly, although several studies already considered the relationship 
between morbidity and cognition, the majority, if not all, of these studies lacked data on 
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disease duration. This drawback was overcome in the present study, since date of diagnosis 
was used as an indicator for the duration of exposure to the disease. 
Despite the previous mentioned strengths, our findings must be interpreted in light of 
some possible limitations. Firstly, since the present study evaluated the effects of 96 chronic 
medical conditions on cognition, clustering was needed in order to conduct the statistical 
analyses. The clustering was based on the medical knowledge and consensus of three of the 
co-authors. It should be mentioned that this still remains a rather subjective method for 
clustering, which could have compromised the validity of the clusters. Furthermore, by 
evaluating the effects of clusters of medical conditions (instead of specific single medical 
conditions) on cognition, a potential strong association between a single disease and 
cognitive function may become diluted when mixed with the effects of other diseases 
within a cluster. Secondly, defining multimorbidity by a simple disease count might be 
overly simplistic for studies like the one conducted here. Evidence suggests that disease 
severity might yield a more accurate relationship between morbidity and cognitive 
functioning36. Thirdly, the total number of conditions registered in the RNH database 
reflects the GPs perspective of the health status and relevant health problems of his patients. 
As a result, some health problems may still be missing because the patient did not report 
them to the GP or because the GP did not judge them to be clinically significant. The 
number of undocumented health problems, however, appears to be rather small20. 
Furthermore, the registered date of diagnosis may not always correspond fully to the actual 
onset of a disease19, which could have resulted in a slight underestimation of disease 
duration. 
The current results underscore earlier claims that morbidity status can be considered as 
a possible mediating factor in cognitive dysfunction9. Since the present study needs to be 
viewed as a first explorative study on the association between chronic medical diseases and 
cognitive decline, it is important to replicate the present research. Considering the large 
number of patients who suffer from multimorbidity, a more detailed exploration of the 
impact of chronic diseases on cognition becomes even more important the next few 
decades. Evaluating the influence of multimorbidity on “better” or overall desirable 
cognitive functioning, and “worse” or undesirable cognitive functioning might be useful for 
translating the present results into prevention and intervention programs to reduce 
cognitive decline mediated by morbidity status. 
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APPENDIX I 
 
ICPC codes and the corresponding clusters  
Cluster description ICPC code 
All malignancies  A79, B72, B73, D74, D75, D76, D77, F74, N74, 
R84, R85, S77, T71, U75, U76, U77, W72, X75, 
X76, X77, Y77, Y78 
Peptic ulcers D85, D86 
Other chronic gastro-intestinal diseases D92, D93, D94, D97 
Diseases of the eye F83, F84, F94 
Diseases of the ear H83, H86, 
Ischemic diseases K74, K75, K76 
Pulmonary embolism and phlebitis K93, K94 
Cerebrovascular diseases K89, K90, K91 
Arrhythmias & heart failure K78, K79, K80, K77, K82, K83 
Other cardiovascular diseases K87, K92 
Movement disorders L84, L85, L88, L89, L90, L91, L95, L98  
Parkinsonism N87 
Migraine & Headache N89, N90 
Other diseases of the nervous system N92, N70, N86, N88 
Mood disorders P76, P73 
Alzheimer P70 
Other mental disorders P28, P71, P72, P74, P75, P77, P79, P80, P98 
Asthma, COPD and bronchitis R91, R95, R96, 
Other chronic respiratory diseases R70, R75, R97 
Eczema, psoriasis and chronic skin ulcer  S87, S91, S97 
Endocrine diseases T85, T86, T92, T93, T99 
Diabetes mellitus (Type I and II) T90 
Diseases of the urinary tract U04, U85, U88 
 
 
  
 
 - 49 -
CHAPTER 4 
The effect of multimorbidity on health related functioning: 
temporary or persistent? Results from a longitudinal cohort 
study 
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ABSTRACT 
Background 
Multimorbidity is known for its negative effects on health related functioning. It remains 
unclear if these effects are stable over time. The aim was to investigate if the relation 
between single morbidity/multimorbidity and health related functioning, as measured by 
the SF-36, is temporary or persistent. 
Methods 
Data were collected as part of the Maastricht Aging Study (MAAS), a prospective study 
into the determinants of cognitive aging. Participants (n= 1,184), 24–81 years old, were 
recruited from a patient database in primary care (Registration Network Family Practices). 
Morbidity status (i.e. healthy, single morbidity or multimorbidity) and the Short Form 
Health Survey (SF-36) were both assessed at baseline, at 3-and 6-year follow-up. 
Results 
At baseline but not at 3-and 6-year follow-up, participants with single morbidity reported 
poorer physical functioning than their healthy counterparts. Multimorbidity was associated 
with poorer physical functioning at all measurements. Participants with multimorbidity 
showed a steep decrease in physical functioning between 3-and 6-year follow-up. 
Multimorbidity appeared to be unrelated to mental functioning. At baseline and at 3-year 
follow-up, participants who had a change in morbidity status reported more decline in 
physical functioning than their healthy counterparts. 
Conclusions 
The decline in physical functioning that accompanies multimorbidity is persistent and may 
even increase over time. People, who acquire one or more diseases during 3-year follow-up, 
already showed a decreased physical functioning at baseline than people who remained 
healthy during these years. Post-hoc analyses, using the SCL-90 as an outcome measure, 
did show that multimorbidity was related to depressive and anxiety complaints. However, 
these complaints seem to decline over time 
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INTRODUCTION 
Multimorbidity, the co-occurrence of two or more chronic diseases within one person 1, is 
the rule rather than the exception2, 3. In a previously conducted study based on a general 
practice cohort, using a broad nosological spectrum of disease entities, 52 percent of the 
participants (aged between 21 to 84 years) were suffering from multimorbidity4. As a result 
of aging populations and advances in medical care, the prevalence of multimorbidity is 
expected to increase even more the upcoming decades. Since a higher prevalence of 
multimorbidity will lead to higher health care utilization and thus to higher health care 
expenditure5, the influence of multimorbidity on society will be marked. 
The questions remains whether the consequences of single morbidity and 
multimorbidity on indicators of physical6 and mental health7 are temporary or persistent 
over time. For example, it might be argued that a long-term experience with a chronic 
illness shows a different relationship with adverse health outcomes than a recently acquired 
chronic medical condition. The period directly after a newly acquired disease may lead to 
significant decrease in self-reported physical and mental health related factors8 (e.g. 
decreased quality of life and increased levels of disability 9) while these consequences might 
diminish or even disappear when a person has adjusted to the newly acquired illness. 
Health problems caused by single morbidity or multimorbidity could also be permanent or 
could even increase over time. Untangling the longitudinal association between single 
morbidity and multimorbidity on one side and health related functioning on the other is a 
crucial first step towards the development of adequate disease management that could 
ameliorate functional problems caused by multimorbidity. 
The present study provides the first data documenting possible changes in health 
related functioning caused by single morbidity and multimorbidity. The following two 
research questions were addressed: 1. Are the effects of single morbidity and 
multimorbidity on health related functioning status stable over time? 2. Does a change in 
morbidity status lead to a drop in health related functioning? 
METHODS 
The present study was based on two cohorts: The Registration Network Family Practices 
(RNH) and the Maastricht Aging Study (MAAS). Participants in MAAS were originally 
recruited from the Registration Network Family Practices, which contains demographic 
and medical information for over 120.000 patients inhabiting in the South of Limburg, the 
Netherlands10. 
Registration Network Family Practices (RNH) 
Overall morbidity status of all MAAS participants at baseline, 3- and 6 year follow-up was 
retrieved from the RNH database. The RNH is a continuously updated database, which 
contains the electronic medical records of patients from 21 family practices, in which 65 
general practitioners (GPs) are participating . This database includes all relevant current 
and past health problems. A health problem is defined as ‘anything that has required, does 
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or may require health care management and has affected or could significantly affect a 
person’s physical or emotional well-being’. A diagnosis is made by the GP or, in case of 
complex conditions, by a medical specialist to whom a patient has been referred. The RNH 
database contains health problems that are only coded by the GP when they are permanent 
(no recovery expected), chronic (duration longer than 6 months) or recurrent (more than 
three recurrences within 6 months), or when they have lasting consequences for the 
functional status or prognosis of the patient. Problems are coded in a standardized fashion, 
according to the International Classification of Primary Care (ICPC)11, using the criteria of 
the International Classification of health in Primary Care (ICHPPC-2) and other more 
current guidelines of the Dutch College of GPs. 
All patients included in the RNH database have been informed about the potential 
anonymous use of their health information. Inclusion in the RNH registry ends following 
migration or death; however, if a patient does not agree to the use of his/her health 
information, the inclusion of this patient in the RNH database can be stopped. 
Sociodemographical characteristics of samples in other studies using the RNH database was 
shown to be comparable to the Dutch population12. 
Maastricht Aging Study (MAAS) 
In 1992, 10 396 people were recruited from the RNH database of whom 4490 were willing 
to participate (43.2%) in MAAS, 3531 refused participation (34%), and 2375 did not 
respond (22.8%). Since MAAS was aimed to investigate healthy cognitive aging in a wide 
age range, people aged 24 to 81 years were included. Participants were excluded from 
baseline participation when medical records from the RNH database contained the 
following conditions which are known to interfere with cognition: history of coma, 
cerebrovascular disorder, tumour of the nervous system, multiple sclerosis, Parkinsonism, 
epilepsy, dementia, organic psychosis, schizophrenia, affective psychosis, mental retardation 
or congenital malformation of the nervous system13. The 4490 eligible participants were 
screened by telephone for medical conditions not documented in the RNH database (i.e. 
history of transient ischemic attack, brain surgery, electroconvulsive therapy, daily 
psychotropic drug use and haemodialysis for renal failure). Of the remaining 4189 
participants (301 were excluded based on the telephone screening), 1823 were randomly 
selected for participation in the test program of MAAS. Of them, 1353 individuals also 
participated in the 6 year follow-up test programme. 
The MAAS study consists of five measurements: baseline, 3-year follow-up, 6-year 
follow-up, 9-year follow-up and 12-year follow-up. Since the outcome variable of the 
present study was not measured at baseline and the 3-year follow-up only included 
participants aged 55 years and older, the 6-year follow-up was set as baseline assessment for 
the present study. The 9-and 12 year follow-up measurements were set as respectively, the 
first (i.e. 3-years follow-up) and second follow-up (i.e. 6-years follow-up) measurement. 
Participants who had no information regarding the SF-36 or who lacked morbidity status 
in RNH (n= 169) (e.g. because of movement and mortality) were excluded from all the 
analyses. 
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Dependent Variables 
The Short Form Health Survey (SF-36), also known as the RAND-36, is a widely used 
generic measures aimed as assessing health related functioning, which relies upon patient 
self-reports14. The 36 generic and coherent questions are aimed at covering the full 
spectrum of health related functioning and are grouped into eight dimensions of health (i.e. 
physical function, role-physical, bodily pain, general health, energy/vitality, social function, 
role-emotional, and mental health). These dimensions are indicators for behavioural 
function and dysfunction, distress and well-being, and self-rated health. The present study 
made use of the mental and physical health subscales as defined by Ware and Sherbourne14. 
For both subscales a higher score is indicative for better health related functioning. The SF-
36 was administered at all three follow-up measurements. 
Independent Variables 
Overall morbidity status (i.e. healthy, single morbidity or multimorbidity) of all MAAS 
participants was assessed by looking at the medical records at baseline and at the two 
follow-up measurements. Letting morbidity status vary at every time point resulted in ten 
mutually exclusive groups (see Appendix I). However, the majority of these groups 
consisted only of a very small number of participants which resulted in a lack of power. 
Consequently, the present study focused on the following three groups: people who were 
healthy (i.e. no disease present) on all three measurements, people with single morbidity 
(i.e. one disease present) on all three measurements and people with multimorbidity (i.e. 
two or more diseases present) on all three measurements. 
Based on medical literature15 and on clinical experience, the following chronic medical 
conditions were included: malignancies, movement disorders, chronic respiratory diseases, 
cardiovascular diseases (heart failure, ischemic diseases, arrhythmias and cerebrovascular 
diseases), endocrine diseases, neurological disturbances and psychological disorders (see 
Appendix I). The medical conditions on which exclusion for MAAS participation was 
based were also included to monitor incident cases after baseline. 
Since the present study only included medical conditions that were judged by the GP 
to be permanent, chronic, recurrent or when they have lasting consequences for the 
functional status or prognosis of the patient, the assumption was made that people who 
were suffering from single morbidity or multimorbidity could not return to a healthy status 
and people suffering from multimorbidity could not be suffering from single morbidity on 
a follow-up measurement. In order to evaluate the effects of a change in morbidity status 
on one side and physical and mental health on the other, an additional statistical analysis 
was conducted in which participants who were healthy at baseline as well as at 3 year 
follow-up were compared with participants who were healthy at baseline but who had 
single morbidity or multimorbidity at the 3 year follow-up measurement. 
Possible Confounders 
Potential confounders were taken into account: age, sex, educational level (low, medium or 
high; low was defined as primary school and/or lower vocational education, medium as 
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secondary school and/or medium level vocational education, high as higher vocational 
education or university degree)16, living arrangements (two categories; living alone vs. living 
together), current smoking behaviour (yes or no) and alcohol intake (excessive drinker: 
yes/no; excessive was defined as more than 21 glasses per week for men and more than 14 
glasses per week for women). 
Statistical Analyses 
As the independent variable and the outcome measures were measured three times, data 
were analyzed with Linear Mixed Models. Since measurements within subjects are more 
alike than measurements between subjects, there is correlation between the repeated 
measurements. This within-subjects variation, that accounts for changes within each 
subject through repeated measurements in time, and the between-subjects variation, 
accounting for differences between the subjects performance, can be established by a 
multilevel approach17. Moreover, missing data may depend on the observed covariates and 
outcome measures (missing at random). When evaluating the plots of the residuals and 
when taking the Maximum Likelihood ratio into account, a marginal model with the 
unstructured covariance structure provided the best fit 17. 
The multilevel models included fixed terms for morbidity status, follow-up (time of 
measurement), age, sex, education, living arrangement, smoking behaviour and alcohol 
intake. Age, sex and education were included in all the analyses irrespective of significance. 
The remaining covariates were only included in the model and reported if they significantly 
influenced the outcome under study (p ≤ 0.05). Interaction effects between morbidity 
status and follow-up were evaluated in order to detect possible changes in physical and 
mental health which might be due to single morbidity or multimorbidity. The additional 
statistical analysis (i.e. participants who were healthy at baseline as well as at 3 year follow-
up were compared with participants who were healthy at baseline but who had single 
morbidity or multimorbidity at the 3 year follow-up measurement) were analyzed using 
Multiple Linear Regression Analyses. P-values of 0.05 or less were considered statistically 
significant. All analyses were conducted with the SPSS statistical software package version 
17.0 for Windows (SPSS Inc., Chicago, IL, USA). Graphs (included in the Appendix) will 
be presented using z-scores with a mean of zero and a standard deviation of one. 
RESULTS 
Participants (n= 169) who were excluded from all the analyses were older (p < 0.001), less 
educated (p < 0.001) and more likely to be female (p= 0.047). Moreover, the excluded 
participants were less likely to be healthy or to be suffering from single morbidity, but were 
more likely to be suffering from multimorbidity (p < 0.001). Descriptive characteristics of 
the study sample (n= 1184) are reported in Table 1. Of all participants, 19.6% suffered 
from single morbidity at all three measurements while 35.5 % suffered from 
multimorbidity at all three measurements; 83.6% (n=990) of all participants had the same 
morbidity status throughout the three measurements. Only participants who had no 
change in morbidity status were included for the analysis leading to a total of 990 
participants (see Appendix II).  
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At baseline but not at 3-and 6-year follow-up, participants with single morbidity reported 
significantly more decline in physical functioning than their healthy age mates (Table 2 and 
Figure 1.a.). Between baseline and 3-year follow-up, people with single morbidity showed 
less decline in physical functioning than healthy participants. No effect of morbidity status 
(i.e. healthy vs. single morbidity) was found between 3-and 6-year follow-up.  
 
Table 1. Descriptive characteristics of the study population at baseline (N=1184) 
Characteristics  
Mean age in year (SD)  55.4 (15.2) 
Gender: females (%)  573 (48.4) 
Morbidity status  
   Healthy  338 (28.5) 
   Single morbidity 232 (19.6) 
   Multimorbidity 420 (35.5) 
Education   
   Low (%) 371 (31.3) 
   Medium (%) 441 (37.2) 
   High (%) 320 (27.0) 
Living arrangement (% living with family) 903 (76.3) 
Smoking (% yes) 178 (21.3) 
Alcohol consumption (% yes) 107 (9.0) 
Morbidity status refers to participants who had the same morbidity status at all three measurements │ 
16.4% (n=194) of the participants did show a change in morbidity status during the 6 year follow-up. 
 
On all three measurements, participants with multimorbidity reported significantly lower 
physical functioning than their healthy counterparts. Moreover, between 3-and 6-year 
follow-up, there was a significant interaction between morbidity status (i.e. healthy vs. 
multimorbidity) and follow-up, which suggest that participants with multimorbidity 
showed a significant steeper decrease in physical functioning than healthy participants. 
Between baseline and 3-year follow-up, no effect of morbidity status was found. Higher age 
and low education were significantly related to lower physical functioning. 
At 6 year follow-up, a significant relation between single morbidity and mental 
functioning, as measured by the SF-36, was detected. (Table 2 and Figure 1.b.). No 
significant interaction between morbidity status (i.e. healthy vs. single morbidity) and 
follow-up measurement was found. On all three measurements, multimorbidity was not 
significantly related to mental functioning. Moreover, no significant interactions between 
morbidity status (i.e. healthy vs. multimorbidity) and follow-up measurement were found. 
Lower age, female sex and lower education were all significantly related to lower mental 
functioning. 
Participants with a change in morbidity status (i.e. who were healthy at baseline and 
had either single morbidity or multimorbidity at 3-year follow-up; n= 47) between baseline 
and 3-year follow-up reported significant lower physical functioning than their healthy 
counterparts (n= 294) (Table 3 and Figure 2.a.). These two groups did not differ regarding 
mental functioning (Table 3 and Figure 2.b). On the physical as well as on the mental 
subscale no interaction effect between morbidity status and follow-up measurement was 
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found; both groups showed the same change in physical and mental functioning during the 
3-year follow-up. High age and lower education were significantly related to lower physical 
functioning. Lower education was also significantly related to lower mental functioning. 
Although all the abovementioned associations were adjusted for age, sex and educational 
level, all associations were significantly related to the outcome at hand when no adjustment 
had taken place. 
 
Table 2. Multilevel analyses for the association between single morbidity and multimorbidity on one 
side and mental and physical health on the other, adjusted for age, gender and education 
 Physical health Mental health 
 Parameter 
estimate 
P-value Parameter 
estimate 
P-value 
Age -0.148 < 0.001 0.037 0.041 
Gender -0.853 0.081 -1.474 0.002 
Education 1.616 < 0.001 1.166 < 0.001 
Single morbidity     
    Baseline -2.030 0.013 -0.008 0.993 
    3 year follow-up -0.273 0.722 0.971 0.247 
    6 year follow-up -0.907 0.262 -0.552 0.048 
Multimorbidity     
    Baseline -5.643 < 0.001 -0.839 0.300 
    3 year follow-up -5.505 < 0.001 -1.090 0.163 
    6 year follow-up -6.74 < 0.001 -1.038 0.169 
Interaction     
   Single morbidity * time 
  (baseline and 3 year follow-up) 
1.756 0.027 0.979 0.302 
   Single morbidity * time 
  (3 year FU and 6 year follow-up) 
0.634 0.364 1.524 0.092 
   Multimorbidity * time 
  (baseline and 3 year follow-up) 
-0.138 0.843 -0.253 0.0761 
   Multimorbidity * time 
  (3 year FU and 6 year follow-up) 
1.231 0.049 -0.054 0.946 
Note: the reference group consisted of healthy participants 
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Table 3. Multilevel analyses for the association between a change in morbidity status (between 
baseline and 3 year follow-up) and mental and physical health, adjusted for age, gender and 
education 
 Physical health Mental health 
 Parameter 
estimate 
P-value Parameter 
estimate 
P-value 
Age -0.080 0.001 0.041 0.120 
Gender -0.891 0.111 -1.158 0.071 
Education 2.240 < 0.001 1.116 0.012 
Change in morbidity status     
   Baseline -3.468 < 0.001 -0.992 0.276 
    3 year follow-up -3.438 < 0.001 -1.115 0.221 
Interaction      
    Change in morbidity status * time  
    (baseline and 3 year follow-up)    
-0.030 0.962 -1.140 0.846 
The reference group consisted of participants who were healthy at baseline and at 3 year follow-up; i.e. no 
change in disease status (participants who were healthy at baseline and at 3 year follow-up) vs. a change in 
disease status (participants who were healthy at baseline and had single morbidity or multimorbidity at 3 
year follow-up.). 
DISCUSSION 
The present study describes the possible changes in health related functioning, divided in 
physical and mental functioning, as a function of morbidity status. Apart from an negative 
association between single morbidity and physical functioning on baseline, which might be 
due to a statistical phenomenon called ‘regression to the mean’ (i.e. the healthy participants 
who report an ‘extreme’ value on the SF-36 on the first measurement will tend to be closer 
to the mean at the 3 year follow-up), single morbidity appears to be unrelated to physical 
functioning. This is in contrast with a previous study conducted by Galenkamp and 
colleagues that claimed that the first chronic medical condition increases the chance of poor 
health functioning more than each co-occurring disease18. However, while cross-sectional 
study assessed self-reported general health (i.e. based on the question: “How is your health 
in general?”), our longitudinal study made a clear distinction between physical and mental 
functioning as assessed by the SF-36. Hence, comparison between this study and the 
present one is not straightforward. 
At all three measurements, participants with multimorbidity did report poorer physical 
functioning than their healthy counterparts, which is in congruence with previous 
research18, 19. Moreover, people with multimorbidity tended to show a steeper decrease in 
physical functioning between 3-and 6-year follow-up as compared to their healthy 
counterparts. Hence, in contrast to people with single morbidity, people with 
multimorbidity may not adjust to the challenging physical demands that complement their 
illnesses which may result in an ongoing decrease in physical functioning. People who are 
suffering from multimorbidity are also more prone to acquire a new medical condition20, 
which could have further decreased their physical functioning. 
In order to evaluate the effects of a change in morbidity status on one side and physical 
and mental functioning on the other, another analysis was conducted in which participants 
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who were healthy at baseline and at 3-year follow-up were compared with participants who 
were healthy at baseline but who had single morbidity or multimorbidity at 3-year follow-
up. At baseline, participants who showed a change in morbidity status (i.e. who were 
healthy at baseline and had either single morbidity or multimorbidity at 3-year follow-up) 
reported significant lower physical functioning than their healthy counterparts. This effect 
was still present at 3-year follow-up. These results indicate that at baseline, when both 
groups were still healthy, those individuals who acquired one or more medical conditions in 
the subsequent 3 year already experience lower physical functioning than those who 
remained healthy during the 3-year follow-up. Hence, it might be argued that a decrease in 
physical functioning is already present far before a disease diagnose is made by a GP or a 
specialist. The lack of an interaction effect between the two groups and follow-up indicates 
that the acquisition of one or more medical conditions did not lead to a sudden decrease in 
physical functioning. 
Our results are in congruence with a study by Rijken and colleagues (2005) which 
concluded that comorbidity in chronic diseased patients was not significantly related to 
mental functioning as measured by the SF-3618. Moreover, a study by Fortin and co-
workers (2006) also indicated that multimorbidity causes greater deterioration in physical 
functioning than in mental functioning, as measured by the SF-36. Hence, the question 
might rise whether SF-36 is a sensitive index to detect psychological complaints caused by 
single morbidity or multimorbidity in a normal population. Hence, post-hoc analyses in 
which the effects of single morbidity and multimorbidity on the depression and anxiety 
subscales of the Symptom CheckList-90 (SCL-90; a higher score is indicative for more 
depressive and anxiety related complaints) were conducted (see appendix IV for table and 
figures). At baseline, but not at 3-and 6-year follow-up, people with multimorbidity 
reported significantly more depressive complaints than their healthy counterparts. At 
baseline, people with multimorbidity also reported significantly more anxiety complaints 
than their healthy counterparts. While this effect, although smaller, was still significant at 
3-year follow-up, it was absent at 6-year follow-up. No differences between healthy people 
and people with single morbidity were found. Female sex was significantly related to more 
depressive complaints; lower education was significantly related to more complaints of 
depression and anxiety. The results of these post-hoc analyses indicate that, although 
multimorbidity is related to elevated levels of depressive and anxiety complaints, these tend 
to decline over time. It might be argued that people with multimorbidity eventually learn 
to adapt to their acquired illnesses which in turn might lead to a decrease in feelings of 
depression and anxiety. Moreover, the use of the SCL-90 yielded different results than 
using the SF-36. This might be due to the fact that, while the SF-36 is an index of 
subjective general health and probes somatic and psychosomatic health functioning, the 
SCL-90 subscales are more dedicated checklists aimed at evaluating psychological and 
psychopathological complaints. Such indexes may therefore be more sensitive for 
psychological distress that is caused by multimorbidity21. 
The current study has several advantages over previously conducted studies. Firstly, 
although several studies already considered the relationship between (multi)morbidity on 
one side and mental and physical functioning on the other, the present study is the first to 
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evaluate the stability of these negative consequences. Secondly, by including 96 medical 
conditions, a more complete inventory of the effect of morbidity and multimorbidity on 
mental and physical functioning could be made, in contrast to previous conducted 
studies18. Thirdly, this study provides longitudinal data based on a large population-based 
sample. Since changes in health related functioning caused by medical conditions are 
expected to develop in the course of weeks, months and year, a realistic picture of the 
influence of (multi)morbidity status on mental and physical functioning has been provided. 
Fourthly, the causal relationship between multimorbidity and general health was 
investigated in a general practice based sample with a large age range. Consequently, the 
results are more representative for the general population than results of studies conducted 
in smaller, less homogeneous or clinical samples. Moreover, the current study made use of 
medical conditions diagnosed by general practitioners instead of using self-reported medical 
status. 
The current results should also be viewed in light of some possible limitations. Firstly, 
defining multimorbidity by a simple disease count might be overly simplistic for studies 
such as the present one. Evidence suggests that disease severity, which could not be 
evaluated in the present study, might yield a more accurate relationship between 
multimorbidity and relevant health outcomes22. Secondly, it cannot be ruled out that 
patients could be cured from a few of the included medical conditions. However, since the 
present study only included medical conditions that were perceived by the GP as 
permanent, chronic, recurrent or having lasting consequences, this percentage is expected 
to be rather small. Thirdly, since the 6 year follow-up of the MAAS was set as an artificial 
baseline, it could be argued that the ‘healthy ill’ are overrepresented in the current study. 
This ‘survivor effect’ may have lead to underestimations of the obtained associations. 
Consequently, the finding that the association between single morbidity and 
multimorbidity on one side and mental health on the other diminishes over time, may not 
be generalized to more ‘disadvantaged’ individuals with single morbidity or 
multimorbidity.; the negative association between morbidity status and physical health may 
be more profound in these individuals. 
Despite these limitations the present study provides the first data documenting if the 
effects of single morbidity and multimorbidity on health related functioning are temporary 
or persistent. The present results indicate that the decrease in self-perceived physical 
functioning, caused by multimorbidity, might be permanent. Moreover, the association 
between single morbidity and multimorbidity on one side and mental health, as measured 
by the SCL-90, on the other seems to decline over time. In conclusion, our results suggest 
that the association between multimorbidity and physical functioning may be permanent 
while the association between multimorbidity and mental health seems to decline over 
time. Since poor physical functioning is known to underlie several adverse outcomes, 
including hospitalization and nursing home admission 23, appropriate disease management 
that is aimed at amelioration or even prevention of physical problems is needed. 
Because several morbidity groups included only a small number of participants (see 
Appendix I), evaluating the association between these groups and the outcome at hand 
appeared unfeasible. Hence, in order to evaluate the association between all these morbidity 
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groups on one side and physical and mental functioning on the other, the present study 
should be repeated using a larger sample size. Moreover, repeating the present study in 
older individuals (e.g. aged 70 and over) may also yield different results. 
The question remains how the decrease in physical functioning influences the daily 
living of people with multimorbidity. Do the present results indicate that people with 
multimorbidity perceive hindrance in their activities of daily life (e.g. bathing, walking etc) 
or can they still carry out these activities as well as their healthy counterparts? Since the SF-
36 is not a diagnostic instrument, it is difficult to obtain a validated cut-off score on which 
clinical relevant conclusions can be based. Hence, the stability of physical and mental 
health, caused by disability status, should be investigated since disability might be a better 
predictor for health related functioning. 
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APPENDIX I 
Prevalence of (multi)morbidity groups on baseline, 3 and 6 year follow-up  
Group Baseline 3 yrs FU 6 yrs FU N 
0 Healthy Healthy Healthy 338 
1 Healthy Healthy Morbidity 33 
2 Healthy Healthy Multimorbidity 17 
3 Healthy Morbidity Morbidity 29 
4 Healthy Morbidity Multimorbidity 11 
5 Morbidity Morbidity Morbidity 232 
6 Morbidity Morbidity Multimorbidity 43 
7 Morbidity Multimorbidity Multimorbidity 47 
8 Healthy Multimorbidity Multimorbidity 14 
9 Multimorbidity Multimorbidity Multimorbidity 420 
APPENDIX II 
ICPC codes and the corresponding clusters  
Cluster description ICPC code 
All malignancies  A79, B72, B73, D74, D75, D76, D77, F74, N74, 
R84, R85, S77, T71, U75, U76, U77, W72, X75, 
X76, X77, Y77, Y78 
Peptic ulcers D85, D86 
Other chronic gastro-intestinal diseases D92, D93, D94, D97 
Diseases of the eye F83, F84, F94 
Diseases of the ear H83, H86, 
Ischemic diseases K74, K75, K76 
Pulmonary embolism and phlebitis K93, K94 
Cerebrovascular diseases K89, K90, K91 
Arrhythmias & heart failure K78, K79, K80, K77, K82, K83 
Other cardiovascular diseases K87, K92 
Movement disorders L84, L85, L88, L89, L90, L91, L95, L98  
Parkinsonism N87 
Migraine & Headache N89, N90 
Other diseases of the nervous system N92, N70, N86, N88 
Mood disorders P76, P73 
Alzheimer P70 
Other mental disorders P28, P71, P72, P74, P75, P77, P79, P80, P98 
Asthma, COPD and bronchitis R91, R95, R96, 
Other chronic respiratory diseases R70, R75, R97 
Eczema, psoriasis and chronic skin ulcer  S87, S91, S97 
Endocrine diseases T85, T86, T92, T93, T99 
Diabetes mellitus (Type I and II) T90 
Diseases of the urinary tract U04, U85, U88 
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APPENDIX III 
 
Figure 1.a. Age, sex and education adjusted z-scores (with mean= 0 and standard deviation=1) for 
physical health per morbidity status (i.e. healthy vs. single morbidity and healthy vs. 
multimorbidity)  
 
Figure 1.b. Age, sex and education adjusted z-scores (with mean= 0 and standard deviation=1) for 
mental health per morbidity status (i.e. healthy vs. single morbidity and healthy vs. multimorbidity). 
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Figure 2.a. Age, sex and education adjusted z-scores (with mean= 0 and standard deviation=1) for 
physical health per morbidity status (i.e. no change in disease status (healthy > healthy) vs. a change 
in disease status (healthy > single morbidity or multimorbidity).  
 
 
Figure 2.b. Age, sex and education adjusted z-scores (with mean= 0 and standard deviation=1) in 
mental health, i.e. no change in disease status (healthy > healthy) vs. a change in disease status 
(healthy > single morbidity or multimorbidity).  
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APPENDIX IV 
 
Table 4. Multilevel analyses for the association between single morbidity and multimorbidity on one 
side and depressive and anxiety complaints (SCL-90) on the other, adjusted for age, gender and 
education 
 Depression Anxiety 
 Parameter 
estimate 
P-value Parameter 
estimate 
P-value 
Age 0.017 0.352 0.011 0.332 
Gender 1.104 0.021 0.364 0.198 
Education -1.222 < 0.001 -0.730 <0.001 
     
Single morbidity     
    Baseline 1.198 0.286 1.155 0.115 
    3 year follow-up -0.650 0.419 -0.235 0.625 
    6 year follow-up 0.066 0.939 -0.018 0.970 
     
Multimorbidity     
    Baseline 3.164 0.002 2.236 0.001 
    3 year follow-up 1.120 0.138 1.310 0.004 
   6 year follow-up 0.638 0.447 0.219 0.632 
     
Interaction     
    Single morbidity * time 
   (baseline and 3 year follow-up) 
-1.850 0.142 -1.390 0.090 
    Single morbidity * time 
   (3 year FU and 6 year follow-up) 
0.718 0.470 -0.217 0.686 
     
    Multimorbidity * time 
   (baseline and 3 year follow-up) 
-2.041 0.059 -0.926 0.186 
    Multimorbidity * time 
   (3 year FU and 6 year follow-up) 
-0.485 0.586 1.092 0.023 
Note: the reference group consisted of healthy participants 
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Figure 3.a. Age, sex and education adjusted z-scores (with mean= 0 and standard deviation=1) for 
depressive complaints per morbidity status (i.e. healthy vs. single morbidity and healthy vs. 
multimorbidity).  
 
 
Figure 3.b. Age, sex and education adjusted z-scores (with mean= 0 and standard deviation=1) for 
anxiety complaints per morbidity status (i.e. healthy vs. single morbidity and healthy vs. 
multimorbidity). 
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CHAPTER 5 
Co-presence of disability and multimorbidity with frailty: an 
examination of heterogeneity in the frail older population 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Under review as: 
S. Aarts, K.V. Patel, M. E. Garcia, M. van den Akker, F.R.J. Verhey, J.F.M. Metsemakers, 
M.P.J. van Boxtel, V. Gudnason, M.K. Jonsdottir, K. Siggeirsdottir, P.V. Jonsson, T. B. 
Harris and L.J. Launer. 
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ABSTRACT 
Background 
Frailty is often associated with multimorbidity and disability. We investigated 
heterogeneity in the frail older population by characterizing five subpopulations according 
to quantitative biological markers, multimorbidity and disability, and examined their 
association with mortality and nursing home admission. 
Methods 
Participants (n=4,414, mean age 76.4; SD: 5.5) were from the population-based Age 
Gene/Environment Susceptibility Reykjavik Study. Frailty was defined by ≥ 3 of the 
following five characteristics: weight loss, weakness, reduced energy levels, slowness and 
physical inactivity. Multimorbidity, the co-occurrence of two or more chronic medical 
conditions, was assessed using a simple disease count, based on 13 prevalent conditions. 
Disability was assessed by five activities of daily living; participants who had difficulty with 
one or more tasks were considered disabled. Differences among frail subpopulations were 
based on the co-presence of multimorbidity and disability. Differences among the following 
subpopulations were examined: 1) Non-frail (reference group); 2) Frail only; 3) Frail with 
disability; 4) Frailty with multimorbidity; 5) Frail with disability and multimorbidity. 
Results 
Frailty was present in 10.7% (n=473). Although frailty was associated with increased risk 
for mortality (OR 1.40; 95% CI 1.16–1.70) and nursing home admission (OR 1.17; 95% 
1.15–2.10), risks differed by subpopulations. Compared to the non-frail, the frail only 
group had poorer cognition and increased inflammation levels but did not have increased 
risk for mortality (OR 1.36; 95% 0.82–2.25), or nursing home admission (OR 1.03; 95% 
0.48–2.23). Compared to the non-frail, the other three frail subpopulations had 
significantly poorer cognition, increased inflammation levels, more white matter lesions, 
higher levels of calcium, glucose and red cell distribution width and increased risk for 
mortality and nursing home admission. 
Conclusions 
The adverse health risks associated with frailty in the general older adult population may 
primarily be driven by increased disease burden and disability. 
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INTRODUCTION 
Frailty is described as a state of increased vulnerability that may result from decreased 
physiological reserve, multi-system dysregulation and diminished capacity to maintain 
homeostasis1. Although the prevalence of frailty depends on the case definition and source 
population, all studies demonstrate that frailty increases with advancing age2. For example, 
the overall prevalence of frailty among 5,317 community-dwelling older adults 
participating in the Cardiovascular Health Study was 6.9%, but in participants who were 
80 and older the prevalence was 30%2. Frailty increases the risk for a variety of adverse 
health outcomes including hospitalization3, disability4 and mortality5, 6, which may exert 
a high burden on health care systems. 
Attempts to study frailty are complicated by the lack of consensus on the operational 
definition of frailty7; the term frailty is often used interchangeably with other geriatric 
conditions, such as multimorbidity and disability. However, previous research suggests that 
frailty not only exists independent of age-associated diseases, but could also contribute to 
the incidence and progression of multimorbidity and disability2. Moreover, frailty and 
multimorbidity are both known to be independent risk factors for disability. Disability in 
turn, may exacerbate the health related problems associated with frailty and 
multimorbidity. Hence, the three conditions are interrelated but the degree of mutual 
dependence is not well established. While previous studies have examined the effect of 
frailty on mortality and nursing home admission adjusting for the presence of disability and 
multimorbidity, no studies have characterized the co-occurrence of frailty with disability 
and multimorbidity in relation to health outcomes. Therefore, it remains unclear whether 
the risks for adverse outcomes associated with frailty are driven by disease burden8, 
including possibly subclinical diseases and impairments that may underlie frailty8. 
Given the correlation between frailty, multimorbidity and disability, we sought to 
investigate heterogeneity within the frail population in a large cohort of community-
dwelling older adults. . The first aim was to estimate the overall prevalence of frailty in 
community dwelling older adults as well as to estimate the co-presence of disability and 
multimorbidity within the frail population. The second aim was to characterize 
subpopulations of frail older adults with quantitative physiological markers. Since the risk 
of adverse outcomes may differ per subpopulation of frailty, the last aim was to examine the 
risk for mortality and nursing home admission in subpopulations of frail and non-frail 
older adults. 
METHODS 
Study Population 
The Age Gene/Environment Susceptibility-Reykjavik (AGES-Reykjavik) Study is based on 
the Reykjavik Study, a population-based cohort established in 1967 by investigators at the 
Icelandic Heart Association (IHA)9, 10. This cohort originally comprised a random sample 
of men and women born between 1907 and 1935 and living in Reykjavik at baseline. The 
initial follow-up examination for AGES-Reykjavik started in 2002 and was completed in 
200611. As part of the AGES-Reykjavik Study, participants (n=5,764) completed interviews 
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about a variety of health related factors, including functional status, medical conditions, 
health behaviours, and family history. Moreover, participants had a series of standardized 
health examinations. AGES-Reykjavik was approved by the National Bioethics Committee 
in Iceland that acts as the institutional review board for the IHA and by the National 
Institute on Aging’s Institutional Review Board. Release of data for analysis is governed by 
rules created by these bodies to protect the privacy of Icelandic participants11. Participants 
with Parkinson’s disease (i.e. their symptoms and functional impairments would interfere 
significantly with the frailty assessment), participants who had not undertaken an MRI scan 
or had missing data on the variables on which the subpopulations of the current study were 
based (i.e. frailty characteristics, multimorbidity and disability) were excluded (n=1,350; 
23.4%). People who were excluded were older and less educated than those included in the 
analysis. There was no difference in the sex distribution. The final analytic study sample 
yielded 4,414 participants. 
Assessment of Frailty 
The present study used the operational definition of frailty developed by Fried and 
colleagues6,12. The phenotype of frailty was identified by the presence of three or more of 
the following characteristics6: 
(1) Weight loss: unintentional weight loss of 5kg or more in the past 12 months or a Body 
Mass Index (BMI) less than 18.5. 
(2) Weakness: hand grip strength in the lowest 20% adjusted for height and sex. 
(3) Low energy: reduced energy level determined by the respondent answering ‘no’ to ‘Do 
you feel full of energy?’ in the Geriatric Depression Scale. 
(4) Slowness: slowest 20% of the study population, based on usual gait speed over a 6-
meter course, adjusted for height and sex. 
(5) Low physical activity: no swimming or walking during the summer and winter season 
and no participation in low and moderate/vigorous physical activity during the last 12 
months. 
Assessment of Disability 
Difficulty in carrying out activities of daily living (i.e. walking from one room to another, 
getting in and out of bed, eating, dressing and showering/bathing) were assessed by five 
questions13. Each question had a 4-point Likert response: 1) ‘no difficulty’, 2) ‘some 
difficulty’, 3) ‘much difficulty’, and 4) ‘I am unable to do it’. Participants who had 
difficulty with at least one ADL task (i.e. a score of 2 or more on one of the five questions) 
were considered disabled. 
Assessment of Multimorbidity 
Multimorbidity was defined as the co-occurrence of two or more diseases 14 and was 
quantified by counting the number of diseases 15 (see Appendix). Anemia was defined based 
on the World Health Organization criteria of hemoglobin concentration of <12g/dL in 
women and <13g/dL in men. CKD was defined by using an estimated glomerular filtration 
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rate of less than 60mL/min/1.73m2 calculated by the Modification of Diet in Renal Disease 
(MDRD)16. Diabetes was defined as a history of diabetes, use of glucose-modifying 
medication, or fasting blood glucose of >7 mmol/L. CHD and angina pectoris were both 
based on electrocardiograms and questionnaire17.  
To assess cognitive status and diagnose dementia cases, participants with an MMSE 
score of ≤ 2418 and a DDST score of ≤ 1719, were administered a diagnostic battery of 
neuropsychological tests and were examined by a neurologist. A consensus diagnosis of 
dementia, according to international guidelines, was made by a panel that included a 
geriatrician, neurologist, neuropsychologist and neuroradiologist. The remaining medical 
conditions were based on the AGES health questionnaire. All questions related to these 
medical conditions were formulated in the same manner (e.g. ‘Has a doctor or other health 
professional ever told you that you had cancer?’). The answer ‘I don’t know’ was assigned a 
missing value. 
Frailty Groups 
The following four subpopulations of participants with frailty were examined: 1) ‘Only 
frail’ (no disability or multimorbidity); 2), ‘Frail with disability’ (FD; no multimorbidity); 
3) ‘Frail with multimorbidity’ (FM; no disability), and 4) ‘Frail with disability and 
multimorbidity (FDM). For all analyses, the non-frail participants, who did not meet 
frailty criteria, served as the reference group. 
Assessment of Markers of Physiological Dysfunction 
The following quantitative markers which are known to reflect disease burden and/or 
subclinical impairment were examined: White matter hyperintensities (WMH) were 
assessed by MRI and divided by total intracranial volume,. The presence of brain infarcts 
was identified as defects in the brain parenchyma with hyperintensities on T2 and FLAIR 
images with a maximal diameter of at least 4mm20. Glucose levels were determined by a 
fasting morning blood draw. Coronary artery calcium level (CAC) was quantified by 
summing all 4 coronary arteries according to the Agatston method 20, 21. Estimated 
Glomerular Filtration Rate (eGFR) was calculated using the Modification of Diet in Renal 
Disease (MDRD) formula16. The red cell distribution width (RDW) was reported as part 
of the complete blood count22. C-Reactive Protein (CRP) was measured on a Hitachi 912, 
using reagents from Roche Diagnostics23. Bone Mineral Density was assessed by the 
amount of bone matter per cubic centimeter 24. Composite scores for speed of processing, 
memory and executive functioning were constructed (details have been described 
elsewhere25). 
Assessment of Mortality and Nursing Home Admission 
Every participant was followed until 31, May 2010 for mortality and nursing home 
admission. Mean follow-up was 5.94 (SD: 1.22) year for nursing home admission and 7.76 
(SD: 1.44) for mortality. Mortality information is provided by Statistics Iceland 
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(www.statice.is). Information on nursing home admission stems from the Inter Resident 
Assessment Instrument (InterRAI)26. 
Statistical Analysis 
Linear and logistic regression analyses, adjusted for age and sex, were used to determine 
differences in quantitative disease markers by subpopulations of frailty. Cox proportional 
hazards models were used to determine the association of frailty status with mortality and 
incident nursing home admission.  
The first model was adjusted for age and sex only, while the second model was adjusted 
for age at time of examination, sex, education (high vs. low education; primary and 
secondary school vs. college and university), smoking status (never smoked, former smoker 
and current smoker), alcohol intake (number of glasses per week), living arrangement 
(living alone vs. living together), depressive symptoms (assessed by the 15-item Geriatric 
Depression Scale), disability, all included diseases and total disease count. Hazard ratios 
(HR) and 95% confidence intervals (CI) are reported. P-values of 0.05 or less were 
considered statistically significant. Statistical analyses were conducted using the SPSS 
statistical software package version 18.0 for Windows (SPSS Inc., Chicago, IL, USA). 
RESULTS 
Figure 1 illustrates the co-occurrence of frailty, disability and multimorbidity. The overall 
prevalence of frailty was 10.7% (n=473). In total, 4.3% (n= 190) of older adults had frailty, 
disability and multimorbidity, while 2.1% (n= 94) were frail and disabled and 2.8% (n= 
125) had frailty and multimorbidity. Among the 473 frail participants, 40.2% (n=190) had 
disability and multimorbidity. Although the majority of frail participants reported ADL 
disability and/or multimorbidity, 13.5% (n=64) did not report ADL disability and did not 
have any of the condition used to assess multimorbidity (i.e. ‘only frail’). Descriptive 
characteristics of the 4,414 participants are shown in Table 1. The average age was 76.4 
years and 57.4% (n=2532) were female. 
Frail individuals were older, less educated, more likely to be living alone and reported 
more depressive symptoms than non-frail participants. In general, frailty characteristics 
were similarly distributed across the frail subpopulations; however, the weight loss criterion 
was more common in the ‘only frail’ group compared with the other frail subpopulations 
(Table 2). 
Frail older adults were approximately twice more likely to die or be admitted to a 
nursing home compared with non-frail participants, adjusting for age and sex (Model 1, 
Table 4). The effect of frailty on each outcome remained significant after further adjusting 
for individual diseases, total disease count, and disability although the effect sizes were 
attenuated (Model 2). 
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MM= 1271(28.8)
F= 64 (1.4)
D >1= 360 (8.2) 458 (10.4)
190 (4.3)
94 (2.1) 125 (2.8)
 
 
Figure 1. Venn diagram displaying the overlap in prevalence (%) between frailty, multimorbidity 
and disability. F= Only frail , D=Disability, MM=Multimorbidity. Note: total n=4414; healthy 
n=1852 (42.0%; i.e. no frailty, multimorbidity or disability). 
 
After adjusting for age and sex, several quantitative markers of disease burden and 
functional impairment were significantly associated with ‘only frail’ status (Table 3). 
Participants who were ‘only frail’ had decreased memory function, processing speed and 
executive function and had higher CRP values compared with non-frail participants. 
Interestingly, however, there was no difference between these two groups in terms of white 
matter lesions and brain infarcts as well as no differences in BMD, CAC, eGFR, glucose 
level and RDW. The other three frail subpopulations (FD, FM and FDM) had poorer 
neurocognitive performance than the non-frail group, but also higher white matter lesions, 
CAC, and RDW values. No differences in BMD or eGFR were observed in these groups. 
 
Table 5 shows the relative risks for mortality and nursing home admission according to frail 
subpopulations. Compared with non-frail older adults, frail participants with 
multimorbidity (FM and FDM subpopulations) had a significantly increased risk for 
mortality; however, those who were ‘only frail’ and those with frailty and disability (FD) 
did not have an increased mortality risk. In addition, the ‘only frail’ subpopulation without 
disability and multimorbidity did not have an increased risk for nursing home admission 
compared with non-frail participants. In contrast, frail participants with disability and frail 
participants with frailty, disability and multimorbidity were significantly more likely to be 
admitted to a nursing home compared with non-frail older participants 
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Table 2. Prevalence of frailty characteristics  
 Nonfrail 
 
 
(n=3941) 
Only 
Frail 
 
(n=64) 
Frail and 
disability 
 
(n=94) 
Frail and 
multimorbidity 
 
(n=125) 
Frail and 
disability and 
multimorbidity 
(n=190) 
Total 
 
 
(n=4414) 
Low energy 1798 
(45.6) 
62 (96.9) 89  
(94.7) 
121  
(96.8) 
184  
(97.0) 
2254 
(51.1) 
Low physical 
activity 
345  
(8.8) 
32 (50.0) 55  
(58.5) 
56  
(44.8) 
107  
(56.3) 
595 
(13.5) 
Weakness 512 
(13.0) 
46 (71.9) 64  
(68.1) 
95  
(76.0) 
125  
(65.8) 
842 
(19.1) 
Weight loss 127  
(3.2) 
20 (31.3) 12  
(12.8) 
27  
(21.6) 
37  
(19.5) 
223  
(5.1) 
Slowness 435 
(11.0) 
44 (68.8) 79  
(84.0) 
95  
(76.0) 
167  
(87.9) 
820 
(18.0) 
Mean (SD) § 0.82 
(0.74) 
3.19 
(0.39) 
3.18 
(0.39) 
3.15  
(0.38) 
3.26  
(0.48) 
1.07 
(1.03) 
§ Mean number of frailty characteristics. │Low energy: reduced energy level determined by the respondent 
answering ‘no’ to ‘Do you feel full of energy?’ in the Geriatric Depression Scale; Low physical activity: 
based on questionnaire, respondents who report not swimming or walking during the summer and winter 
season and not participating in low and moderate/vigorous physical activity during the last 12 months; 
Weakness: hand grip strength in the lowest 20% adjusted for height and sex; Weight loss: unintentional 
weight loss of 5kg or more in the past 12 months or a Body Mass Index (BMI) less than 18.5; Slowness: 
slowest 20% of the study population, based on usual gait speed over a 6-meter course, adjusted for height 
and sex. 
 
Table 4. Risk of death and nursing home admission according to frailty status 
 # events 
(% within 
group) 
Event rate per 
1000 
person years 
Model 1 
HR (95% CI)  
Model 2 
HR (95% CI) 
Mortality     
    Nonfrail 656 (16.6) 29 1.00 1.00 
    Frail 191 (40.3) 79 1.86 (1.57–2.21) 1.40 (1.16–1.70) 
Nursing home admission    
    Nonfrail 280 (7.1) 12 1.00 1.00 
    Frail 123 (26.5) 48 2.36 (1.89–2.95) 1.17 (1.15–1.20) 
Note: The reference groups consist of non-frail participants. │HR: Hazard Ratio; CI: Confidence Interval. 
│Model 1: adjusted for age and sex; Model 2: adjusted for age, sex, education, smoking status, alcohol 
intake, living arrangements, disability, depressive symptoms, all included diseases and disease count. 
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Table 5. Risk of death and nursing home admission in frail subpopulations 
  # events 
(% within group) 
Event rate per 
1000 
person years 
Model 1 
HR (95% CI) 
Model 2 
HR (95% CI) 
Mortality     
    Nonfrail 656 (16.6) 29 1.00 1.00 
    Only frail 18 (28.1) 52 1.24 (0.78–1.99) 1.36 (0.82–2.25) 
    FD 27 (48.7) 54 1.14 (0.78–1.69) 1.17 (0.74–1.86) 
    FM 56 (44.8) 90 2.10 (1.59–2.78) 1.50 (1.11–2.02) 
    FDM 89 (46.8) 94 2.37 (1.89–2.98) 1.43 (1.10–1.85) 
Nursing home admission    
    Nonfrail 280 (7.1) 12 1.00 1.00 
    Only frail 8 (12.9) 22 1.13 (0.56–2.29) 1.03 (0.48–2.23) 
    FD 28 (30.4) 59 2.80 (1.91–4.20) 2.03 (1.23–3.34) 
    FM 32 (26.4) 46 2.10 (1.47–3.10) 1.46 (0.98–2.19) 
    FDM 54 (28.7) 53 2.65 (1.96–3.58) 1.44 (1.02–2.03) 
Note: The reference groups consist of non-frail participants. │ FD: Frail and disability; FM: Frail and 
Multimorbidity; FDM: Frail, Disability and Multimorbidity. │HR: Hazard Ratio; CI: Confidence Interval. 
│Model 1: adjusted for age and sex; Model 2: adjusted for age, sex, education, smoking status, alcohol 
intake, living arrangements, disability, depressive symptoms, all included diseases and disease count. 
DISCUSSION 
The present study, conducted in a large population-based sample of older adults, sought to 
investigate the heterogeneity within the frail population by examining subpopulations of 
frailty. The present study shows that, although frailty is often accompanied by 
multimorbidity and disability, 13.5% of all frail people appeared to be ‘only frail’ (i.e. frail 
without the presence of multimorbidity and/or disability). Apart from weight loss, which 
was more apparent in the ‘only frail’ group, in general, the frailty characteristics were evenly 
distributed across the frail subpopulations. Compared with non-frail participants, the ‘only 
frail’ subgroup had significantly lower cognitive function and higher levels of CRP Our 
findings not only show that frailty can exist without the presence of multimorbidity and 
disability but also suggest, in congruence with previous research2, that frailty can result 
from age related physiologic changes that are not disease or disability based. The other 
three subpopulations of frailty not only showed a decrease in neurocognitive performance 
and elevated inflammation values, but were also associated with higher levels of white 
matter lesions (the FD and FDM group), CAC (i.e. the FM and FDM group) and RDW 
values (i.e. the FM and FDM group). In addition, the ‘only frail’ group was not at an 
increased risk of mortality and nursing home admission. While the FM and FDM group 
had an increased risk for mortality; the FD and FDM group had an increased risk for 
nursing home admission. 
The present results indicate that although frailty is often accompanied by 
multimorbidity and disability, a substantial portion of older individuals are frail without 
having multimorbidity and/or disability. Our results are in congruence with a study by 
Fried and colleagues which claimed that frailty is not synonymous with either the presence 
of chronic diseases or disability2. A study by Fried and colleagues showed that 27% of the 
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participants were frail without having comorbid diseases and ADL disability, while 21.5% 
of participants were frail with multimorbidity and ADL disability6. In the present study 
these percentages were respectively 13.5 and 40.2. The dissimilarity in prevalence estimates 
between the present study and the study conducted by Fried and colleagues could be due to 
differences regarding the assessment of frailty, ADL disability and multimorbidity. For 
example, while the study by Fried and colleagues used a more elaborate index to assess ADL 
disability, our study used a more complete nosological spectrum to assess multimorbidity. 
Moreover, the abovementioned difference in obtained prevalence estimates may also be 
explained by the difference in populations under study (i.e. Icelandic population and 
Americans from European and African descent) 
Cognitive functioning, as assessed by memory function, processing speed and executive 
function, was significantly decreased in all frail subpopulations as compared with non-frail 
participants. White matter hyperintensities were only related subpopulations of frailty in 
which ADL disability was present (i.e. FD and FDM group). Previous evidence suggest that 
frailty is not only associated with cognitive decline but also with Alzheimer pathology on 
postmortem examination27. The mechanism through which neurocognitive dysfunction 
plays a role in frailty has not yet been defined. It is speculated that accumulation of 
Alzheimer pathology could affect components of frailty by impairing neural systems 
involved in planning and monitoring physical functioning27. Compared to the non-frail, 
the presence of brain infarcts was much higher in all subpopulations of frailty. Nevertheless, 
no significant association between brain infarcts and frail subgroups were detected. A study 
by Newman, based on the Cardiovascular Health study, illustrated that there is significant 
association between frailty and cerebral infarcts8. This difference in obtained effects might 
be due to the fact that the present study investigated subpopulation of frailty while 
Newman and colleagues investigated different stages of frailty (i.e. nonfrail, intermediate 
frail and frail). 
Interestingly, the frail subpopulations with ADL disability (i.e. the FD and FDM 
group) showed elevated CAC levels. Although frailty has been associated with 
cardiovascular disease related outcomes8, the present results indicate that elevated CAC 
levels are not associated with frailty per se, but merely with the co-presence of ADL 
disability. The present study also provides evidence for the relation between inflammation 
and frailty, since elevated CRP levels appear to be present in all frail subpopulations. Recent 
evidence suggests that frailty is not related to one deficient dominant deregulated system 
(e.g. inflammation) but is associated with the total number of abnormal physiological 
systems28. Consequently, frailty has been suggested to be a nonlinear complex system that is 
independent of any specific system abnormalities28. Our results provide evidence for this 
postulation since various quantitative markers, such as CRP, RDW and fasting glucose29 all 
appear to be associated with frailty. The mechanism by which these impairments influence 
frailty still remains to be determined. 
When evaluating the risk of mortality and nursing home admission for different frail 
subpopulations, our results indicate that, while mortality is primarily driven by disease 
burden, functional limitations seem to be the driving force behind nursing home 
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admission. Hence, the absence of multimorbidity and disability in the ‘only frail’ lowers 
their risk for mortality and nursing home admission. 
The current study does have some limitations that should be considered. Several 
medical conditions and disability were based on participants’ self-reports, which could have 
compromised the validity of these data. Although self-reported disease status has been 
shown to correlate reasonably well with medical records, the oldest old (i.e. people aged 90 
and over) tend to under-report certain diagnosed medical conditions 30. Moreover, the 
present study included thirteen highly prevalent medical conditions, all well known for 
their profound negative effects on health. Nevertheless, other medical conditions that were 
not evaluated could not only have underestimated the prevalence of multimorbidity, but 
could also underlie some of our findings. Participants with one or more missing frailty 
characteristics were included in the present study, which could resulted in an 
overrepresentation of ‘healthy’ participants. This ‘survivor effect’ may have lead to an 
underestimations of the associations obtained in this study. In addition, because of the 
small sample size of frail subpopulations, the current study could have lacked power to, for 
example, detect an increased risk of mortality and nursing home admission for ‘only frail’ 
participants. However, since the confidence intervals of all survival analysis a rather small, it 
is not likely that a lack of power comprised our results. 
In summary, the present study indicates that heterogeneity within the frail populations 
should not be ignored. Heterogeneity in the frail older adult population present a challenge 
to understanding whether frailty is a reflection of disease burden or disability or is a true 
underlying state of vulnerability. The current study identified a subpopulation of older 
adults (‘only frail’) who were not at an increased risk for mortality or nursing home 
admission, but that did display decreased neurocognitive performance and increased CRP 
levels. Although this subpopulation of frailty appears small, this group will be of use in 
order to further investigate the pathogenesis of frailty and frail subpopulations. 
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APPENDIX 
Prevalence (and percentage) of medical conditions included in the present study  
 Nonfrail 
(n=3941) 
Only Frail 
(n=64) 
FD 
(n=94) 
FM 
(n=125) 
FDM 
(n=190) 
 Diabetes 451 (11.4) 4 (6.3) 6 (6.4) 18 (14.4) 44 (23.2) 
 Dementia 150 (3.8) 3 (4.7) 9 (9.6) 20 (16.0) 38 (20.0) 
 Anemia 280 (7.1) 3 (4.7) 2 (2.1) 35 (28.0) 46 (24.2) 
 Osteoporosis 78 (2.0) 0 1 (1.1) 3 (2.4) 11 (5.8) 
 Arthritis 1440 (36.5) 13 (20.3) 27 (28.7) 68 (54.4) 106 (55.8) 
 Cancer 493 (12.5) 4 (6.3) 7 (7.4) 31 (24.8) 51(26.8) 
 Coronary Heart Disease 805 (20.4) 5 (7.8) 6 (6.4)  41 (32.8) 68 (35.8) 
 Kidney disease 1142 (29.0) 7 (10.9) 3 (3.2) 76 (60.8) 101 (53.2) 
 Liver disease 54 (1.4) 1 (1.6) 2 (2.1) 3 (2.4) 0 
 Fractures (pelvis/hip) 86 (2.2) 1 (1.6) 0 6 (4.8) 14 (7.4) 
 Asthma 532 (3.1) 3 (4.7) 2 (2.1) 24 45 (23.7) 
 COPD 123 (3.1) 0 2 (2.1) 6 (4.8) 16 (8.4) 
 Stroke 197 (5.0) 3 (4.7) 2 (2.1) 17 (13.6) 34 (17.9) 
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Diabetes mellitus type II as a risk factor for depression: a 
lower than expected risk in a general practice setting 
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ABSTRACT 
Background 
The aim of the present study was to determine whether a diagnosis of diabetes mellitus 
(DM) in a primary setting is associated with an increased risk of subsequent depression. 
Methods 
A retrospective cohort design was used based on the Registration Network Family Practice 
(RNH) database. Patients diagnosed with diabetes mellitus at or after the age of 40 and 
who were diagnosed between 01–01–1980 and 01–01–2007 (N = 6140), were compared 
with age-matched controls from a reference group (N = 18416) without a history of 
diabetes. Both groups were followed for an emerging first diagnosis of depression (and/or 
depressive feelings) until January 1, 2008. 
Results 
2.0% of the people diagnosed with diabetes mellitus developed a depressive disorder, 
compared to 1.6% of the reference group. After statistical correction for confounding 
factors diabetes mellitus was associated with an increased risk of developing subsequent 
depression (HR 1.26; 95% CI: 1.12–1.42) and/or depressive feelings (HR 1.33; 95% CI: 
1.18–1.46). After statistical adjustment practice identification code, age and depression 
preceding diabetes, were significantly related to a diagnosis of depression. 
Conclusions 
Patients with diabetes mellitus are more likely to develop subsequent depression than 
persons without a history of diabetes. Results from this large longitudinal study based on a 
general practice population indicate that this association is weaker than previously found in 
cross-sectional research using self-report surveys. Several explanations for this dissimilarity 
are discussed. 
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INTRODUCTION 
It is generally known that co-morbid depression is highly prevalent in persons diagnosed 
with a chronic illness1. Especially, the co-occurrence of depression in persons diagnosed 
with diabetes mellitus has been a major topic in recent epidemiologic research. This 
research suggests that depression is more prevalent among adults with diabetes than in 
those without this condition2–4. More precisely, a review and meta-analysis involving 42 
cross-sectional studies by Anderson et al. (2004) suggests that diabetes doubles the odds of 
a co-morbid depression5. 
The impact of depression on patients with diabetes has also been an area of interest. 
Gonzales and colleagues (2007) defined co-morbid depression as a risk factor for non-
adherence to important aspects of diabetes self-care, such as medication and diet regimens6. 
In addition, diabetic patients with a depression reported a greater number of physical 
symptoms related to diabetes4, and showed lower levels of metabolic control 7 and quality 
of life8. 
In the past decade, literature on the association between diabetes mellitus and 
depression has grown considerably. However, the temporal or causal relationship between 
diabetes mellitus and depression still remains unclear since only few longitudinal studies 
have evaluated diabetes as a risk factor for depression9. Most studies that were of 
longitudinal nature focused on the relation between depression and the development of a 
subsequent diagnosis of diabetes mellitus10–12 have produced contradictory results10,13,14. 
The few studies that did focus on the longitudinal relation between diabetes and 
subsequent depressive disorder showed that diabetes type II is associated with an increased 
risk of developing depressive symptoms13,15,16. However, these studies were either restricted 
to small populations16 or lacked a proper adjustment for the presence of other chronic 
diseases 13, 15. Consequently, the results of these studies must be considered less 
representative for the general population. 
Finally, another major drawback in previous mentioned longitudinal studies concerns 
the use of self-report surveys to identify depression (e.g. CES-D11, 13, 16, HADS6, BDI-II17, 
PHQ4) or self-reported diabetes16. An important consequence of this differential assessment 
is the wide variability in the presence and strength of the established association between 
diabetes and depression11. Besides, self-report surveys may not be the most appropriate 
measure for the assessment of depressive disorder for several reasons. Data from self-report 
scales cannot be used for making a clinical diagnosis of depression. Moreover, by using 
different cut-off points to define depression5, comparison between these studies is hindered. 
Finally, health questionnaires are known to suffer from several conceptual problems. For 
example, the results of self-reports and questionnaires are based on a particular point in 
time that frequently do not include information about the intensity or consistency of the 
complaints or problems, personal growth or coping strategies18. 
In the present study, the previously mentioned drawbacks were defied. The aim of the 
present study was to assess the risk of depression over time in patients with diabetes 
mellitus compared with those without a history of diabetes. For this purpose, a large 
retrospective cohort study was performed in a large general practice setting. 
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METHODS 
Sample Frame 
The present study was carried out within the context of the Registration Network Family 
Practices (RegistratieNet Huisartspraktijken, RNH). Descriptive background characteristics 
of samples in other studies which made use of the RNH database were found to be 
comparable to the Dutch population19. The RNH is a continuously updated database, 
which contains the medical records of patients from 21 family practices in which 65 general 
practitioners (GPs) working in the south of the Netherlands are participating. This 
database includes all relevant current and past health problems. A health problem is defined 
as ‘anything that has required, does or may require health care management and has 
affected or could significantly affect a person’s physical or emotional well-being’20. These 
problems are coded in a standardized fashion, according to the International Classification 
of Primary Care (ICPC), using the criteria of the International Classification of health in 
Primary Care (ICHPPC-2) 21 and other more current guidelines of the Dutch College of 
GP’s. A diagnosis is made by the GP or by a medical specialist who is consulted by the GP. 
Especially in complex medical conditions, registration is often based on a specialist 
diagnosis reported to the GP. In general, health problems are only coded by the GP when 
they are permanent (no recovery expected), chronic (duration longer than 6 months) or 
recurrent (more than three recurrences within 6 months), or when they have lasting 
consequences for the functional status or prognosis of the patient. The database also 
contains background information on the patient’s sex, date of birth, marital status, type of 
household, practice identification code and level of education. Membership of the RNH 
population ends by migration or death. All patients included in the RNH database have 
been informed about the anonymous use of their health information and are removed from 
the database if desired. The quality of the data is ascertained by ample instruction and 
training sessions, regular regional consensus groups, quality control audits, an online 
thesaurus available during data-entry and systematic control for erroneous or missing 
entries20. 
Diagnostic Criteria 
ICPC is now widely used in Europe as a diagnostic classification system, which has 
relations both with ICD-9 and with other ICD-9 derived systems being used in primary 
care21. Modified international criteria are followed, as expressed in the guidelines of the 
Dutch College of General Practitioners, for the diagnosis of Diabetes Mellitus (ICPC code 
T90)21. 
The diagnosis of DM requires an elevated glucose level [fasting plasma glucose levels of 
124 mg/dl (6.9 mmol/l) or more, a fasting capillary glucose level of 108 mg/dl (6.0 
mmol/l) or more, or non-fasting plasma or capillary glucose level of 198 mg/dl (11.0 
mmol/l)] that is confirmed using a fasting glucose level a few days later. Since the disease 
contents and progress between type I and type II diabetes may vary considerably, the 
present study was aimed at patients with type II diabetes. In order to diminish the number 
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of patients with DM type I in the present study, only patients diagnosed with DM at or 
after the age of 40 years were included. 
The diagnosis of depressive disorder (ICPC code P76) was made in a diagnostic 
interview conducted by either a general practitioner or a specialist. According to ICPC 
criteria, patients should not be psychotic and comply with at least three of the following six 
criteria: (i) sadness or melancholy more than can be explained by the psychosocial stress, (ii) 
suicidal thoughts or attempt, (iii) indecisiveness, decreased interest in usual activities or 
diminished ability to think, (iv) feelings of worthlessness, self-reproach, or inappropriate or 
excessive guilt, (v) early morning wakening, hypersomnia, or early morning fatigue, or (vi) 
anxiety, hyperirritability, or agitation. The nine symptoms of a depressive episode described 
in the DSM-IV of the American Psychiatric Association are equivalent to the six criteria of 
the RNH following ICPC code P7621. Patients who presented themselves with chronic or 
recurrent depressive feelings, but who did not fully complied with the requirements for 
depressive disorder (ICPC code P76) were coded as having depressive feelings (ICPC code 
P03). 
Study Design 
Data were drawn from the RNH database available on January 1, 2008. Patients with DM 
in our study were diagnosed with ICPC code T90 (Diabetes Mellitus Type I and Type II) 
between January 1, 1980 and January 1, 2007. In order to restrict the number of patients 
with type I diabetes, only patients with diabetes mellitus who were 40 years or older at the 
time of diagnosis were included (N= 6140)3, 22. 
The reference group consisted of subjects with no history of DM. In order to increase 
the power of the current study, individuals in the reference group were matched to the 
diabetes patients by age (year of birth) and were assigned the date of diagnosis of their 
matched counterparts as the starting date for their follow-up period. Each patient was 
matched (according to year of birth) to 3 controls in the reference group (N= 18416), 
except for 4 patients, who could only be matched to 2 controls from the reference group. 
Each subject was followed for an emerging first diagnosis of a depressive disorder. Follow-
up ended on January 1, 2008, or earlier in case of a diagnosis of depressive disorder or due 
to censoring (i.e. migration or death). In the sensitivity analyses, each subject was followed 
for an emerging first diagnosis of a depressive disorder or the emergence of depressive 
feelings (ICPC code P03). Follow-up ended on January 1, 2008, or earlier in case of a 
diagnosis of depressive disorder, depressive feelings or due to censoring (i.e. migration or 
death). 
Statistical Analysis 
Statistical analyses were conducted using the SPSS statistical software package version 16.0 
for Windows (SPSS Inc., Chicago, IL, USA). An independent T-test was used to examine a 
possible difference in mean follow-up time between the diabetes and the reference group. 
Cox proportional hazards survival analysis was applied in which the effect of diabetes on 
depression was corrected for age (ranging from 40 to 97 year), gender, level of education (3 
levels: low, intermediate, and high), number of chronic co-morbid diseases in 7 categories 
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(ranging from 0 to 6 diseases, in which the last category coded for 6 or more diseases) (see 
Appendix A.), the practice where a patient was registered (practice identification code) and 
a diagnosis of depression preceding the start of follow-up. The latter variable coded for all 
subjects who had a diagnosis of depression (and/or depressive feelings in case of the 
sensitivity analysis) before the starting date of the follow-up period. 
All potential confounders in the analyses were declared as categorical and coded into 
dummy variables. Since patients were matched with controls by age (in years), age was also 
declared as a categorical variable. Hazards ratios (HR) and 95% confidence intervals (CI) 
are reported. For the potential confounders the p-value of the survival analysis was 
reported. Potential confounders who were not significantly related (P-values > 0.05) to a 
subsequent diagnosis of depression were excluded from the final analyses using a backward 
method. Two kinds of analyses were conducted. The first analysis made use of the diagnosis 
of depression as event outcome. The second analysis was a sensitivity analysis, in which the 
diagnosis of depressive feelings, not complying with the requirements for depressive 
disorder, was pooled with the diagnosis of depression as event outcome. 
RESULTS 
Descriptive characteristics of the study sample are reported in Table 1. A significant 
difference in time until diagnosis of depressive disorder between the two groups was found 
(P < 0.001).  
 
The mean follow-up was 7.7 years (SD = 5.7) for the diabetes group and 7.9 years (SD = 
6.6) for the reference group. During the follow-up period, 122 patients (2.0%) with 
diabetes mellitus and 295 persons (1.6%) of the reference group developed a depressive 
disorder. 
Gender, co-morbidity and level of education did not have a significant effect and were 
therefore removed as covariates from all statistical analyses. A diagnosis of diabetes mellitus 
was significantly associated with a greater likelihood of developing subsequent diagnosis of 
depression (HR 1.32; 95% CI: 1.19–1.48). Statistical adjustment for the remaining 
confounders (age, practice identification code and depression preceding DM) attenuated 
the strength of this association, but it remained statistical significant (HR 1.26; 95% CI: 
1.12–1.42) (see Figure 1). Adding depressive feelings to the event outcome yielded similar 
results. During follow up diabetes patients were significantly more likely to develop a 
depressive disorder and/or depressive feelings (HR 1.27; 95% CI: 1.15–1.41). After 
controlling for confounding factors (age, practice identification code and depression 
preceding DM) this association became even slightly stronger (HR 1.33; 95% CI: 1.18–
1.46) (see Figure 2). After adjusting for the other variables, practice identification (P = 
0.004), age (P < 0.001) and a diagnosis of depression preceding DM (P < 0.001) code also 
showed a significant association with risk of depression. 
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Table 1. Descriptive characteristics of study population 
 Patients Controls 
Characteristics (n = 6140) (n = 18416) 
No. of subjects with depression preceding diabetes (%) 325 (5.3) 863 (4.7) 
No. of subjects with depression after diabetes (%) 122 (2.0) 295 (1.6) 
Mean age in years (SD)a  63.8 (11.2) 63.8 (11.2) 
Mean number of follow-up years (Range) 7.7 (0–28) 7.9 (0–28) 
Gender   
 Males (%) 2953 (48.1) 8519 (46.3) 
 Females (%) 3187 (51.9) 9897 (53.7) 
Number of co-morbid diseases (%)   
    0 0 (0.0) 3325 (18.1) 
    1 0 (0.0) 3844 (20.9) 
    2 566 (9.2) 3367 (18.3) 
    3 1003 (16.3) 2580 (14.0) 
    4 1040 (16.9) 1950 (10.6) 
    5 929 (15.1) 1377 (7.5) 
    ≥6  2602 (42.4) 1973 (10.7) 
Educational Level   
    Low (%) 3052 (49.7) 9483 (51.5) 
    Medium (%) 945 (15.4) 4143 (81.4) 
    High (%) 264 (4.3) 1460 (7.9) 
Mean age described as date of inclusion cohort │For 30.6% of the diabetic group and 18.1% of the 
reference group educational information was missing or not updated; low is defined as primary school 
and/or lower vocational education, medium as secondary school and/or medium level vocational education, 
high as higher vocational education and/or university. 
 
 
Figure 1. Survival curve stratified for age, practice identification code and a  
diagnosis of depression preceding DM. 
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Figure 2. Survival curve stratified for age, practice identification code and  
a diagnosis of depression preceding DM.  
 
DISCUSSION 
The present study revealed that a diagnosis of diabetes mellitus type II at or after the age of 
forty was associated with an increased likelihood of developing a subsequent depression or 
depressive feelings. After statistical adjustment, practice identification code, age and a 
diagnosis of depression preceding the diagnosis of diabetes mellitus appeared to be 
significantly related to a subsequent diagnosis of depression. 
This is the first longitudinal study on the association between diabetes mellitus and 
subsequent depression based on data from general practices. A meta-analysis by Anderson 
et al. (2001) involving 42 cross-sectional studies reported that patients with type II diabetes 
are twice more likely to experience depressive symptoms than their peers without diabetes5. 
In contrast, the present results suggest that patients with diabetes mellitus are 1.12–1.41 
(CI) times more likely to develop depression and 1.18–1.46 times (CI) more likely to 
develop depression and/or depressive feelings. Our findings confirm the outcome of earlier 
studies in showing an increased incidence of depression among patients diagnosed with 
diabetes mellitus. However, this association appears to be weaker than found in earlier 
studies. This discrepancy can be due to a number of reasons. Firstly, it has been shown that 
depression rates are two to three times higher in studies that use self-reports5. For example, 
self-report measures may identify a broader spectrum of depressive disorders or symptoms 
that may reflect co-morbid psychiatric illness or general distress5, which could result in an 
overestimation of the prevalence of depression13. Secondly, using a diagnosis of depression 
preceding DM as a confounder can have reduced the association between diabetes type II 
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and depression. Although the association between diabetes and depression attenuated 
without this correction, it remained statistical significant. Finally, in the present study GPs 
were not instructed to systematically screen patients for possible depression or depressive 
symptoms which could have led to a lower risk estimate. If this is indeed the case, the 
present study reports an underestimation of depression in diabetes patients. It is important 
for GPs to be aware of the fact that patients with type II diabetes are more likely to 
experience depression than their peers without diabetes. Several studies have shown that 
adherence to a variety of self-care activities6 and metabolic control7 decreases in diabetes 
patient as a consequence of co-morbid depression. Diabetes patients with co-morbid 
depression also show a decline in quality of life8. Moreover, for approximately 75% of the 
people diagnosed with diabetes mellitus in the Netherlands, the GP is the primary medical 
caregiver23, making the GP the proficient person to detect depression or depressive feelings. 
The present findings imply that GPs who are consulted by patients diagnosed with DM 
type II should be especially aware of the patient’s increased risk of developing depression in 
the near future. In short, general practitioners should be alert to possible early signs of 
depression in diabetic patients to ensure early detection and possibly even prevention of a 
depressive disorder. Nurse practitioners for diabetes mellitus, who assist the general 
practitioners and provide a broad range of health care services, could fulfil an important 
role in this aspect. Nurse practitioners focus on patients’ conditions as well as on the effects 
of the illness on the lives of the patients and their families and can therefore serve as a 
“point of entry” for physical as well as mental problems diabetes patients encounter. Nurse 
practitioners could enhance diagnostics by systematically screen diabetes patients for 
possible depression or depressive symptoms in order to prevent underdiagnosis of 
depression in diabetes patients. 
Another intriguing finding of the present study was that practice identification code 
was significantly associated with an enhanced likelihood of developing a depression. It 
appears that in 3 of the 21 practices involved, a relatively high percentage of patients is 
diagnosed with depression (ranging from 9.5 to 9.8% of the patients) while in 3 of the 21 
practices this percentage is noticeably smaller (ranging from 4.0 to 4.7% of the patients). 
Hence, it seems plausible that GPs may differ regarding their inclination to diagnose a 
depression. After investigating the most important characteristics of the practices 
incorporated in the present study, such as geographic place (defined by postal code) of a 
general practice, total number of diagnosed depressive disorders in the general practice, 
number and gender of patients, education of the patients, and number and gender of GPs 
in a practice, we were not able to identify any specific characteristics that could explain this 
effect. This diagnostic variability may have important implications for general practices24. 
Our study has several advantages over previous studies. This is the first longitudinal 
study that evaluated the causal relationship between diabetes mellitus type II and 
subsequent occurrence of depressive disorder and/or depressive feelings in a general practice 
based setting. Consequently, the results seem more representative for the general 
population than results of studies conducted in smaller and more homogeneous 
samples17,25. Also, the sample size used in the present study supports the robustness of our 
risk estimates. Moreover, prior studies commonly relied on a variety of self-report surveys 
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which are known to overestimate the prevalence of depression 5. The six criteria following 
diagnosis of depressive disorder in the RNH database are essentially comparable to the nine 
symptoms of a depressive episode described in the DSM-IV of the American Psychiatric 
Association21. These criteria are a solid foundation for making a uniform diagnosis of 
depression by GPs. 
Despite the previous mentioned strengths, our findings must be interpreted in light of 
some possible limitations. First, since the RNH database does not make a clear distinction 
between diabetes type I and type II, the present study only included patients diagnosed 
with diabetes mellitus at or after the age of 40 years. Consequently, it cannot be ruled out 
that none of the diabetes type I patients were included. Second, the total number of 
conditions registered in the RNH database reflects the GPs perspective of the health status 
and relevant health problems of his patients. As a result, some health problems may be 
missing because the patient did not report them to the GP or because the GP does not 
judge them to be clinically significant26. The number of missing health problems, however, 
appears to be rather small27. Furthermore, GPs have a tendency to use a diagnosis primarily 
as a mean to reach the goal of helping the patient and not as a goal in itself18. This is not 
the case in questionnaires and self-reports, which could have resulted in an underestimation 
of the prevalence of depression. Due to the very large follow-up period (01–01–1980 to 
01–01–2008) it may be argued that no state of the art impression of the association 
between diabetes and subsequent depression is given. However, an additional analysis 
involving a smaller, more recent period of time (01–01–1995 to 01–01–2008) yielded 
similar results. Moreover, an analysis with a follow-up period of only 6 months was also 
conducted, which gave similar results. Finally, one of the drawbacks of studies that 
combine data from multiple practices is the between practice variability 27: it is generally 
assumed that some variability exists between general practitioners in making a diagnose24. 
Possibly, this between practice variability may have resulted in the effect that code of 
practice has on the development of depression. 
Further research is warranted to investigate a multitude of unanswered questions. More 
well-conducted research with adequate control for confounding factors is needed to 
investigate the causal relationship between diabetes and depression mellitus more in depth. 
In particular, the influence of practice setting on the longitudinal association between 
diabetes and depression should be studied in more detail. Future research should also 
explore the role of other confounding factors. For example, the influence of psychosocial 
and social-economic factors on the association between diabetes and depression needs to be 
elucidated. 
In conclusion, the present research adds to the evidence concerning the association 
between diabetes mellitus type II and depression, in that this association also holds in a 
longitudinal setting in a large general practice population. The present results indicate, 
however, that patients with diabetes mellitus are less likely to develop a subsequent 
depression than was expected based on previous research. 
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ABSTRACT 
Background 
To date, we are confronted with large collections of medical datasets and medical 
documents. The aim of the present article is to get the medical researcher acquainted with 
the emerging field of Knowledge Discovery in Databases (KDD), which can aid researchers 
in the context of hypothesis generation. 
Methods 
Descriptive study based on literature. A summary about what KDD is and how it can be 
used to extract information from medical data and documents is provided. The add-on 
value of KDD applications over and above traditional statistical methods is outlined. 
Examples of KDD applications useful in (bio)medical research are provided. 
Results 
KDD extends traditional statistical methods by providing useful tools for exploratory 
research in large amounts of medical data and documents in order to detect (hidden) 
patterns, trends, and anomalies. Rather than to serve as a golden standard, the application 
of KDD is aimed at supporting a (bio)medical expert’s knowledge and decisions. 
Conclusions 
KDD can explore and model large amounts of (bio)medical data and documents in a 
(semi)automatical matter to extract previously unknown, hidden and potentially useful 
information. Although KDD is not a universal solution it can provide innovative and 
useful tools for (bio)medical research. 
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INTRODUCTION 
Today, many health care workers systematically collect electronic patient data (Electronic 
Patient Records, EPRs) as part of their daily routine. When EPRs were first introduced 
these new databases were considered as an important tool for improving quality of care, 
since these medical databases encompass an important amount of information, including 
details about patient encounters, drug prescriptions and disease diagnosis. These relatively 
new types of comprehensive databases enable medical researchers to provide answers on 
many health-related research questions. Examples of such questions are ‘Does drug A and 
drug B cause adverse drug reactions when provided together to cure disease X?’, ‘Is 
comorbid disease A in people diagnosed with disease B associated with a lower quality of 
life when compared to people who are only diagnosed with disease B?’ or ‘Is gene A a 
predictor for the development of disease X?’. They are derived from a priori postulated 
hypotheses and are therefore tested relatively simply using standard statistical analyzing 
methods. 
Large medical databases can also provide the opportunity to conduct more exploratory 
bottom-up research, which exists without a priori postulated hypotheses. This may include 
research questions such as ‘Which combinations of drugs can cause adverse drug reactions?, 
‘Which disease combinations may lead to a significant decrease in quality of life?’ and 
‘Which genes are predictive for disease X’?. In contrast to the first set of research questions 
which are part of the practice of hypothesis testing, the latter type of questions ideally fit 
within hypothesis-generating research. 
Although standard statistical techniques are indeed adequate and useful to evaluate a 
priori postulated hypotheses, they are far less useful in the practice of hypothesis-generating 
research. Moreover, standard statistical techniques are adequate and useful to process 
moderate amounts of data but are less efficient when the amount and complexity of data 
increases1. When analyzing large and complex data sets with traditional statistical 
techniques, the basic problem is that the number of predictive variables be limited a priori. 
As a result, information about relationships that are not obvious or patterns that are not 
expected, but are present in the discarded variables, will remain undiscovered. As a result of 
the lack of ability to extract new information and insight from these large amounts of 
medical data, (bio)medical researchers and epidemiologists may be missing a significant 
portion of medical relevant information. Hence, there is an immediate call for new 
techniques which enable researchers to analyze large amounts of data in a fast and 
(semi)automatically manner without the need of postulating a priori hypotheses. 
 
The need to extract meaningful information and patterns from observed data has always 
been an integral part of science, especially since pattern detection is essential for the 
construction and testing of scientific hypotheses and causal models. Since new associations 
and patterns can be found in large (bio)medical databases which could benefit individual 
patients as well as society, new analytical techniques have been applied to investigate the 
hidden scientific treasures contained in medical databases and in the medical literature2. 
For example, Harpez and collegues evaluated 162.844 reports of suspected Adverse Drug 
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Events (ADEs) in order to investigate which combinations of two or more drugs may cause 
ADEs 3. Using a well established data mining method called association rules they were able 
to explore adverse drug events without postulating any a priori assumptions. Of the 2.603 
produced association rules, 1.167 contained three or more drugs and 67% of the found 
associations were already known, suggesting that the data mining method was a valid 
approach for the identification of ADEs. Some drug combinations that were found, 
including the combination cyclophosphamide, doxorubicin, prednisone and rituximab, 
which was reported to cause febrile neutropenia, was not previously identified as an ADE. 
Another intriguing finding of this study was that atorvastatin in combination with lisinopril 
was found to cause dyspnoea, which also had not been previously recognized3. 
Piatetsky-Shapiro was the first to introduce the term Knowledge Discovery in 
Databases (KDD) when referring to the process of identifying valid, novel, potentially 
useful, and comprehensible patterns in complex and large data sets, without the postulation 
of a priori hypotheses4. Indeed, the primary aim of knowledge discovery is to infer implicit 
and hidden patterns into well-grounded and testable hypotheses5. In contrast to traditional 
statistical analyzing methods, KDD allows much more variables (in data) and text (in 
documents) to be examined in relationship to one another and to the outcome in a more 
efficient, inexpensive and objective manner6. For example, a study by Swindell and 
colleagues (2010) was able to include as much as 377 different patient characteristics in 
4.097 subjects to identify the factors predictive for successful aging in older women7. The 
multivariate model, using a cross-validation approach involving random splitting of 
subjects into “training” and “testing” sets (explained below) integrated these 377 factors to 
represent a multidimensional ‘healthy aging’ phenotype. 
In this paper we want to provide an overview of what KDD techniques can offer to 
biomedicine and epidemiology and how it can be applied in health care research. We will 
focus on two sources of information; (large) medical databases, in particular those involving 
patient records, and repositories of (bio)medical literature (e.g. Medline/Pubmed). This 
paper is not intended to provide an exhaustive overview of all available knowledge discovery 
techniques. Rather, it is aimed at giving a concise and comprehensible outline of knowledge 
discovery by providing the mere value of KDD over statistical exploratory research and to 
discuss several interesting applications of KDD that are useful in the practice of hypothesis 
generating in epidemiology and (bio)medical research. 
TRADITIONAL STATISTICAL TECHNIQUES VERSUS KDD 
In medical research two general approaches can be discerned: a closed process, which is 
defined by testing hypotheses, and an open discovery process, which is characterised by the 
generation of hypotheses5. Traditional statistical techniques are defined as serving a closed 
approach; the researcher should know in advance what he is looking for, based on 
previously conducted research and his own knowledge and experience. In pursuing this 
route, the researcher will not easily find something outside his direct scope of interest8. 
Moreover, researchers are subject to confirmation bias; their reaction to empirical results 
highly depends on whether these results support their a priori postulated hypotheses9. 
Databases constructed for this type of research primarily serve the purpose to address a 
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particular (medical) problem. This type of research is concerned with establishing a 
statistical model that provides a good explanation of the associations observed in the data2. 
These traditional statistical analyses are therefore known as ‘confirmatory analyses’10. In 
contrast, knowledge discovery techniques serve an open discovery process, aimed at 
discovering unexpected patterns, without a priori postulating hypotheses. Such techniques 
are therefore, in principle, exploratory and ad hoc. The goal is to find the unexpected, that 
is, to acquire knowledge that is not necessarily the result of observations made in earlier 
research. Such findings may generate new hypotheses and the search for associations 
between phenomena that were not previously thought of 8. Knowledge discovery 
techniques are often applied to data that are collected without any predetermined purpose. 
The contents of these databases are, most often, dynamically changing (e.g. electronic 
patient records). 
Because of the proliferation of data in the past decades, there are several statistical 
analyzing methods that are aimed at exploratory research, such as cluster analyses and 
decision trees. However, these traditional statistical methods are of limited value for 
exploratory research when applied to large datasets2; patterns in a scatterplot become 
difficult to interpret when containing thousands or even millions of data points2. Creating a 
correlation matrix of thousands or millions of variables is extremely time-consuming and 
perhaps even impossible when conducted by traditional statistical methods. Moreover, 
statistical methods are known to rely on a arbitrary division in “significant” or “non-
significant” findings (i.e. it commonly employs a threshold of P= 0.05, i.e. a type I error of 
5%)11. However, in a large dataset this employed strategy will find evidence for even the 
smallest effects. Consequently, chance findings will be published based on the criteria for 
statistical significance11. In sharp contrast, in the interactive KDD process the subjective 
judgment of the (medical) user is extremely relevant; the user (being the expert) has to 
decide if the discovered patterns indeed satisfy a priori stated criteria (i.e. predictive validity 
on new data, novelty of the patterns, clinical relevance, pragmatic utility)10. For example, 
the researcher should come up with a theoretical framework that explains the patterns that 
were found. Thus, instead of interpreting the data in terms of statistical significance (i.e. p-
values and confidence intervals), data mining needs more careful considerations: e.g. are the 
discovered patterns new, important and clinically valuable12? Furthermore, in contrast to 
KDD applications, statistical methods should adjust for confounding factors (i.e. factors 
that are related to the independent as well as the dependent variable). Since KDD is aimed 
at hypothesis generation rather than on explaining the patterns observed in the data, i.e. 
investigating whether A causes B, B causes A or an unknown factor that causes both, KDD 
application do not have to adjust for possible confounding factors. 
THE KDD PROCES 
Knowledge discovery incorporates a new generation of data analyses that has emerged from 
the need to identify meaningful patterns in sometimes massive amounts of data. The basic 
steps of the KDD process, as first introduced by Fayyad, Piatetsky-Shapiro and Smyth1, 
will be outlined here. An ideal system for KDD should support all these steps starting with 
raw data up to producing useful knowledge (see Figure 1)13. Some steps in the KDD 
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process are merged and simplified in order to maintain the conciseness and 
comprehensibility of this paper. Although many KDD applications are readily applicable, 
real-world databases present difficulties due to the nature of their contents which tend to be 
dynamic, incomplete, redundant and noisy14. Enhancing the consistency of the data will 
consequently improve the next steps of the KDD process15. This first step is known to be 
the most time consuming step of the KDD process. Data recorded using manual data entry 
can contain incorrect or imprecise data and may be the cause of malfunction and error13. 
Data cleaning and pre-processing is therefore an important and necessary preparatory step. 
This includes the detection and correction of inaccurate records including the removal of 
outliers and duplicate records and decisions on strategies how to handle missing data1. 
 
 
 
 
Figure 1. The KDD process (simplified) as firstly introduced by Fayyad, Piatetsky-Shapiro and 
Smyth (1996). Printed with permission from Piatetsky-Shapiro. 
 
Redundant data or data irrelevant for the problem at hand must eliminated in order to 
simplify the task of discovering of hidden patterns in the datasets16. For example, data 
beyond the scope of the study, i.e. data on younger people when the study at hand concerns 
people aged 70 and older can be deleted without loss of information. 
In order to achieve the primary goals of the researcher, a data-mining method, suitable 
for the database and research at hand must be found, which is the second step in the data 
mining process. Data mining has different purposes to give meaning to data, which include 
summarizing, classification, regression or clustering. Although these data mining purposes 
might appear different at first glance, they share many components and it is therefore not 
uncommon to find that they can be applied to the same analyzing problem 1. For example, 
a study by Gregori and co-workers (2009) compared six, commonly used data mining 
methods to determine the covariates selection, predictive accuracy and clinical indication of 
analytical models for predicting mortality in patients with diabetes mellitus 17. Using these 
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new techniques the authors were able to conclude that their techniques did not severely 
differ in predictive capability (around 70%) and that therefore multiple techniques can be 
used to analyze one and the same data set. 
The third step involves the actual ’mining’ of the data. Data mining is the process of 
discovering patterns in large databases in an automatic or semiautomatic manner1. This 
can, for example, result in new classification schemes, newly generated hypotheses or new 
predictive models which were previously unknown. For example, a data mining technique 
referred to as ‘association rules’ can, in contrast to traditional statistical methods, evaluate 
tens or even hundreds of different prognostic variables in order to predict disease outcome. 
In the last, fourth step, the ‘mined’ patterns must be interpreted in a meaningful way 
in order to be presented as ‘knowledge’. The patterns discovered by data mining should be 
meaningful and lead to some particular advantage. The knowledge of a domain expert is 
crucial when the found patterns are evaluated from a conceptual point of view. Since the 
judgment of the user is essential, the KDD process can be viewed as an interactive process 
between automated, data mining driven techniques and the expert in (bio)medical research 
or epidemiology. The user can decide if the discovered patterns indeed satisfy the a priori 
postulated criteria by evaluating the predictive validity of the data mining technique on the 
one hand, and the novelty, the pragmatic utility and the comprehensibility of the end 
results on the other18,19. For instance, the degree of concordance in predictive accuracy of a 
model when applied to new data may be an important criterion, since patterns and 
associations found in database A should also be present in database B when it contains the 
same type of information. This final step in the KDD process may involve visualization of 
the extracted patterns but can also, as can be seen from the figure below, include returning 
to previous steps in the KDD process if necessary19. 
KNOWLEDGE DISCOVERY TECHNIQUES 
Ever since KDD started to be recognized as a well-defined area of research, investigators 
have developed new techniques and tools for the automatic extraction of useful 
information20. KDD techniques can be subdivided into two primary approaches: directed 
data mining, also named supervised learning, and undirected data mining, also known as 
unsupervised learning6. 
Directed or supervised data mining involves ‘training’ of a model in order to explain 
patterns in data in the most appropriate manner. Supervised data mining operates under 
‘supervision’ by being provided with the actual outcome for each training example (e.g. 
risk/no risk group or frailty vs. successful aging). Directed or supervised data mining 
techniques include classification, prediction models (e.g. regression models) and association 
rules. Undirected data mining involves the search for similarities between objects in the 
data in order to determine how they can be characterized. Hence, no predetermined 
outcome measures are set. Neural networks, clustering and feature extraction techniques are 
examples of undirected or unsupervised data mining. 
Roiger (2003) clarified the difference between supervised and unsupervised data 
mining by comparing classification methods to clustering methods21. For example, assume 
that a supervised model was conducted with a prior postulated dichotomous outcome 
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measure called ‘diseased yes/no’ (i.e. diseased vs. healthy persons). The supervised data 
mining approach will use the available variables (e.g. genetics, and sociodemografic and 
pathophysiologic variables) to predict the outcome at hand. In contrast, unsupervised data 
mining will use the same variables in order to examine if the two clusters (i.e. diseased and 
healthy) are naturally formed without a predetermined outcome21. Hence, supervised 
classification models are conducted by forming concept definitions from sets of data 
containing predefined classes, while unsupervised clustering builds models from data 
without the aid of predefined classes. In the latter, data are grouped together based on a 
similarity scheme defined by the clustering method. Two examples of data mining 
techniques, association rule learning and classification, which both are highly usable for 
(medical) epidemiologic research, will be outlined hereafter. 
Association-Rules 
Association rule learning is one of the most popular data mining applications for 
discovering relations between variables. Association rules, firstly described by Agrawal 
(1993), are aimed at producing rules that can establish relationships between events by 
predicting the occurrence of one event based on the occurrence of another event22. An 
association rule makes use of the form X→Y. Such a rule could be, for example, [high 
blood pressure + high cholesterol]→[cardiovascular disease], meaning a diagnosis of high 
blood pressure and high cholesterol encompasses an increased risk for cardiovascular 
disease. The primary aim of association rules is to find relationships that apply to a large 
number of items (e.g. patients) and have a high accuracy23. The best known and generally 
used criteria for association rules are support and confidence which will be explained 
hereafter, by using a simple database in clinical epidemiology. 
Consider a small data table as displayed in Table 1. The support of an association rule 
is the ratio (in %) of the instances for which it predicts correctly, often also called the 
coverage of a rule. Hence, support is the frequency of coexistence of certain attributes (i.e. 
variables). 
 
Table 1. Example database including 4 medical conditions and 6 patients   
# High blood pressure High cholesterol Pulmonary heart 
disease 
Cerebrovascular 
accident 
1 1 1 0 0 
2 0 1 1 0 
3 1 1 1 0 
4 0 1 0 0 
5 0 0 0 1 
6 1 1 0 1 
Note: 0 = diagnosis is absent and 1 = diagnosis is present 
 
In the previous example, [High blood pressure + high cholesterol] has a support of 3/6 = 
0.5 since this combination occurs in 50% of all patients. In general, rules with large 
support are preferred over rules with low support. For example, clinical epidemiologists 
may be more concerned about how two (or more) medical conditions are related if they 
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occur in 20% of all patients than a combination that occurs in only 2% of all patients. 
However, while a high support often is desirable, this is not always the case. Even if a 
combination of medical conditions does not occur very frequently, association rules 
showing a relationship between two medical conditions that has serious consequences (e.g. 
pneumonia in people with Chronic Obstructive Pulmonary Disorder (COPD)) is highly 
important. 
A second important requirement is confidence. The Confidence of a rule is the ratio 
(in %) of the instances that is predicted correctly, expressed as a proportion of all instances 
it applies to. Confidence indicates the degree of correlation in the dataset between X and Y 
and is therefore a measure of the strength of a rule22. For example, the rule [high blood 
pressure + high cholesterol]→[pulmonary heart disease] has a confidence of 0.17/0.5=0.33. 
This means that 33% of patients, diagnosed with both high blood pressure and high 
cholesterol, will be diagnosed with pulmonary heart disease. 
In general, a minimum support and confidence threshold are specified before the data 
mining will be applied. Hence, the mining of association rules from a database implies to 
find all rules that meet the specified threshold for support and confidence22. The previous 
example illustrates that association rules are not restricted to establishing relationships 
between two attributes. Thus, many different association rules, predicting various different 
outcomes (e.g. pulmonary heart disease or cerebrovascular accident) can be derived from 
even a small dataset with a limited amount of attributes, which we will explain below. 
A study conducted by Ordonez (2006) was aimed at relating perfusion measurements 
and risk factor to vessel disease to improve actual diagnosis. The dataset contained 655 
patients and 25 medical attributes, including personal information (e.g. age, a diagnosis of 
diabetes or prior stroke and smoking habits) and medical measurements (e.g. weight, heart 
rate, blood pressure). In contrast to traditional statistical techniques, association rules are 
able to evaluate 25 different variables and their elaborative interactions. The techniques 
produced 771 association rules related to healthy arteries and 522 rules related to diseases. 
Some rules were expected (i.e. low age, female sex and low cholesterol levels appeared to be 
related to healthy arteries), which confirmed the validity of the technique. Other results 
were more surprising; a defect in a specific heart region (Septo-Anterior) relates positively 
with a chance of having a diseased Left Anterior Descending artery24. This study concluded 
that association rules provide an alternative for statistical techniques when many possible 
predictive factors are available. Moreover, although data mining can evaluate tens or even 
hundreds of attributes, this example shows that it is also possible to generate clinically 
relevant information from a small number of attributes in a small data set. 
Association rules can be applied to a large variety of problems since each association 
rule represents a different kind of knowledge. Association rules can, for example, predict 
drug prescription given a certain disease combination and such a priori knowledge could 
subsequently be used to prevent adverse drug interactions. Furthermore, as illustrated by 
the abovementioned example, association rules can also predict future diagnoses of diseases 
based on already present risk factors. Association rules can thereby promote early detection 
and possibly even prevention of diseases. 
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Classification 
Classification is probably the most widely used data mining technique and aims to explain 
data by predicting the classification of objects (e.g. patients) into the correct class (e.g. 
being at risk yes/no)25. Its primary goal is to divide the dataset into mutually exclusive 
classes such that the units within each class are as “close” as possible to one another, and the 
units between different classes are as “far” as possible from one another. The difficulty is to 
define classifiers (also known as attributes or variables) that serve as decision markers for 
classifying the data appropriately and in a meaningful manner. 
In order to conduct a classification task the sample at hand needs to be divided into 
two independent representative samples of the original data sets: a training and a test set23. 
The training set is used to construct the classification model, i.e. to learn how to classify the 
data appropriately. The performance of this model can be measured in terms of an error 
rate: the proportion incorrectly classified objects in the data set. In order to predict the 
performance and utility of the classification model on new data, and thereby assess the 
‘goodness-of-fit’ of the model, the error rate needs to be checked on a dataset that was not 
used to construct the actual model23. This independent dataset is called the test set. A test 
set is a set of data that is independent of the training data, but that follows the same 
probability distribution as the training data. Hence, the test set is inevitable for the 
evaluation of the model conducted by making use of the training set. The larger the test 
sample, the more accurate the error estimate will be. Some models, conducted based on the 
training data, tend to ‘overfit’ the data; some relationships, identified in the training data, 
do not hold in general (i.e. in other databases). If a certain model fits both the training and 
the test set well, minimal ‘overfitting’ has taken place. 
Besides predicting accuracy of the model on new data, the ecological validity of the 
classification model is also very important. For example, to support a medical doctor in his 
daily routine, a model needs to be able to support doctors’ decisions25. Typically, the more 
complex models may fit the data better but may also be more difficult to interpret 1. In 
some cases a third data set, the validation set, is necessary in order fine-tune the model. Of 
course, all data sets have to be representative samples of the data at hand. By using similar 
data for training and testing, one can minimize the effects of data discrepancies and better 
understand the characteristics of the constructed model. 
If enough data are available, splitting the data into two or even three independent test 
sets is a useful option. The division of the data into a training and test set when only a 
limited amount of data is available might lead to biased results, since the error rate is 
expected to remain large. A k-fold cross-validation can maximize the use of the training and 
test data. The data can be divided into k subsets of equal size (normally k=10). The training 
set will include k-1 subsets, while one subset is used for testing. This process then can be 
repeated k times so that all subsets are used once as a testing set. The average performance 
on the k subsets can then be computed. 
In a study conducted by Bae and colleagues, decision trees, a type of classification 
method, were used to predict good social functioning in schizophrenia patients26. A 
decision tree is a tree structure that makes use of decision rules to predict class partnership. 
Non-terminal nodes in a decision tree represent decisions on one or more classifiers and 
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terminal nodes reflect decision outcomes. The advantage of using decision trees is that it 
can include all possible variable combinations into one decision tree. This study included 
67 schizophrenia patients and a total of 51 variables including data on demographic 
characteristics, medical history, social cognition and neurocognitive and psychiatric 
symptoms. The aim of the study was to integrate these possible factors in order to find 
relationships among variables that were not previously considered. The authors decided to 
make use of decision trees, since analyzing 51 variables while only 67 subjects are included 
made the use of traditional statistical techniques unfeasible. By integrating so many possibly 
relevant predictive factors, the authors concluded that the best social functioning can be 
predicted by the combination of three variables: good sustained attention, good Theory Of 
Mind performance and low sensitivity for negative emotions26. 
Another study, conducted by Panzarasa and colleagues (2010), investigated if 
compliance with clinical guidelines improved health in patients who recently had a stroke27. 
The primary aim of the study was to assess which individual health recommendations 
improve health outcomes in 5.079 stroke patients, by making use of classification trees. In 
contrast to their expectations, they found that graded compression stockings as well as 
pneumatic compression did not benefit the health of patients with a severe initial stroke 
status. This result was in accordance with results from a randomized controlled trail 
conducted by Dennis and colleagues, which raised doubts about such prevention 
procedures28. 
TEXT MINING 
To date, we are not only confronted with data gathered in medical databases but also with a 
vast body of information published in medical literature. MEDLINE, the main repository 
of published (bio)medical literature, and therefore widely used among medical researchers, 
contains references to medical, nursing, dental, veterinary and health care journal articles 
that were published since 1948. It incorporates over 18 million citations (i.e. a reference to 
a published source), including links to full text articles and other related resources, and is 
growing at a rate of 500.000 citations each year. 
Although text is the predominant medium for information exchange among (medical) 
experts29, it has become impossible for medical researchers, health policy makers and 
medical doctors to keep abreast with all the publications. This abundance in available 
literature may be so overwhelming that they may soon inhibit rather than stimulate 
scientific progress30. However, all these medical articles, even those beyond the direct scope 
of the researcher, may contain valuable information related to medical research and clinical 
applications. 
Increasing amounts of information and observations, recorded in medical research 
articles, are derived from different, apparently unrelated areas of research (e.g. genetic 
research, epidemiology, primary care research). Useful implications of scientific discoveries 
can go unnoticed or unutilized because they exist only implicitly in scattered information 
in different areas of research. However, they can contribute to a greater understanding 
when considered collectively31. 
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To use the increase of scientific publications to its full extent, text mining techniques have 
been introduced that can support the scientific reader with automatic tools to investigate 
substantial amounts of text. Text mining involves analyzing large collections of documents 
to discover promising new hypotheses 32,33. This information might involve relationships or 
associations that are hidden in (collections of) documents that would otherwise remain 
undiscovered. Text mining, as well as, data mining, is a highly interactive and user-involved 
procedure. Domain experts are needed to evaluate the validity and usability of the newly 
generated hypotheses. 
Text mining discovers and extracts knowledge from literature in three consecutive 
steps. First, information retrieval takes place in order to identify those documents that 
match a user’s query. This step is aimed at reducing the number of documents for analysis, 
by applying computational algorithms to large collections of documents (i.e. Medline). 
Secondly, information is extracted from these selected documents. Information extraction is 
the automatic process of obtaining structured data from an unstructured text document. 
Information extraction selects specific facts about pre-specified entities (e.g. genes, proteins, 
medical conditions) that are available in the documents34. Most efforts in medical 
information extraction are devoted to ‘term analysis’; the identification of terms denoting 
specific classes of (bio)medical entities. In the last step of the text mining process the actual 
knowledge discovery takes place, i.e. specific relations between the extracted pieces of 
information are screened for (e.g. protein-protein interactions or disease combinations). 
The idea behind text mining is to relate or associate entities to each other based on their 
associated sets of texts35. Text mining approaches typically rely on the occurrence or co-
occurrence of terms and have been successfully applied to a number of problems. These 
entities can be investigated for hidden patterns or can be classified or clustered. 
Consequently, implicit knowledge can be detected, which may result in well-motivated and 
testable hypotheses5. 
There are a variety of automatic text mining approaches to infer implicit knowledge 
from literature databases. One of these approaches is Swanson’s ABC model (see Figure 2) 
which is commonly described as the possibility to link different scientific disciplines 
through intermediate or shared interests36.  
 
Figure 2. Swanson’s ABC model 
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Start with object A (i.e. a chronic disease). We can identify other object(s) B (i.e. co-
occurring chronic diseases) that are related to A within the (medical) literature. By 
identifying the co-occurrence of A and B within Medline records, the relationship between 
A and B can be established. Similarly, each object B can then be queried to identify other 
objects like C, which co-occurred with B, but not with A, within the titles or abstracts of 
articles within Medline. Thus, every object C is only implicitly related to A, since A and C 
are not mentioned within the same title or abstract. They only share one or more 
relationship with B. This list of implicit relationships may lead to potential discoveries of 
new relationships. 
Swanson and co-workers were the first to demonstrate that text mining, by making use 
of Medline, can lead to the discovery of new knowledge. They used Medline to make 
connections between seemingly unrelated entities, in this case the connection between 
migraine and magnesium deficiency36. Swanson and co-workers were also able to identify a 
relationship between Reynaud’s disease and the dietary effects of fish oil, which led to 
hypothesis and subsequent proof that compounds within dietary fish oil could ameliorate 
the symptoms of Raynaud’s disease37. Swanson’s ABC approach has also been applied to 
other areas of medicine resulting in new relationships between medical conditions38 and the 
generation of new therapeutic indications of pharmaceuticals39. 
CONCLUSIONS 
The rapid development of tools for acquisition and storage of information has lead to vast 
medical databases with large amounts of medical records as well as vast amounts of available 
medical literature. Medical databases tend to increase in both the number of N records (e.g. 
patients) as well as in the number of fields, or variables19. The large medical datasets as well 
as the large body of medical literature can be potentially relevant in the context of dedicated 
medical research questions and can, eventually, lead to the improvement of health care. 
Nevertheless, medical researchers, health policy makers and medical doctors have not yet 
taken full advantage of the potential to effectively extract useful information from these 
enormous amounts of data and text. 
Although some traditional statistical methods are also aimed at hypotheses generation, 
KDD approaches tend to be far more suited for exploratory research40. Knowledge 
discovery approaches are not intended to replace the statistical analyzing techniques, but 
can be of use in the practice of hypotheses generation. Of course, these hypotheses still need 
further evaluation and validation using in-depth research. Hence, KDD merely extends 
current statistical methods by taking advantage of technology and the development in 
research areas, such as computational power, artificial intelligence and machine learning6. 
Moreover, when using KDD, researchers have no or limited conformation biases since no a 
priori hypotheses are postulated. 
As is the case with all analyzing methods, uncritical appraisal of implementation of 
data and text mining applications (critized as ‘data dredging’ or ‘fishing expeditions’19) can 
lead to the discovery of erroneously, meaningless or invalid patterns. Therefore, medical 
researchers confronted with large amounts of medical data and/or medical documents are 
recommended to consult an expert in the field before using, interpreting and reporting on 
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these KDD applications. Knowledge discovery typically combines automated mining 
approaches, as the nature of data and text mining methods imply, with medical user 
interaction to ensure accurate, useful, and understandable results. Human involvement and 
knowledge and expertise is needed to evaluate if the discovered knowledge is of value to the 
medical researcher40. Rather than to serve as a golden standard, the application of data and 
text mining in the medical domain is primarily aimed at supporting a specialist’s decisions. 
The objective of the present paper was to introduce and to give a short background on 
knowledge discovery in databases. Given the broad spectrum of knowledge discovery, only 
a snapshot could be presented here. Consequently, a direct extension of this work is needed 
to make researchers, who are already familiar with statistical analyzing methods, more 
acquainted with other analyzing methods that knowledge discovery in databases can 
provide. Moreover, more information related to the implementation of these methods 
should be available in order to support researchers in the actual use of data and text mining. 
In conclusion, knowledge discovery refers to a broad process of finding implicit 
knowledge that can only be inferred by data mining and text mining tools integrated in the 
practice of hypothesis-driven health research. Although knowledge discovery is not a 
universal solution, it has proven to be useful tool that has the potential to expand our 
knowledge by opening up hidden sources of knowledge contained in medical data6. 
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Patterns of multimorbidity: identifying psychiatric and 
somatic disease combinations using an exploratory analyzing 
approach 
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ABSTRACT 
Background 
Multimorbidity, the co-occurrence of two or more chronic medical conditions within a 
single individual, is a highly prevalent health problem. A thorough understanding of 
frequently co-occurring medical conditions could improve health care delivery for 
individuals with multiple pathology. This study was aimed at identifying novel, potentially 
relevant psychiatric and somatic disease combinations using a knowledge discovery 
approach. 
Methods 
We focused on disease combinations with a prevalence of ≥10 in a large general practice 
database (The Registration Network Family Practices; N= 87,837) and an 
observed/expected ratio of ≥1.5. Six conditions from the ICPC P (psychological) chapter 
were involved: affective psychosis (P73), depressive disorder (P76), schizophrenia (P72), 
mental retardation (P85), personality disorder (P80) and suicide attempt (P77). The 
following ICPC chapters with somatic conditions were used: D (Digestive), K 
(Circulatory), L (Musculoskeletal), N (Neurological), R (Respiratory) and T (Endocrine, 
metabolic and nutritional). In total, 166 different disease combinations (i.e. a combination 
of one psychiatric and one somatic condition) were selected. Observed/expected ratio’s, 
odds ratio’s and corresponding confidence intervals were calculated. An expert evaluation 
phase was employed to evaluate and discuss several disease combinations in more detail. 
Results 
In total, 37of the 166 disease combinations passed the prevalence and observed/expected 
ratio threshold and were evaluated by three medical experts. The following five disease 
combinations representing the broad scope of interaction between psychiatric and somatic 
disorders were discussed in detail during an expert meeting; appendicitis and personality 
disorder, uncomplicated hypertension and psychotic affective disorders, migraine disorder 
and personality disorder, pulmonary emphysema and depressive disorder, and lipid 
metabolism and depressive disorder. 
Conclusions 
Using a knowledge discovery approach, in which two selection criteria were combined with 
an expert evaluation phase, the present study identified several undiscovered and potential 
relevant disease combinations in a large general practice data set. These disease 
combinations need to be confirmed in other, preferable general practice based, datasets. In 
addition, the findings indicate that hypothesis-driven research using general practice based 
data is able to generate novel medical information. 
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INTRODUCTION 
Multimorbidity, the presence of two or more co-occurring diseases within one person1, is 
not evenly distributed among individuals: while some individuals remain healthy their 
entire life, others get one disease after the other. Patterns of multimorbidity, i.e. a specific 
combination of two or more chronic conditions, might co-occur if conditions cause, 
precipitate, or maintain one another directly or indirectly2. Psychiatric and somatic disease 
combinations have a tendency to co-occur2, 3. Co-occurring psychiatric and somatic 
conditions are well-known for their adverse health effects; besides causing distress and 
functional disability, comorbid psychiatric illnesses are also related to non-adherence of 
self-care (e.g. improper use of medication) and prolonged recovery time4. Moreover, 
patients suffering from multiple medical conditions use health care services more frequently 
and use a greater array of health services than other consumers of care5. Because of the 
increase in multimorbidity, general practitioners are increasingly confronted with complex 
health care situations of patients with co-occurring conditions especially since one 
condition might influence and even exacerbate the other conditions(s)6. 
Research suggests that some chronic conditions co-occur more frequently than would 
be expected when these conditions were statistically independent. Several psychiatric and 
somatic disease combinations such as depressive disorder in individuals with diabetes 
mellitus type II7 and metabolic syndrome in individuals with schizophrenia8, have already 
been established. Nevertheless, given the large spectrum of chronic psychiatric and somatic 
conditions more clusters of co-occurring psychiatric and somatic conditions are anticipated. 
However, if we want to investigate all possible existing combinations of co-occurring 
chronic conditions we face an enormous amount of possible disease combinations. Hence, 
with exception of some studies9, 10, researchers have avoided these difficulties by studying 
only on a limited number of frequently occurring chronic conditions11 or by selecting an 
index disease12. One way to cope with this overload of medical information is by means of 
knowledge discovery approaches13, which incorporates a new generation of data approaches 
including data mining. These approaches have emerged from the need to identify 
meaningful patterns in large amounts of data14–16 and are aimed at finding the unexpected, 
that is, to discover associations and patterns that do not logically follow from earlier 
research17, 18. These exploratory methods offer significant advantages over more traditional 
analyzing techniques, not in the least because of increased computational power14, 19. 
We hypothesized that a knowledge discovery approach will be able to analyze a large 
general practice based data set in order to successfully identify novel (i.e. not previously 
considered in the medical field), potentially relevant (i.e. useful in the practice of health 
care) combinations of psychiatric and somatic conditions. Knowledge regarding frequently 
occurring disease combinations can improve health care delivery for individuals with 
multimorbidity by, for example, improving our ability to predict and diagnose co-occurring 
medical conditions and adjust health care delivery for individuals with specific disease 
combinations. 
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METHODS 
Study Population 
Data stems from the Registration Network Family Practices (RegistratieNet 
Huisartspraktijken, RNH) available on July 1st, 2010 and consisted of 87,837 individuals 
of all ages. The RNH is a continuously updated database, in which 70 general practitioners 
(GPs) working in 22 family practices in the south of the Netherlands are participating. This 
database includes all relevant current and past health problems. A health problem is defined 
as ‘anything that has required, does or may require health care management and has 
affected or could significantly affect a person’s physical or emotional well-being20. In 
general, health problems are only corded by the GP when they are permanent (no recovery 
expected), chronic (duration longer than 6 months) or recurrent (more than three 
recurrences within 6 months), or when they have lasting consequences for the functional 
status or prognosis of the patient. These problems are coded in a standardized fashion, 
according to the International Classification of Primary Care (ICPC) and other more 
current guidelines of the Dutch College of GP’s. ICPC is a diagnostic classification 
developed under the umbrella of Wonca and the WHO, with relations to other disease 
classifications such as the ICD21. In complex medical conditions registration is almost 
always based on a specialist diagnosis reported to the GP. 
This database contains background information on the patient’s sex, date of birth, 
marital status, type of household, code of practice and, level of education. Membership of 
the RNH population ends by migration or death. All patients included in the RNH 
database have been informed about the anonymous use of their health information and 
their medical information is not incorporated in the database if desired. The quality of the 
data is ascertained by ample instruction and training sessions, regular regional consensus 
groups, quality control audits, an online thesaurus available during data-entry and 
systematic control22–24. The present study population was comparable to the Dutch 
population with regard to socio-demographic variables25. This renders the RNH a valid and 
precise database for medical research. 
Included Chronic Diseases 
In order to limit the number of disease combinations, the following six conditions, coded 
in ICPC chapter P (Psychological), were involved: affective psychosis (P73), depressive 
disorder (P76), schizophrenia (P72), mental retardation (P85), personality disorder (P80) 
and suicide attempt (P77). Four of these conditions (i.e. affective psychosis, depressive 
disorder, schizophrenia and personality disorder) need to be considered severe psychiatric 
disorders (in contrast to mental retardation and suicide attempt). Although not all six 
conditions can be defined as psychiatric conditions, in order to preserve the 
comprehensibility of the present article, the term ‘psychiatric’ will be used throughout the 
manuscript to refer to the abovementioned six conditions. 
The following ICPC chapters with somatic conditions were included: D 
(Gastrointestinal), K (Circulatory), L (Musculoskeletal), N (Neurological), R (Respiratory) 
and T (Endocrine, metabolic and nutritional). Only lifetime prevalences of diagnostic 
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ICPC codes were included. ICPC codes representing symptoms and complaints were not 
selected even as test results not leading to a diagnosis, disease absence, deviations of normal 
function, superficial injuries, and risk factors. In total, 166 different disease combinations, 
which consisted of one psychiatric (i.e. ICPC chapter P) and somatic condition (i.e. ICPC 
chapter D, K, L, N, R and T), were selected for evaluation. 
Selection Criteria 
In order to select potentially relevant disease combinations two selection criteria with 
corresponding thresholds were employed. Firstly, disease combinations that are relatively 
prevalent among patients were selected, i.e. only disease combinations with a prevalence of 
≥ 10 (i.e. 10 individuals or more) in the RNH were selected. Secondly, Observed/Expected 
ratio’s (O/E ratio’s) were calculated. The observed probability of a specific combination of 
two diseases is more meaningful when compared to the expected probability26, 27, since it 
can filter out disease combinations that are likely to follow from mere chance alone. The 
O/E ratio is a measure of strength between two diseases; it allows disease combinations to 
be classified as positively associated, negatively associated, or not associated10. Calculation 
of the probability of two co-occurring diseases is based on the assumption of statistical 
independence (i.e. the two diseased co-occur at random) of the diseases concerned. An O/E 
ratio with value 1 indicates that the observed proportion of patients with a specific diseases 
combination equals the expected proportion. Hence, if the observed and expected 
probabilities are equal, a combination of diseases more likely will be independent of one 
another. Disease combinations with an O/E ratio of 1.5 (i.e. the disease combinations 
occurs 50% more frequently as would be expected given the prevalence estimates of the two 
diseases) or more was considered statistically dependent9. 
When evaluating associations between a maximum of two disorders, patterns of 
frequently occurring disease combinations are also commonly addressed by Odds Ratio’s 
(ORs)2, 28. Compared to O/E ratio’s, which suffer from several conceptual problems (e.g. 
lack of symmetry), ORs provide a more natural measure of performance29. ORs are defined 
as the ratio of the odds of an event (e.g. a psychiatric condition) to the odds of another 
event (e.g. a somatic condition)30. For 57 potentially relevant psychiatric and somatic 
disease combinations (i.e. combinations with a high prevalence and a high O/E ratio), ORs 
and corresponding 95% confidence intervals (CIs), based on the logarithm of the odds 
were calculated29. 
Expert Evaluation 
The expert evaluation included three phases. The first phase consisted of the evaluation of 
the 166 disease combinations by one expert. The second phase required the evaluation of a 
selection hereof by three experts. The third phase involved an expert meeting in which 
several disease combinations were discussed. In the first and second phase, the experts were 
instructed to evaluate disease combinations with one of the following ratings: 0) no causal 
relation; 1) causal relation possible; 2) causal relation expected; and 3) otherwise related 
(e.g. as epiphenomenon or as a result of the diagnostic process). The experts were not 
allowed to use any knowledge resources to base their evaluation upon. For the third expert 
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phase, a discussion among experts in an expert meeting, five potential relevant disease 
combinations were selected as examples of the large set of psychiatric and somatic disease 
combinations. Every disease combination was discussed in 5 to 10 minutes. The three 
experts were asked to bring forward their thoughts, ideas and reasoning schemes behind 
their evaluation. This expert meeting comprised a brainstorming type31, 32; this meeting 
was not intended to achieve consensus among the three experts but was aimed at evoking 
the thoughts and views behind the experts’ evaluations regarding the disease combinations. 
RESULTS 
Descriptive Characteristics 
Descriptive characteristics of the general practice-based population sample from RNH are 
reported in Table 1.  
While 19.7% had none of the included diseases, 16.3% of the participants were 
diagnosed with one medical condition and 64% of the study sample was diagnosed with 
multimorbidity (i.e. two or more chronic conditions present). In the 87,837 individuals, 
302,808 chronic conditions were diagnosed, including 13,384 psychiatric disorders. In 
total, 10,807 (12.3%) of the participants reported one or more psychiatric disorders; 
somatic conditions were present in 69,798 (79.5%) participants.  
Disease Combinations Passing the Selection Criteria 
Table 2 displays the number of disease combination in relation to the two selection criteria, 
i.e. a prevalence of 10≥ and a O/E ratio of ≥1.50. Of the 116 disease combinations, 54 
(46.6%) disease combinations passed the threshold of the two postulated criteria. 
Expert Evaluation 
The first step of the expert evaluation phase required the evaluation of the 166 disease 
combinations by a psychiatrist/scientific research in the field of psychiatry and neuro-
psychology. Table 3 shows the relation between the two postulated selection criteria and 
this expert evaluation. 
Of the 166 disease combinations, 6.0% (n= 10) were evaluated as ‘causal relation 
possible’, 1.8% (n= 3) were evaluated as ‘causal relation expected’, and 12.0% (n= 20) of 
the disease combinations were evaluated as ’related as epiphenomenon’. Moreover, 80.1% 
(n= 133) of the disease combinations were evaluated as ‘no causal relation expected’. Note 
that disease combinations are only evaluated as ‘causal relation possible’, ‘causal relation 
expected’ and ‘otherwise related’, if they have a high O/E ratio and a relatively high 
prevalence. In contrast, disease combinations with a low O/E ratio and a low prevalence are 
also evaluated as ‘no causal relation’. Hence, in general, medical conditions within a disease 
combination with a high prevalence and a high O/E are known to be (causally) related. 
Moreover, the medical conditions in the majority of disease combinations with a low O/E 
ratio and low prevalence are not known for their (causal) relation. However, as can be seen 
in table 3, there are also several disease combinations with a high prevalence and a high 
O/E ratio which are evaluated as ‘no causal relation’. This indicates that although these 
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disease combinations are prevalent and have a high O/E ratio, the expert is not aware of a 
causal relation. Therefore, these disease combinations might be novel for domain experts 
(i.e. experts in the field of psychiatry).  
 
 
Table 1. Descriptive characteristics of the general practice-based population from RNH (N= 87,837) 
Characteristics Number of participants (%) 
Gender (% females) 44,996 (51.2) 
Age  
    0–19 16,137 (18.4) 
    20–39 18,937 (21.6) 
    40–59 28,342 (32.3) 
    60–79  20,250 (23.1) 
    ≥ 80 4,171 (4.7) 
Number of chronic conditions  
    0 17,273 (19.7) 
    1 14,328 (16.3) 
    2 12,762 (14.5) 
    3 10,350 (11.8) 
    4 8,056 (9.2) 
    5 6,143 (7.0) 
    6 ≥ 18,925 (21.5) 
Psychiatric conditions  
   0 conditions 77,030 
   1 conditions 8,410 
   2 conditions 1,891 
   3 conditions 410 
   4 conditions 75 
   5 conditions 15 
   ≥6 conditions 6 
  
Somatic conditions  
   0 conditions 18,048 
   1 conditions 14,982 
   2 conditions 13,109 
   3 conditions 10,279 
   4 conditions 7,970 
   5 conditions 5,859 
   ≥6 conditions 17,590 
Note: the number of chronic conditions includes psychiatric and somatic conditions. Note that when the 
number of chronic conditions increases, the number of individuals decreases. 
 
Table 2. Cross-table of prevalence and observed/expected ratio’s  
 Observed/expected ratio   
 ≤1.49 ≥1.50 Total 
Prevalence ≤9 38 22 60 
≥10 52 54 106 
Total 90 76 166 
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In total, 54 disease combinations passed the threshold for the two postulated criteria, i.e. a 
prevalence of ≥10 in the RNH and with an O/E ratio of ≥1.5 (Table 4 and Appendix I). 
Of these 54 combinations, 31.5% (n= 17) was evaluated as ‘causal relation possible’, 
‘causal relation expected’ or ‘otherwise related’. Hence, 68.5% (n= 37) disease 
combinations were evaluated as ‘no causal relation’, i.e. according to the expert a causal 
relation appeared to be unlikely. By using the two selection criteria (i.e. prevalence and O/E 
ratio), 51.5% of the disease combinations (17 out of 33) that were evaluated as either 
‘causal relation possible’, ‘causal relation expected’ or ‘otherwise related’ were included for 
further evaluation. 
 
Only 27.8% (37 out of 133) of the disease combinations that were evaluated as ‘no causal 
relation’ were included using the two criteria. Since all the excluded disease combinations 
have a low prevalence and/or a low O/E ratio, it is unlikely that any potentially interesting 
disease combinations were missed. In order to identify disease combinations that are not yet 
known to experts (i.e. novel disease combinations), only disease combinations that were 
evaluated by the expert as ‘no causal relation present’ (i.e. an evaluation as 0) were selected 
for further evaluation resulting in a final list of 37 disease combinations. 
Two months after the first expert evaluation, the 37 disease combinations were 
randomly ordered and were again valuated by a psychiatrist/scientific research in the field of 
psychiatry and neuropsychology. However, in order to acquire a more detailed evaluation, a 
medical doctor/scientific researcher in the field of psychiatry and neuropsychology and a 
general practitioner/ scientific researcher in the field on general practice also evaluated the 
disease combinations. These 37 disease combinations were evaluated using the above-
mentioned four categories (i.e. 0, 1, 2 or 3). 
Expert Meeting 
An expert meeting was arranged in order to discuss several potential relevant disease 
combinations. As stated previously, the aim of this meeting was not to reach consensus 
among the experts, but was aimed at discussing the thoughts and ideas behind the expert’s 
evaluation regarding the disease combinations. Five disease combinations were selected as 
examples of the broad scope of interactions between psychiatric and somatic conditions. 
The following disease combinations were discussed during the expert meeting (marked in 
table 3 with an asterisk*); appendicitis and personality disorder, uncomplicated 
hypertension and psychotic affective disorders, migraine disorder and personality disorder, 
pulmonary emphysema and depressive disorder, and lipid metabolism disorders and 
depressive disorder. 
In the expert meeting it became apparent that the experts used different approaches 
when evaluating the disease combinations (see Box 1). Different risk factors, biological as 
well as environmental factors, were formulated as underlying causes of the disease 
combination at hand. Moreover, the experts had different concepts and definitions in mind 
when evaluating the disease combinations, which, on several occasions, explained 
differences in evaluation. 
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Table 3. Distribution of 166 disease combinations according to prevalence, observed/expected ratio 
and expert evaluation  
 N Observed/expected ratio Total 
Expert evaluation  ≤0.49 0.5–0.99 1–1.49 ≥1.5  
(0) No causal relation       
  1–4 2 3 6 4 15 
  5–9 0 12 9 14 35 
  10–24 1 7 16 12 36 
  25–49 0 6 7 12 25 
  50–99 0 1 2 8 11 
  100–199 0 0 4 1 5 
  ≥200 0 1 1 4 6 
  Total 3 30 45 55 133 
(1) Causal relation possible      
  1–4 1 0 0 0 1 
  5–9 0 0 1 0 1 
  10–24 0 0 1 3 4 
  25–49 0 0 0 1 1 
  100–199 0 0 0 2 2 
  ≥200 0 0 0 1 1 
  Total 1 0 2 7 10 
        
(2) Causal relation expected      
  1–4 0 0 1 0 1 
  5–9 0 0 0 1 1 
  ≥200 0 0 0 1 1 
  Total 0 0 1 2 3 
        
(3) Related as epiphenomenon      
  1–4 0 1 0 1 2 
  5–9 1 0 1 2 4 
  10–24 0 0 3 5 8 
  25–49 0 0 1 1 2 
  50–99 0 0 0 2 2 
  100–199 0 0 1 0 1 
  ≥200 0 0 0 1 1 
  Total 1 1 6 12 20 
        
  Total 5 31 54 76 166 
Note: grey area indicates those disease combinations that were selected by means of two criteria; prevalence 
of ≥10 in RNH and a O/E ratio of ≥1.5). Using these two criteria of interestingness, 51.6% of the disease 
combinations (17 out of 33) that were evaluated as either ‘causal relation possible’, or ‘causal relation 
expected’ or ‘otherwise related’ are included for further evaluation. In total, 27.8% (37 out of 133) of 
disease combinations that were evaluated as ‘no causal relation’ were selected using the two criteria. Since all 
the excluded disease combinations have a low prevalence and/or a low O/E ratio, it is unlikely that any 
potentially interesting disease combinations are missed out on. 
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Table 4. Odds Ratio(OR) and 95% Confidence Interval (CI) for 37 (out of 54) selected psychiatric 
and somatic disease combinations  
# Somatic condition Psychiatric condition N O/E OR 95% CI 
1 Esophageal diseases Personality disorders 48 1.97 2.03 1.52–2.72 
2 Duodenal ulcer Suicide attempt 15 1.83 1.86 1.11–3.11 
3 Duodenal ulcer Personality disorder 32 1.61 1.64 1.15–2.33 
4 Appendicitis Schizophrenia 14 1.70 2.37 1.11–5.03 
5 Appendicitis Depressive disorder 300 1.77 1.86 1.65–2.11 
6 Appendicitis Suicide attempt 53 2.37 2.53 1.90–3.36 
7* Appendicitis Personality disorder 102 1.88 1.98 1.61–2.43 
8 Hernia, hiatal Affective disorders, 
psychotic 
10 1.81 1.84 0.98–3.46 
9 Hernia, hiatal Suicide attempt 18 1.76 1.79 1.12–2.87 
10 Hernia, hiatal Personality disorder 50 2.01 2.08 1.56–2.78 
11 Angina pectoris Depressive disorder 214 1.68 1.79 1.56–2.05 
12 Angina pectoris Suicide attempt 11 1.99 2.07 1.48–2.89 
13* Uncomplicated 
hypertension 
Affective disorders, 
psychotic 
65 1.79 1.92 1.46–2.52 
14 Cerebrovascular accident Mental retardation 20 1.50 1.51 0.97–2.37 
15 Femoral fractures Mental retardation 20 3.09 3.21 2.04–5.03 
16 Dislocations Personality disorder 20 1.52 1.54 0.99–2.41 
17 Dislocations Mental retardation 10 1.73 1.75 0.94–3.29 
18  Osteoarthritis, spine Suicide attempt 27 1.53 1.56 1.06–2.30 
19 Shoulder syndrome Suicide attempt 32 1.89 1.95 1.36–2.79 
20 Osteoporosis Suicide attempt 29 1.78 1.83 1.26–1.66 
21 Meningitis/encephalitis Personality disorder 13 1.72 1.75 1.01–3.04 
22 Meningitis/encephalitis Mental retardation 11 3.31 3.41 1.87–6.24 
23 Brain concussion Depressive disorder 94 1.93 2.06 1.66–2.55 
24 Brain concussion Suicide attempt 20 3.18 3.31 2.11–5.19 
25 Brain concussion Personality disorder 34 2.23 2.31 1.63–3.26 
26 Epilepsy Personality disorder 48 2.73 2.87 2.14–3.86 
27 Epilepsy Mental retardation 85 11.01 13.53 10.69–17.14 
28 Migraine disorders Suicide attempt 34 1.88 1.94 1.37–2.75 
29* Migraine disorders Personality disorder 77 1.75 1.82 1.44–2.30 
30 Bell palsy Depressive disorder 36 1.54 1.56 1.13–2.25 
31 Chronic bronchitis/ 
bronchiectasis 
Personality disorder 22 1.72 1.75 1.14–2.69 
32* Pulmonary emphysema Depressive disorder 295 1.99 2.19 1.93–2.48 
33 Pulmonary emphysema Personality disorder 96 2.07 2.19 1.77–2.70 
34 Myxedema Affective disorders, 
psychotic 
30 3.00 5.25 3.60–7.67 
35 Myxedema Mental retardation 19 1.54 1.56 0.98–2.47 
36* Lipid metabolism disorders Depressive disorder 569 1.70 1.88 1.71–2.06 
37 Lipid metabolism disorders Suicide attempt 65 1.51 1.57 1.21–2.04 
* Disease combinations selected for expert meeting. │Data are reported as OR (and corresponding 95% CI) 
indicating (non)independence between two chronic conditions. │N refers to the prevalence of disease 
combination in RNH (N=87.837). 
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Box 1. Topics brought forward during the expert meeting 
 Diseases can be related because they share common biological pathways or mechanism 
 Diseases can be related because of shared psychosocial risk factors  
 The diagnostic process of some diseases can cause relations between two diseases  
 The medication or therapy for on disease might act as a risk factor for another disease 
 
The multi-disciplinary expert meeting produced various reasons that could underlie the 
specific disease combinations; diseases could be causally related because they share similar 
biological or psychosocial risk factors or because one condition may act as a risk factor for 
the other conditions (e.g. migraine disorder and personality disorder). In addition, the 
experts also mentioned that a disease combination could be causally related because one 
condition might occur as a result of the pharmacological treatment of the other condition. 
For example, the experts suggested that medication for pulmonary emphysema might 
promote depressive symptoms, which could result in a diagnosis of a depressive disorder. 
Several questions concerning diagnostic labels were brought forward during the expert 
meeting. For example, the question rose if general practitioners also coded a diagnosis of 
‘personality disorder’ (i.e. ICPC code P80) when only minor personality changes, e.g. after 
a stroke were present (instead of a full-blown personality disorder). Moreover, the experts 
stated that individuals who visit their general practitioner on a regular basis have a greater 
likelihood of being diagnosed with a (co-morbid) medical condition than people who 
hardly ever visit their general practitioner. This kind of information provided insight in the 
thoughts and ideas regarding the relations between the diseases of the disease combinations. 
Even if all three experts had no idea regarding underlying relations between two diseases, 
when being confronted with the prevalence of the disease combination in the RNH and the 
corresponding O/E ratio, the experts were surprised and intrigued which lead to additional 
in-depth discussion regarding the disease combination at hand. 
DISCUSSION 
The last decade, the amount of medical information, systematically stored in electronic 
primary care databases, has increased substantially. This study was aimed at discovering 
novel and potential relevant psychiatric and somatic disease combinations, using a broad 
nosological spectrum in order to utilize this enormous amount of medical data. 
The present study introduces several undiscovered, potentially relevant disease 
combinations including appendicitis and personality disorder, uncomplicated hypertension 
and psychotic affective disorders, migraine disorders and personality disorder, pulmonary 
emphysema and depressive disorder, and lipid metabolism disorders and depressive 
disorders. Before these disease combinations can be investigated in-depth for plausible 
underlying (causal) relations, these disease combinations need to be confirmed in other, 
preferable general-practice based, datasets. Subsequently, cross-sectional or longitudinal 
studies could investigate underling shared risk factors or pathophysiological pathways. 
Our results indicate that the two postulated criteria regarding prevalence and 
observed/expected ratio are useful to identify novel, potentially relevant patterns of 
multimorbidity. Disease combinations with a low prevalence and a low O/E ratio, in 
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general, are only evaluated as ‘no causal relation’. Hence, by using these two criteria, hardly 
any disease combinations that are evaluated as ‘causal relation possible’ or ‘causal relation 
expected’ are excluded. The two criteria postulated in the present study can aid the medical 
researcher by being a first selective filter to select potentially relevant disease combinations 
with a plausible causal relationship. 
Our expert meeting was intended to discuss the ideas and thoughts of three experts 
regarding plausible relationships between the diseases of several disease combinations. An 
expert meeting is a common way to collect opinions and knowledge from domain experts. 
Moreover, including experts with various, related backgrounds, will result in a broad, 
multi-disciplinary perspective. Our findings suggest that a multi-disciplinary expert 
meeting provides additional information over and above the two selection criteria and 
individual expert evaluations. This underscores previous research which suggest that the 
input of medical experts cannot be ignored in identifying undiscovered, potential relevant 
medical findings33. 
Although the present study did not evaluate all possible ICPC codes that describe 
chronic conditions, the present study does include a large spectrum of frequently occurring 
psychiatric and somatic conditions in order to identify novel, potentially relevant disease 
combinations. Previous research used only a limited number of chronic conditions to 
identify frequently occurring disease combinations. For example, a study by Laux and 
colleagues investigated disease combinations in only five chronic conditions34. Other 
studies focused on combinations of systems, such as respiratory and cardiac systems, rather 
that on single diseases34. Secondly, the large sample size increases the generalisability of our 
results. Thirdly, the majority of individuals registered by means of the RNH are between 
40 and 59 years of age. Hence, the present study was not only directed at older people (i.e. 
aged 80 and over). 
Our findings must be interpreted in light of some possible limitations. First, some 
caution is needed when appraising disease combinations that just pass the selection criteria, 
i.e. prevalence of ≥10 and an O/E ratio of ≥1.5. Hence, in order to select those disease 
combinations of which the two diseases are most likely to be causally related, the threshold 
for these two criteria needs to be augmented (e.g. disease combinations with a O/E ratio of 
2.5≥). For example, in case of finding new biological and psychosocial causal pathways it 
might be preferable to explore the subset of more prevalent disease combinations with 
higher odds ratio’s. Secondly, the diagnoses that are registered in the RNH database reflect 
the GPs perspective of the health status and relevant health problems of the patient. As a 
result, some health problems may be missing because a patient did not report them to the 
GP or because the GP does not judge them to be clinically significant1. Nevertheless, the 
number of missing health problems appears to be small, especially in the case of permanent, 
chronic conditions that require medical care25. 
Despite these drawbacks, this study used a large nosological spectrum to identify novel 
and potential relevant occurring disease combinations by means of a general practice based 
population. Our findings demonstrate that using two selection criteria in combination with 
an expert evaluation phase is useful in the practice of identifying novel, relevant disease 
combinations. Increasing our understanding regarding co-occurring diseases can improve 
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disease diagnosis and management for individuals with multimorbidity. The present results 
need to be confirmed in other, preferable general practice based datasets. In addition, the 
presence of the potential relevant disease combinations introduced in the present study 
should be investigated in specific subgroups, i.e. based on age or sex. As a result, health care 
delivery can be adjusted to those subgroups which are more prone to experience certain 
disease combinations. 
CONCLUSIONS 
The present study demonstrates that a knowledge discovery approach can be used to 
analyze large medical databases in order to identify disease combinations not (yet) known 
to medical experts. As is inherent to exploratory and hypotheses generating research, other 
studies are needed to replicate the present findings. Subsequently, cross-sectional and 
longitudinal studies are needed to answer whether or not the disease combinations 
presented here are indeed (causally) related.   
The exploratory method employed in the present study, in which two selection criteria 
were combined with an expert evaluation phase, provides novel avenues to identify novel 
and relevant disease combinations. In addition, our findings indicate that general practice 
based databases are an excellent resource for exploratory research. Careful and precise 
registration of medical conditions is an important prerequisite hereof. 
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 APPENDIX I 
Odds Ratio (OR) and 95% Confidence Intervals (CI) for the remaining 17 (out of 54) psychiatric 
and somatic disease combinations 
# Somatic condition Psychiatric condition Na O/E ORb 95% CI 
1 Esophageal diseases Suicide attempt 17 1.69 1.72 1.06–2.79 
2 Diverticulosis Affective disorders, psychotic 10 1.63 1.63 0.87–3.07 
3 Cardiovascular 
abnormalities 
Mental retardation 18 5.44 5.76 3.57–9.30 
4 Cerebrovascular 
accident 
Depressive disorder 208 2.13 2.34 2.02–2.71 
5 Cerebrovascular 
accident 
Suicide attempt 25 1.99 2.04 1.36–3.06 
6 Epilepsy Affective disorders, psychotic 11 2.81 2.90 1.58–5.30 
7 Epilepsy Suicide attempt 16 2.21 2.26 1.37–3.73 
8 Cluster Headache Depressive disorder 14 2.35 2.55 1.45–4.47 
9 Tuberculosis, 
Pulmonary 
Depressive disorder 45 1.87 1.99 1.45–2.70 
10 Malignant neoplasm 
bronchus/lung  
Depressive disorder 16 1.73 1.80 1.08–3.02 
11 Chronic bronchitis/ 
bronchiectasis  
Depressive disorder 68 1.67 1.74 1.36–2.24 
12 Hyperventilation  Depressive disorder 222 2.80 3.22 2.79–3.73 
13 Benign neoplasm of 
thyroid gland  
Depressive disorder 13 2.24 2.42 1.35–4.32 
14 Goiter  Depressive disorder 98 2.30 2.51 2.03–3.11 
15 Hyperthyroidism/ 
thyrotoxicosis  
Depressive disorder 133 2.08 2.26 1.88–2.71 
16 Myxedema  Depressive disorder 186 2.07 2.25 1.93–2.63 
17 Diabetes Mellitus  Depressive disorder 487 1.56 1.68 1.52–1.85 
Data are reported as OR (and corresponding 95% CI) indicating (non)independence between two chronic 
conditions. │ N refers to the prevalence of disease combination in RNH (N=87.837). 
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General practitioners are increasingly confronted with patients who suffer from 
multimorbidity, the co-occurrence of two or more chronic medical conditions. 
Multimorbidity is associated with poor quality of life1–3, physical disability4, 5, higher use of 
health care facilities6 and higher mortality risk7. In general, individuals who suffer from 
multimorbidity require more complex health care compared to individuals with a single 
medical condition6. For example, individuals with multimorbidity consult more health care 
professionals than individuals with single morbidity. Managing multimorbidity by health 
care providers is therefore complicated, not in the least because of possible interactions 
between the occurring medical conditions8. 
In order to improve health care delivery for and quality of life in patients with 
multimorbidity, it is important to provide a more detailed picture of multimorbidity. For 
this purpose, the following two research questions were postulated: 1) to report on several 
adverse health effects and related concepts associated with multimorbidity, and 2) to 
introduce and apply innovative research strategies useful for analyzing large amounts 
medical data. The current chapter summarizes the main findings and relates them to the 
current medical literature. Possible limitations, with special attention to methodological 
considerations, are also discussed. In addition, implications for daily clinical practice 
regarding multimorbidity are put forward. Recommendations for future research on 
multimorbidity are presented at the end of this chapter. 
MAIN FINDINGS 
The studies included in this thesis underscore that multimorbidity is highly prevalent in the 
adult population. Prevalences of more than 50% of the population under study are 
reported9, 10. Conversely, a much smaller percentage is without any chronic conditions. 
Although the prevalence of multimorbidity varies considerably in the medical literature, 
our prevalence estimates of multimorbidity are in congruence with those reported in a 
recently published systematic review11. 
Adverse Health Consequences and Related Constructs 
 
Multimorbidity and Cognitive Functioning 
Various factors related to functional health have been proposed as prognostic factors for 
pathological cognitive functioning12. In this notion, the relation between morbidity and 
multimorbidity on one side and subjective and objective cognitive functioning on the other 
was studied. The following questions were postulated: 1) Is multimorbidity associated with 
memory complaints? and 2) What is the longitudinal association between multimorbidity 
and cognitive functioning? 
The findings related to the first research question illustrate that individuals with one or 
more chronic medical conditions reported more subjective memory complaints than their 
healthy counterparts. This association was more profound in individuals with 
multimorbidity. Although this study provides evidence for a strong association between 
multimorbidity and cognitive complaints, the question remains whether this observed 
association reflects an objective decrease in cognitive functioning. Another research 
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question was aimed at investigating the relation between multimorbidity and objective 
cognitive performance. The results from this longitudinal study with a 12 year follow-up, 
underscore earlier claims that morbidity can be considered as a possible mediating factor in 
cognitive dysfunction12. Nevertheless, the effects of suffering from a single chronic 
condition and multimorbidity on cognition appear to be small in a normal healthy aging 
population. 
It might be argued that the presence of diseases makes an individual more prone to 
experience cognitive problems since the suffering from one or more chronic conditions 
might occupy the cognitive resources of an individual (e.g. through ‘worrying’)13. 
Moreover, the cognitive problems (older) people experience may easily be interpreted as the 
first signs of cognitive decline instead of normal forgetfulness that increases with age. 
Special attention, aimed at improving one’s beliefs and expectations regarding their 
cognitive functioning, could be given to these patients. 
 
Multimorbidity and Functional Health 
To gain more insight in the association between multimorbidity and adverse health effects, 
we investigated if the contribution of multimorbidity to physical and mental health is 
temporary or long lasting. This study claims that the decrease in self-perceived physical 
functioning caused by multimorbidity may be permanent and may even increase over time. 
Moreover, the association between single morbidity and multimorbidity on one side and 
mental functioning on the other seems to disappear over time. Our findings suggest that 
multimorbidity is associated with long-term physical problems rather than with mental 
problems. Since physical problems are known to underlie several adverse outcomes, 
including hospitalization and nursing home admission14, early disease diagnosis and 
appropriate disease management that is aimed at ameliorating or postponing these physical 
problems is therefore an important aim. 
 
Multimorbidity and Related Constructs 
The term multimorbidity has been, and often still is, used interchangeable with other 
gerontological constructs such as frailty and disability. The studies presented in this thesis 
indicate that individuals who were frail but who did not suffer from multimorbidity and/or 
disability did not show an increased risk for nursing home admission or mortality. In 
addition, while mortality seems to be primarily driven by disease burden, functional 
limitations seem to be the driving force behind nursing home admission. It might therefore 
be concluded that the adverse health risks associated with frailty in the general older adult 
population may primarily be driven by multimorbidity and disability. 
 
Diabetes mellitus and Depression 
Cross-sectional studies have demonstrated a high presence of depression in individuals with 
diabetes mellitus and depression, a specific pattern of multimorbidity. Although our results 
claim that patients with type II diabetes were more likely to develop subsequent depression 
than persons without a history of type II diabetes, the association between diabetes and 
depression obtained in our longitudinal study was weaker than previously reported. Type II 
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diabetes might lead to depression because the rigors of managing diabetes can be stressful or 
because of the biochemical changes caused by diabetes mellitus or its treatment15, 16. 
Although several explanations for the association between type II diabetes and depression 
have been postulated, the pathophysiological mechanisms underlying this particular disease 
combination remains inconclusive. Since this disease combination is known for its 
substantial disease burden17, better recognition of depression in patients with type II 
diabetes could the adverse effects of this pattern of multimorbidity. 
 
Innovative Analyzing Strategies 
In the last decade, large volumes of medical data are collected in hospitals, clinics and 
general practices because of a switch to computerized medical record keeping18. Since 
traditional analyzing techniques are less adequate when the amount and complexity of data 
increases, there is a growing need for practical applications to assist medical researchers in 
extracting (new) information and knowledge from large amounts of medical data. 
Knowledge discovery in Databases (KDD) describes the process of (semi)automatically 
searching large volumes of data for novel and potentially relevant patterns or associations19, 
20. In contrast to traditional analyzing methods which are characterized as ‘confirmatory’ in 
nature, knowledge discovery techniques serve an exploratory process, aimed at discovering 
unexpected patterns and associations, without a priori postulation of a priori hypotheses21. 
Consequently, KDD causes no or limited conformation biases. Moreover, KDD extends 
traditional analysis techniques by taking advantage of new technologic developments, such 
as the increase in computational power22. 
As is the case with all analyzing methods, uncritical appraisal of implementation of 
KDD applications (sometimes referred to as ‘data dredging’ or ‘fishing expeditions’) can 
lead to the discovery of erroneously, meaningless or invalid patterns23. Understanding and 
applying KDD requires a different research perspective compared to using traditional 
statistical analyzing approaches; potentially interesting findings found should be interpreted 
solely as suggestions for subsequent, in-depth, research. Moreover, the interpretation of the 
medical findings obtained by means of KDD approaches requires careful evaluation from 
medical domain experts. Since the amount of data stored in medical database is only 
expected to rise, new analysing strategies are required to give meaning to these large and 
complex medical datasets. By using exploratory analyzing approaches, medical researchers 
are able to exploit large amounts of medical data in order to gain new insights and 
knowledge. 
Patterns of multimorbidity 
Despite the high prevalence of multimorbidity, knowledge concerning frequently 
occurring disease combinations is still scarce. This might be due to the fact that we face an 
enormous amount of possible disease combinations when investigating possible 
combinations of all co-occurring chronic medical conditions. For patients as well as for 
health care professionals, multimorbidity becomes particularly challenging when one 
condition influences the care of the other conditions through, for example, interactions 
between therapies and contraindications to medication. Consequently, knowledge of 
frequently co-occurring diseases may improve disease diagnosis in individuals with or at risk 
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for multimorbidity which, as a result, can improve health care outcomes in patients with 
multimorbidity. 
In this thesis, several novel, potentially relevant patterns of psychiatric and somatic 
conditions were introduced including appendicitis and personality disorder, depressive 
disorder and pulmonary emphysema, migraine disorder and lipid metabolism disorder, and 
uncomplicated hypertension and psychotic affective disorders. These disease combinations 
need to be confirmed in other general practice-base databases. Subsequently, prospective 
cross-sectional and longitudinal studies should evaluate underling shared risk factors or 
pathophysiological pathways in order to assess plausible causal relationships among the 
medical conditions within these disease combinations. Identification of these novel and 
potentially relevant disease combinations in a general practice database24, promotes 
hypothesis-driven studies regarding patterns of multimorbidity. 
METHODOLOGICAL CONSIDERATIONS 
Definition and Operationalization of Multimorbidity 
A major problem in research on multimorbidity is the lack of a universally accepted 
definition and operationalization of multimorbidity25–27, which complicates the 
comparability and generalisability of studies on multiple pathology. The studies presented 
in this thesis made use of the widely used conceptualization postulated by van den Akker 
and colleagues who defined multimorbidity by ‘the co-occurrence of multiple chronic or 
acute diseases and medical conditions within one person’28. 
In this thesis, multimorbidity was assessed by means of a simple disease count. 
Although a simple disease count does not takes disease severity into account, simply 
counting the number of disease an individual is affected by is a simple and efficient 
approach. This assessment of multimorbidity assumes that every additional disease has a 
similar additive effect on the outcome at hand. A simple disease count is particularly useful 
when considering a large nosological spectrum to study multimorbidity. Using a large 
nosological spectrum is a prerequisite for research on multimorbidity since the exclusion of 
large number of diseases could yield a non-realistic picture of multimorbidity. Moreover, 
the set of included diseases is not only decisive for the prevalence of multimorbidity but 
also highly affects the number of conditions present in an individual. When evaluating a 
large nosological spectrum, making use of a simple disease count is often preferred over 
other approaches to operationalized multimorbidity. For example, the use of specific disease 
clusters or combinations of diseases are not feasible when using a large nosological 
spectrum, especially in terms of labour intensiveness and lack of statistical power because of 
low prevalences. 
By using a simple disease count to assess multimorbidity, individuals are often divided 
into three, mutually exclusive, groups: healthy individuals (i.e. the reference group), 
individuals with single morbidity (i.e. one disease present) and individuals with 
multimorbidity (i.e. ≥ 2 diseases present). In this thesis, the latter two groups were 
compared to the reference group in order to study the effects of a single disease or 
multimorbidity on a specific outcome measure (e.g. cognition and functional health). The 
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question is if dividing individuals into these three mutually exclusive groups is the most 
optimal way to discriminate between groups of individuals. Hence, it remains to be 
investigated which groups can best be formed when studying multimorbidity. 
Characteristics of the Databases 
In order to provide a concise and unambiguous picture of multimorbidity, the present 
thesis presents findings obtained by means of national and international databases as well as 
general practice based data and data on community-dwelling individuals. Each of the three 
databases has its own rationale, objectives and design. Consequently, every database 
contains different characteristics which will be outlined hereafter. 
The Registration Network Family Practices 
To advance our knowledge on multimorbidity, structural, objective information regarding 
chronic medical conditions is highly imperative. Therefore, four of the eight studies 
included in this thesis were carried out within the context of the Registration Network 
Family Practices (RegistratieNet Huisartspraktijken, RNH). The RNH is a continuously 
updated database, which contains the medical records of patients from 21 family practices, 
supported by 65 general practitioners (GPs)29, 30. In the RNH, health problems are only 
coded by the GP when they are permanent (no recovery expected), chronic (duration 
longer than 6 months) or recurrent (more than three recurrences within 6 months), or 
when they have lasting consequences for the functional status or prognosis of a patient. 
The studies in this thesis which were conducted by means of RNH focused on major 
health problems. Hence, all ICPC codes representing symptoms or complaints as well as 
pregnancy and delivery, test results not leading to a diagnosis, variations of normal 
functioning, superficial injuries and risk factors were excluded. Nevertheless, it remains 
possible that a medical condition that was coded by the GP, at one point becomes 
‘inactive’; for example, a GP could label ‘depression’ from ‘active’ to ‘inactive’ when being 
confronted with an individual, who did suffer from depression (i.e. an active ICPC code), 
but, at the given time, has no depressive symptoms (i.e. an inactive ICPC code). However, 
since health problems in the RNH are only coded when they are permanent, chronic or 
recurrent, or when they have lasting consequences for the functional status or prognosis of 
the patient, the studies in this thesis used the lifetime prevalence of medical conditions. 
In the Netherlands, the general practitioner delivers continuous care and acts as a 
gatekeeper to other health care facilities. Nevertheless, studies based on primary care data 
can result in an underestimation of the prevalence of single morbidity and multimorbidity, 
since the GP can only register those medical conditions that are brought to his or her 
attention. However, non-attendees’ in general practice showed little serious and chronic 
pathology31. It might be argued that the clinical burden of multimorbidity is higher in 
general practice than would be expected from data collected for the general population. 
This highlights the importance of having prevalence estimates at the practice level, and the 
development and implementation of practice-based epidemiological research. 
The quality of the data is ascertained by ample instruction and training sessions, 
regular regional consensus groups, quality control audits, an online thesaurus available 
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during data-entry and systematic control for erroneous or missing entries29. In conclusion, 
the studies presented in this thesis advocate that the RNH can be seen as a precise sample 
frame that provides a objective, general practice based view on multimorbidity. 
The Maastricht Aging Study 
The Maastricht Aging Study (MAAS) is a longitudinal cohort study on the determinants of 
successful aging32, 33. After the baseline assessment in 1992–1993, all participants were 
reassessed after a 3, 6, 9 and 12 years. In total, 1823 randomly selected individual (aged 24 
to 81 years), participated at the baseline of the MAAS. RNH morbidity data were linked 
with questionnaire and test data of MAAS. In contrast to cross-sectional research which 
may at best suggest correlation, a longitudinal design like MAAS permits conclusions 
regarding the long-term effects of multimorbidity. 
Because of the large sample frame and large age range of the participants, findings from 
studies carried out within MAAS are generalizable to the general population. However, 
relatively ‘unhealthy’ individuals might be underrepresented in MAAS because of, for 
example, sample bias, admission to nursing homes or premature mortality. This ‘healthy 
survivor effect’ may have lead to an underestimation of the associations found in some of 
the studies present in this thesis. Repeating these studies in more medically disadvantaged 
populations, such as those in nursing homes or hospitals, might lead to more profound 
associations between multimorbidity and the adverse health effect at hand. 
Age, Gene/Environmental Susceptibility Study 
The Age, Gene/Environmental Susceptibility (AGES Reykjavik) Study34, which consisted 
of more than 5,000 individuals (75+ years) living in Iceland, was used to investigate the 
relation between multimorbidity, frailty and disability. Findings from this large study 
sample can be generalized to geriatric populations in other Western countries. Some 
caution is warranted when generalizing these findings to younger individuals or to older 
individuals in more restricted populations, such as those in nursing homes and hospitals 
wince these populations are expected to differ from the geriatric populations as a whole. 
Public Health Service 
The study based on data from the Public Health Service (Geneeskundige Gezondheids-
dienst; GGD) consisted of more than 15,000 community-dwelling individuals (55+ years) 
living in the most southern part of the Netherlands, and may therefore not only be 
generalized to the remaining Dutch population (i.e. within the same age range), but may 
also be translated to comparable populations in other Western countries. 
CONCLUSIONS 
This thesis contributes to the growing collection of knowledge regarding multimorbidity by 
reporting on several adverse health effects, related constructs, innovative analyzing strategies 
and co-occurring psychiatric and somatic disease combinations. 
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The empirical studies in this thesis underscore that general practitioners are increasingly 
being confronted with individuals with multimorbidity35. Individuals with multimorbidity 
pose special challenges for general practitioners, not in the least because one condition 
might influence the care of other conditions (e.g. interaction between treatments)8. 
Our results suggest that the relation between multimorbidity and physical functioning 
is more profound than the relation between multimorbidity and other adverse health effects 
such as cognitive and mental functioning. It could therefore be argued that general 
practitioners should especially focus on the long-lasting reduction in physical functioning 
that accompanies multimorbidity. Since physical problems are known to underlie several 
adverse outcomes, appropriate disease management for and disease monitoring of 
individuals with multimorbidity seems to be of utmost importance. By providing this kind 
of health care, general practitioners can alleviate, ameliorate or even prevent physical 
detoriation in patients with multimorbidity. 
Individuals with one or more co-occurring psychiatric conditions are known to 
experience more, and more severe, adverse health effects than individuals with merely 
somatic multimorbidity36. For example, the presence of comorbid psychiatric condition is 
related to other health effects including non-adherence of self-care27 (e.g. improper use of 
medication) and prolonged recovery time. General practitioners should be aware of the 
possible presence of psychological symptoms, which can further complicate disease 
management in these complex patients37. Hence, these patients require special care and 
disease monitoring to improve their mental health problems, which, in turn, might 
improve outcomes related to their somatic conditions. Gaining knowledge regarding 
psychiatric and somatic disease combinations can contribute to improvement in health care 
for individuals with these kinds of multimorbidity patterns. 
Our results suggest that frailty, as a distinct concept, has little discriminant validity 
over and above the presence of multimorbidity and disability when predicting nursing 
home admission and mortality. Hence, information regarding the presence of co-occurring 
diseases and disability (as assessed using five short questions) seems to be sufficient in order 
to identify those patients that are at increased risk for adverse outcomes. Consequently, it 
seems redundant for general practitioners to assess frailty characteristics in order to classify 
the most vulnerable (older) individuals. 
The results also demonstrates that knowledge discovery approaches can explore and 
model large amounts of medical data and documents to extract previously unknown, 
hidden and potentially relevant medical information. A knowledge discovery approach was 
employed to identify disease combinations not yet known to medical experts by means of a 
large general practice based dataset. Several novel and potentially relevant diseases 
combinations, which serve as an example of the broad range of possible disease interactions, 
are introduced. As is the case with all exploratory and hypotheses generating research, our 
findings need to be replicated in other, preferably general practice based, datasets. 
Subsequently, hypothesis confirming studies are needed to investigate the identified disease 
combinations pattern in more detail (e.g. underlying pathogenesis). In addition, our 
findings suggest that general practice based data are an excellent resource for exploratory 
research. Careful and precise registration of (chronic) medical conditions is an important 
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prerequisite hereof. Although KDD is not a universal solution, it can provide novel 
techniques in order to gain knowledge on multimorbidity or other medical topics. Because 
of its ability to effectively and efficient analyse large amounts of data, knowledge discovery 
approaches are expected to continue to gain popularity in medical research. 
IMPLICATIONS 
Individuals with multimorbidity often require complex health care with special attention, 
knowledge and skills from multiple health care providers, often located in different health 
care settings6. These health care providers are often focused on only one medical condition 
and may therefore fail to notice any detoriation or problems in other health-related 
aspects38. For many individuals with multimorbidity, this fragmentation of care may lead to 
various health problems (e.g. adverse drug effects, hospitalization), not in the least because 
of the complex medication management and treatment regimes which are often 
contradictory. Consequently, health care for individuals with multimorbidity should not be 
focused on single medical conditions but should instead adopt a more holistic approach. 
Findings of this thesis underscore the need to move away from a more disease-specific 
approach towards a more integral based approach of the individual with multimorbidity9, 35. 
To illustrate, the present thesis designates that general practitioners should not only be 
aware of the physical problems in individuals with multimorbidity but should also pay 
attention to the cognitive status of these individuals. 
The lack of clinical practice guidelines (CPGs) for individuals with multimorbidity 
complicates a person-centred, multidimensional health care approach. Although CPGs 
provide detailed information for managing single diseases, they fail to address how to 
optimally integrate these guidelines within the practice of health care for multimorbidity32. 
However, the consideration of people with multimorbidity is essential considering its 
increasing prevalence. In general, recommended guidelines intended for single medical 
conditions might be impractical, irrelevant or even harmful for individuals several co-
occurring medical conditons38. For example, an individual with multimorbidity might be 
treated with multiple medications, which increases the risk of adverse drug events. 
Moreover, multimorbidity is also associated with potentially avoidable hospitalization39. 
Simply translating the standard clinical practice guidelines to individuals with multiple 
medical conditions may not be suitable for the complex medical situations of individuals 
with multimorbidity and might thereby diminish the quality of health care for these 
patients38. Since adding a large combination of possible comorbid medical conditions to 
current, standard CPGs is cumbersome, a critical first step might be to expand the standard 
CPGs by incorporating adapted guidelines for frequently occurring co-morbidities (e.g. a 
depressive disorder in patients diagnosed with diabetes mellitus type II or in patients 
diagnosed with Chronic Obstructive Pulmonary Disease, COPD). By doing so, at least for 
frequently occurring disease combinations, optimal care can be provided. 
Electronic Patient Records for Medical Research 
The present thesis underscores that electronic medical records (EMRs) are an excellent 
resource for scientific research40 since they provide comprehensive, standardized and 
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objective medical information (e.g. by using EMRs the presence of medical conditions or 
the combinations thereof can be identified which may render self-reported medical status 
redundant). In order to use EMRs for scientific purpose, several requisites are needed. For 
example, ample instruction, training sessions and regular consensus groups are a necessity 
in order to inform those health care professionals that provide electronic patient 
information. Moreover, a standard coding system needs to be used to increase the 
objectiveness of the information (e.g. International Classification of Primary Care; 
ICPC41). In addition, a systematic control program, that can handle erroneous or missing 
entries, is necessary to maintain a good quality of the data at hand29. Besides, coding socio-
demographic patient characteristics and relevant past and current health problems, EMRs 
may also include more general patient information such as recent and past appointments 
with health care providers, and medication use. This kind of patient related information 
might render EMRs even more useful for scientific research. In conclusion, EMRs can 
provide a rich data source with the potential to answer key research questions that can 
direct or indirectly improve health care. 
RECOMMENDATIONS FOR FUTURE RESEARCH 
The studies presented in this thesis point out several important topics that should be 
addressed in future research in the field of multimorbidity. Firstly, there is an increasing 
need for a universally accepted definition and operationalization of multimorbidity that 
differentiates this term from comorbidity since using these two terms interchangeable may 
lead to indistinctness and incomparable results regarding multimorbidity. Therefore, Van 
den Akker and colleagues proposed a distinction between comorbidity and 
multimorbidity42. A general acceptance of the difference between multimorbidity and 
comorbidity may prevent ambiguity of both concepts. We therefore propose the definition 
by van den Akker and colleagues, who defines multimorbidity as ‘the co-occurrence of 
multiple chronic or acute diseases and medical conditions within one person’42. Consensus 
on the operationalization of multimorbidity is hard to accomplish since the assessment of 
multimorbidity highly depends on the availability and quality of the data and, of course, on 
available financial resources at hand. Therefore, a single operationalization of 
multimorbidity that would be applicable in all circumstances seems unfeasible. 
Consequently, medical researchers should thoroughly report how they handled the 
methodological problems that arise when studying multimorbidity. This will shed light on 
the comparability and generalisability of these studies. 
Secondly, evaluating patterns of multimorbidity might be particularly important for 
future research. Medical conditions might co-occur within an individual if the conditions 
are caused or precipitated by one another directly. Even when two or more conditions do 
not affect each other directly, they might still share the same risk factors or precursors43. 
Knowledge on frequently occurring disease combinations may therefore facilitate and 
accelerate disease diagnosis. The extent to which frequently occurring disease combinations 
represent general disease susceptibility also deserves future exploration. 
Thirdly, in order to enable medical researchers to properly make use exploratory, 
hypothesis-driven techniques more information regarding KDD is needed, e.g. best 
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practices of KDD, which suit different medical problems, should be outlined in more 
detail. Since usage and interpretation of the results of these methods requires significant 
expertise, there is a strong need for more collaboration between KDD experts and medical 
experts. 
Fourthly, because of the high prevalence of multimorbidity, targeted interventions 
programs especially developed for patients with multiple conditions should be given 
priority. Targeted intervention programs are an important prerequisite for reducing the 
prevalence of multimorbidity and for diminishing its adverse consequences. Unfortunately, 
to date, the factors on which targeted intervention programs should be directed in order to 
improve health outcomes for individuals with multimorbidity remain unclear. To 
accomplish this, future research efforts should focus on the risk factors for multimorbidity. 
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Forecasts suggest that, in the upcoming decades, the percentage of people with 
multimorbidity will increase dramatically in the Netherlands. This dramatic increase is 
primarily due to changes in wealth indicators (e.g. improved nutrition and hygiene) which 
have resulted in increased longevity and an increasing number of older individuals. 
Consequently, general practitioners are increasingly confronted with the management of 
individuals with multimorbidity. 
 
The general background, aims and research questions of the studies included in this thesis 
are described in chapter 1. The aim of this thesis is twofold; 1) to report on several adverse 
health-related factors and related constructs and 2) to introduce and apply innovative 
research strategies useful to analyzing large amounts of medical data. 
MULTIMORBIDITY: ADVERSE HEALTH AFFECTS AND RELATED 
CONSTRUCTS 
Chapter 2 and 3 describe the relationship between multimorbidity and (subjective) 
cognitive functioning. The study presented in chapter 2 investigates the association 
between multimorbidity and subjective memory complaints. This cross-sectional study was 
based on data obtained from a postal survey designed by the PublicHealth Service 
(Gemeentelijke Gezondheidsdienst, GGD) concerning 15,188 individuals aged 55 years 
and over, living independently in Limburg, the Netherlands. Multimorbidity was not only 
related to subjective memory problems but was also related to the degree of worrying about 
memory complaints in people who perceived themselves as forgetful. Multimorbidity was 
also related to a larger increase in these subjective memory complaints during the last year. 
In addition, individuals with multimorbidity who were aged 55 to 69 years reported more 
subjective memory complaints compared to individuals with multimorbidity who were 
aged 69 and over. Men who perceived themselves as forgetful and who suffered from 
multimorbidity reported a larger increase in their memory problems during the past year 
compared to their female counterparts. Psychological distress appeared to be related to all 
three subjective memory-related outcome measures. 
 
In chapter 3, the effect of multimorbidity on cognition in a normal healthy aging 
population was investigated. Data were collected as part of the Maastricht Aging Study 
(MAAS), a prospective study into the determinants of cognitive aging. Eligible MAAS 
participants (N=1763), who were 24–81 years of age, were recruited from the Registration 
Network Family Practices (RNH) which enabled the use of medical records of all 
participants. The association between 96 chronic diseases, grouped into 23 disease clusters, 
and cognition at baseline, at 6 and 12 years of follow-up, were analyzed. Cognitive 
performance was measured in two main domains: verbal memory and psychomotor speed. 
Multiple disease clusters appeared to be associated with cognitive functioning. The disease 
cluster combination malignancies and movement disorders also appeared to significantly 
affect cognition. Nevertheless, these effects of disease clusters and combinations of two 
disease clusters and on side and cognition on the other appeared to be relatively small in a 
normal aging population. 
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Multimorbidity is well known for its profound negative effect on mental and physical 
functioning. Nevertheless, it remains unclear if these effects are temporary or persistent. 
Chapter 4 describes a study which investigated if the effects of single morbidity (i.e. a 
single disease within one individual) and multimorbidity on one side and physical and 
mental functioning on the other, are stable over time. Eligible participants from the MAAS 
(N=1184), 24–81 years old, were originally recruited from the Registration Network 
Family Practices. The Short Form Health Survey (SF-36) was used to assess physical and 
mental functioning. In contrast to single morbidity, the adverse effects of multimorbidity 
on physical functioning were persistent over time. At baseline, individuals who acquire one 
or more medical conditions during 3-years follow-up, already reported more decline in 
physical functioning than individuals who remained healthy during these years. The results 
of ad-hoc analyses in which the SCL-90 anxiety and depression scales were used, showed 
that multimorbidity indeed was related to increased levels of depressive and anxiety 
complaints. Nevertheless, these psychological complaints, caused by multimorbidity, 
appeared to decline over time. 
 
Chapter 5 presents a study conducted at the National Institute on Aging, part of the 
National Institutes of Health in Bethesda, Maryland, USA. This study, based on a large 
population-based sample of 4,414 older individuals, aged 70 and older and living in 
Iceland, investigated heterogeneity in the frail older population. The first aim of this study 
was to estimate the overall prevalence of frailty as well as to estimate the co-occurrence of 
disability and multimorbidity within the frail population. The second aim was to 
characterize subpopulations of frailty using various quantitative physiological markers. The 
final aim was to examine the risk for mortality and nursing home admission in 
subpopulations of frail older adults. 
Frailty was defined by having three or more of the following characteristics: weight 
loss, weakness, low energy levels, slowness and low physical inactivity. Multimorbidity was 
based on thirteen highly prevalent conditions. Disability was assessed by five activities of 
daily living (e.g. problems with bathing and walking). The following five subpopulations 
were formed: 1) Non-frail (reference group); 2) Frail only; 3) Frail with disability (FD); 4) 
Frailty with multimorbidity (FM); 5) Frail with disability and multimorbidity (FMD). 
Frailty appeared to be highly prevalent in the Icelandic population. Although frailty is 
often accompanied by multimorbidity and disability, nearly 13.5% of the frail individuals 
were frail without having multimorbidity and/or disability. Compared to non-frail 
individuals, the frail only group showed decreases in cognitive functioning and increased 
levels of inflammation. The other three frail subpopulations did not only showed 
significantly decreases in cognition and increased levels of inflammation but also showed a 
higher incidence of white matter lesions, and increased levels of calcium, glucose and red 
blood cell distribution width. Although frailty was associated with an increased risk for 
mortality and nursing home admission, these risks substantially differed between frail 
subpopulation. When evaluating the risk for mortality and nursing home admission in 
different subpopulations of frailty, the results indicated that, while mortality was primarily 
driven by the presence of multimorbidity (i.e. diseases), disability appeared to be the 
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driving force behind nursing home admission. As a result, the ‘only frail’ group, i.e. frail 
individuals who have no evidence of multimorbidity and disability, was not at an increased 
risk for mortality and nursing home admission. Hence, the adverse health risks associated 
with frailty in the general older adult population may primarily be driven by 
multimorbidity and disability. 
Diabetes Mellitus and Depression 
In chapter 6, the longitudinal association between diabetes mellitus type II and depression 
was investigated. This study was carried out within the context of the RNH. Patients 
diagnosed with diabetes mellitus at or after the age of 40 were compared with age matched 
controls without a history of diabetes. Both groups were followed for an emerging first 
diagnosis of depression and/or depressive feelings with a mean follow-up time of 7.7 years. 
In total, 2.0% of the people diagnosed with diabetes mellitus developed a depressive 
disorder, compared to 1.6% of the reference group. Patients with diabetes mellitus were 
more likely to develop subsequent depression than persons without a history of diabetes. 
Results from this large longitudinal study based on a general practice population indicate 
that the association between diabetes mellitus type II and depression is weaker than 
previously found in cross-sectional research using self-report surveys. 
INNOVATIVE RESEARCH STRATEGIES 
Knowledge Discovery in Databases 
Chapter 7 describes, based on the available literature, the theory and practical applications 
of Knowledge Discovery in Databases (KDD). The aim of this manuscript was to get the 
medical researcher acquainted with this emerging field. KDD is aimed at extracting 
previously unknown, hidden and potentially useful information and incorporates a new 
generation analyzing methods that is able to explore and model large amounts of 
(bio)medical data and documents in a (semi)automatically manner. 
Although KDD approaches are not intended to replace traditional statistical analyzing 
techniques, they may help (bio)medical researchers in the practice of exploratory research 
(i.e. research aimed at hypotheses generation). Rather than to serve as a golden standard, 
the application of KDD is aimed at supporting the knowledge and ideas of medical experts. 
This manuscript described in this chapter discusses several interesting applications of KDD 
that are useful in the practice of hypothesis generating in epidemiology and (bio)medical 
research. 
Patterns of Multimorbidity 
The study presented in chapter 8 presents a study on the identification of novel, interesting 
combinations of psychiatric and somatic diseases. Six conditions, coded in ICPC chapter P 
(Psychological), were involved: affective psychosis (P73), depressive disorder (P76), 
schizophrenia (P72), mental retardation (P85), personality disorder (P80) and suicide 
attempt (P77). The following ICPC chapters with somatic conditions were included: D 
(Gastrointestinal), K (Circulatory), L (Musculoskeletal), N (Neurological), R (Respiratory) 
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and T (Endocrine, metabolic and nutritional). In total, 166 disease combinations (i.e. 
consisting of one medical condition from ICPC chapter P and one medical condition from 
one of the somatic ICPC chapters) were selected for further evaluation. We focused on 
disease combinations with a prevalence of ≥10 (i.e. as assessed by The Registration Network 
Family Practices; N= 87,837) and an observed/expected ratio of ≥1.5. In total, 37 disease 
combinations with a prevalence of ≥10 and an observed/expected ratio of ≥1.5 were 
evaluated by three experts. The following five disease combinations were discussed in detail 
during an expert meeting; appendicitis and personality disorder, uncomplicated 
hypertension and psychotic affective disorders, migraine disorder and personality disorder, 
pulmonary emphysema and depressive disorder, and lipid metabolism and depressive 
disorder. These novel and potential relevant disease combinations need to be confirmed in 
other, preferable general practice based, datasets. Subsequently, these disease combinations 
can be analyzed in cross-sectional or longitudinal studies in order to investigate the 
plausibility of underlying (causal) relationships. In addition, the knowledge discovery 
method described in this chapter illustrates the use of innovative research strategies in order 
to identify prevalent disease combinations. Hence, the present study promotes hypothesis-
driven studies in the field of multimorbidity. 
GENERAL DISCUSSION 
Chapter 9 provides a general discussion of this thesis by discussing its landmarks and 
pitfalls with a specific focus on methodological considerations. The definition and 
assessment of multimorbidity used in this thesis is described even as the consequences 
hereof. Moreover, the quality of the data is discussed as well as the use of (innovative) 
analyzing strategies. Finally, this chapter links the results from the seven research projects to 
daily clinical practice as well as to future research in the field of multimorbidity. 
 
Although each study in this thesis has resulted in several specific conclusions, the following 
general conclusions can be drawn: 
 Multimorbidity is highly prevalent. 
 People with multimorbidity report more subjective memory complaints than their 
healthy counterparts. 
 Multiple disease clusters have an adverse affect on cognitive functioning. 
Nevertheless, these affects appears to be small in a normal aging population. 
 Multimorbidity, disability and frailty should be perceived as distinct concepts, 
since each concept appears to be related differently to quantitative biological 
markers and adverse health outcomes. 
 The adverse healthy risks associated with frailty may primarily be driven by disease 
burden and disability. 
 While mental problems related to multimorbidity appear to decrease over time, 
the decline in physical functioning caused by multimorbidity appears to be 
permanent. 
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 Knowledge Discovery in Databases can aid medical researchers in their search for 
patterns and association (e.g. patterns of multimorbidity) in large amounts of 
medical data or medical text. 
 
To address the above-mentioned conclusions and problems, the following recommen-
dations are postulated: 
 Identifying unknown patterns of multimorbidity is particularly important for 
future research since knowledge on frequently occurring disease combinations 
facilitate and accelerates disease diagnosis. The extent to which frequently 
occurring disease combinations represent general disease susceptibility also 
deserves future exploration. 
 Epidemiologic research is needed to develop a risk profile for multimorbidity. 
This risk profile can direct future intervention programs, aimed at increasing the 
quality of life of people with multimorbidity by ameliorating and diminishing its 
adverse health consequences. 
 Health care should move away from a disease specific approach and should move 
towards an integrated, multidimensional approach of health care, especially when 
confronted with multimorbidity. 
 
This thesis illustrates that multimorbidity is related to several adverse health effects 
including a permanent decline in physical functioning. In addition, it underscores that 
multimorbidity should not be used interchangeably with other gerontological constructs 
such as disability and frailty. Finally, this thesis demonstrates that innovative research 
strategies, such as knowledge discovery techniques, can provide novel and potentially 
relevant medical patterns and associations, including patterns of multimorbidity. 
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Door de vergrijzing van de bevolking en de toenemende levensverwachting zal het aantal 
personen met twee of meer chronische aandoeningen, ofwel multimorbiditeit, in de 
toekomst nog vaker voorkomen. De impact van multimorbiditeit is groot. Zo blijken 
mensen met multimorbiditeit niet alleen een verhoogde kans op lichamelijke beperkingen 
te hebben, maar ook op mentale problemen, hospitalisatie en zelfs sterfte. Tevens blijkt uit 
onderzoek dat het risico op deze uitkomsten groter wordt naarmate het aantal ziektes van 
een persoon toeneemt. Daarnaast kan de zorg voor mensen met multimorbiditeit een grote 
invloed hebben op het dagelijks leven van familie en vrienden. 
Mensen met multimorbiditeit maken vaker en meer gebruik van gezondheidszorg-
voorzieningen. Zo bezoeken zij vaker de huisarts of een medisch specialist en zijn er meer 
zorgverleners betrokken bij mensen die multimorbiditeit hebben. Patiënten met 
multimorbiditeit stellen hun huisarts voor verschillende uitdagingen. Multimorbiditeit 
bemoeilijkt namelijk niet alleen het diagnostisch proces naar nieuwe chronische ziektes 
maar compliceert ook de behandeling van de ziektes. Zo worden mensen met 
multimorbiditeit dikwijls geconfronteerd met tegenstrijdige adviezen en neemt het risico op 
gecontraïndiceerde medicatie toe. Zorg voor mensen met multimorbiditeit is dus 
intensiever en complexer wat resulteert in hogere gezondheidskosten. Kortom, 
multimorbiditeit heeft grote gevolgen voor zowel de patiënt, zijn naasten en voor de 
maatschappij. 
 
Over de definitie en terminologie van multimorbiditeit bestaat tot op heden nog geen 
consensus. De definitie geïntroduceerd door van den Akker en collega’s in 1995, die 
multimorbiditeit omschrijven als twee of meer chronische aandoeningen, zal in dit 
proefschrift gehanteerd worden. Een aan multimorbiditeit verwante term is comorbiditeit; 
de aanwezigheid van een chronische ziekte in combinatie met een index ziekte (bijv. 
depressieve stoornis in mensen met diabetes mellitus type II). Daarnaast wordt 
multimorbiditeit regelmatig in een adem genoemd met andere geriatrische concepten zoals 
‘frailty’ (dwz. broosheid en fragiliteit onder ouderen mensen) en ‘disability’ (dwz. het 
onvermogen om bepaalde activiteiten uit het dagelijkse leven uit te voeren). 
ONDERZOEKSDOELSTELLINGEN- EN VRAGEN 
Hoofdstuk 1 leidt de centrale doelstelling van dit proefschrift in. Dit proefschrift heeft 
twee doelstellingen en wel de volgende: 1) het in kaart brengen van een aantal negatieve 
gezondheidseffecten en gerelateerde constructen van multimorbiditeit en 2) het 
introduceren en toepassen van nieuwe analyse methodes bruikbaar voor het analyseren van 
grote hoeveelheden medische data. 
 
De bovenstaande twee doelstellingen leiden de volgende, meer gedetailleerde, onderzoek-
vragen in: 
 Houdt multimorbiditeit verband met subjectieve geheugenklachten? 
 Wat is het longitudinale effect van multimorbiditeit op het cognitief 
functioneren? 
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 Is de relatie tussen fysieke en mentale gezondheid enerzijds en multimorbiditeit 
anderzijds tijdelijk of permanent? 
 Wat is de relatie tussen multimorbiditeit, frailty en disability? 
 Is diabetes mellitus type II gerelateerd aan depressie in een populatie van 
eerstelijns patiënten? 
 Is Knowledge Discovery in Databases (KDD) bruikbaar voor medisch onderzoek? 
 Welke patronen van multimorbiditeit komen vaker voor bij patiënten dan 
verwacht op basis van toeval? 
DE NEGATIEVE EFFECTEN VAN MULTIMORBIDITEIT 
Multimorbiditeit en Cognitief Functioneren 
Hoofdstuk 2 beschrijft een cross-sectioneel onderzoek naar de relatie tussen 
multimorbiditeit en subjectieve geheugen klachten. Het onderzoek, gebaseerd op een 
schriftelijke vragenlijst opgesteld door de Gemeentelijke Gezondheids Dienst (GGD), vond 
plaats onder 15.188 55-plussers die ten tijden van het onderzoek zelfstandig woonden in 
Zuid-Limburg, Nederland. Multimorbiditeit bleek voorspellend voor de mate van zorgen 
die mensen hebben over hun geheugenklachten; mensen met multimorbiditeit 
rapporteerden meer geheugenklachten dan hun gezonde leeftijdsgenoten. Ook bleek uit 
deze studie dat multimorbiditeit een belangrijke voorspeller is voor het rapporteren van een 
toename van geheugen klachten gedurende het afgelopen jaar. Dit verband bleek meer 
sterker voor mannen dan voor vrouwen. Mensen met multimorbiditeit die ook nog 
psychische klachten hadden, rapporteerden significant meer geheugen klachten dan mensen 
met multimorbiditeit zonder psychische klachten. 
 
In hoofdstuk 3 wordt een studie gepresenteerd gericht op de relatie tussen 
multimorbiditeit en cognitie. Personen tussen de 24 en 81 jaar (N=1.763) werden 
geselecteerd uit het RegistratieNet Huisartspraktijken (RNH) voor deelname aan de 
Maastricht Aging Study (MAAS), een longitudinale studie gericht op het in kaart brengen 
van de determinanten van normale cognitieve veroudering. De longitudinale relatie tussen 
96 chronische ziektes, gegroepeerd in 23 clusters, en cognitief functioneren werd 
onderzocht. Cognitief functioneren werd gemeten in twee domeinen: verbaal geheugen en 
informatieverwerkingssnelheid. Multimorbiditeit was aanwezig bij meer dan 55% van de 
studie populatie. Verscheidene ziekte clusters hadden een negatief effect op cognitief 
functioneren. Mensen met multimorbiditeit die leden aan een combinatie van 
maligniteiten en bewegingsstoornissen toonde een verslechtering in cognitief functioneren. 
Echter, al deze negatieve effecten lijken relatief klein in een een normale populatie. 
Multimorbiditeit en Functionele Gezondheid 
De studie die beschreven wordt in hoofdstuk 4 onderzoekt of de relatie tussen mentale en 
fysieke gezondheid enerzijds en multimorbiditeit anderzijds tijdelijk of permanent van aard 
is. Personen tussen de 24 en 81 jaar (n=1.184) werden uit het RegistratieNet 
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Huisartspraktijken (RNH) geselecteerd voor deelname aan de Maastricht Aging Study 
(MAAS). De morbiditeit status (dwz. gezond, enkelvoudige morbiditeit, het hebben van 
één chronische ziekte, en multimorbiditeit) van de MAAS deelnemers werd op baseline en 
op 3 en 6 jaar follow-up in kaart gebracht. De Rand-36, een vragenlijst gericht op het in 
kaart brengen van functionele gezondheid, werd op dezelfde meetmomenten afgenomen. 
Op baseline, maar niet na 3 en 6 jaar follow-up, bleken deelnemers met enkelvoudige 
morbiditeit een slechtere fysieke gezondheid te rapporteren dan gezonde deelnemers. Op 
elke meetmoment rapporteerde mensen met multimorbiditeit een slechtere fysieke 
gezondheid dan gezonde deelnemers. Daarnaast nam de fysieke gezondheid van deze 
deelnemers verder af naarmate de tijd vorderde. Zowel single morbiditeit als 
multimorbiditeit bleek niet gerelateerd aan mentale gezondheid. Deelnemers die in 3 jaar 
een verandering in morbiditeitsstatus doormaakte (dwz. van gezond naar enkelvoudige 
morbiditeit of van gezond naar multimorbiditeit), rapporteerde een slechtere fysieke 
gezondheid dan mensen die gezond bleven. Post-hoc analyses waarin gebruik werd gemaakt 
van een andere vragenlijst, de Symptom Checklist-90 (SCL-90), toonde wel degelijk een 
relatie tussen multimorbiditeit en gevoelens van angst en depressie. Deze gevoelens bleken 
echter af te nemen naarmate de tijd vorderde. 
Multimorbiditeit, ‘Frailty’ en ‘Disability’ 
Hoofdstuk 5 beschrijft een onderzoek dat is uitgevoerd bij National Institute of Aging, 
onderdeel van National Institute of Health in Bethesda, USA en is gebaseerd op 4.414 
personen, tussen de 77 tot 100 jaar oud, woonachtig in IJsland. De doelstelling van dit 
onderzoek was drieledig: 1) het vaststellen van de prevalentie van frailty als mede de 
prevalentie van frailty in combinatie met multimorbiditeit en disability, 2) het 
karakteriseren van de verschillende frailty-groepen door middel van kwantitatieve 
fysiologische markers en 3) het vaststellen van het risico van de verschillende groepen op 
opname in een verpleeghuis en overlijden. Frailty was gedefinieerd als het hebben van drie 
of meer van de volgende karakteristieken: gewichtsverlies, verminderde kracht, verminderd 
energie niveau, traagheid en fysieke inactiviteit. Dertien chronische ziektes werden 
geïncludeerd om multimorbiditeit vaststellen. Multimorbiditeit was gedefinieerd als het 
hebben van twee of meer chronische aandoeningen. Disability werd geoperationaliseerd 
door vijf vragen die betrekking hadden op verscheidene activiteiten in het dagelijks leven 
(bijv. Hebt u moeite met het lopen van een kamer naar de andere). De volgende vijf frailty 
groepen werden gevormd: 1) niet frail (de controle groep), 2) alleen frail (zonder disability 
en/of multimorbiditeit), 3) frail met disability, 4) frail met multimorbiditeit en 5) frail met 
disability en multimorbiditeit. 
Frailty bleek vaak voor te komen in de IJslandse populatie. Hoewel frailty vaak in 
combinatie met multimorbiditeit en disability voorkomt, zijn er ook mensen die alleen frail 
zijn. Vergeleken met mensen die niet frail zijn, tonen mensen die ‘alleen frail’ zijn een 
verminderd cognitief functioneren, meer witte stof letsel en een verhoogd inflammatie-
niveau. De andere drie frailty-groepen vertoonden niet alleen een verminderd cognitief 
functioneren, meer witte-stofschade en een verhoogd inflammatie niveau maar lieten 
daarnaast ook nog een verhoging in calcium, glucose en distributiebreedte van de rode 
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bloedcellen zien. Hoewel mensen met frailty een verhoogd risico op opname in een 
verpleegtehuis en overlijden vertoonde, toonde de ‘alleen frail’ groep geen verhoogde risico 
op opname of overlijden. Terwijl de groep ‘frailty met disability’ alleen een verhoogde kans 
op opname in een verpleegtehuis had, liet de ‘frailty met multimorbiditeit’ groep alleen een 
verhoogd risico op overlijden zien. Terwijl chronische ziektes primair ten grondslag bleken 
te liggen aan overlijden, bleek een verhoogd risico op opname in een verpleegtehuis 
voornamelijk veroorzaakt te worden door disability. 
Diabetes Mellitus type II en Depressie 
Hoofdstuk 6 beschrijft de relatie tussen diabetes mellitus type II en depressie gebaseerd op 
data van het RegistratieNet Huisartspraktijken (RNH). Van de 6.140 patiënten die 
gediagnosticeerd waren met diabetes mellitus ontwikkelde 2% een depressieve stoornis. Van 
de 18.416 personen zonder diabetes mellitus ontwikkelde 1,6% een depressieve stoornis. 
Kortom, personen met diabetes mellitus blijken een groter risico te hebben op een 
depressieve stoornis dan mensen die niet gediagnosticeerd zijn met diabetes mellitus. Dit 
effect kon niet worden verklaard door leeftijd, geslacht of de aanwezigheid van andere 
chronische aandoeningen. Echter het verband tussen diabetes mellitus en depressie bleek 
minder groot dan beschreven in eerder, cross-sectioneel en/of vragenlijst onderzoek. 
INNOVATIEVE ANALYSE METHODES 
Met de opkomst van de computer is de laatste decennia de hoeveelheid beschikbare 
medische informatie drastisch toegenomen. Zo bestaan er tegenwoordig grote elektronisch 
patiëntendossiers (EPD) waarin zorgverleners relevante medische gegevens kunnen opslaan. 
De grote hoeveelheid medische data heeft er toe geleid dat nieuwe methoden nodig zijn om 
deze gegevens te kunnen analyseren. 
Knowledge Discovery in Databases 
Hoofdstuk 7 introduceert Knowledge Discovery in Databases (KDD), het proces van 
kennis-extractie uit data of tekst. KDD is gericht op het extraheren van voorheen 
onbekende, verborgen en mogelijk nuttige informatie. KDD is een nieuwe generatie 
analysemethoden die in staat om betekenis te geven aan grote hoeveelheden (bio) medische 
gegevens in een (semi) automatisch manier. Hoewel KDD niet tot doelstelling heeft de 
traditionele statistische analyse technieken te vervangen, kan het (bio) medische 
onderzoekers helpen in exploratief onderzoek (dwz. onderzoek gericht op het generen van 
hypotheses). In plaats van te dienen als gouden standaard, is de toepassing van KDD 
gericht op het ondersteunen van de kennis en ideeën van medische experts. Het artikel 
beschreven in dit hoofdstuk bespreekt een aantal interessante toepassingen van KDD die 
van nut kunnen zijn in exploratief medisch onderzoek. 
Clusters van Chronische Aandoeningen 
Hoofdstuk 8 presenteert een studie die gericht is op de identificatie van nieuwe, potentieel 
relevante combinaties van psychiatrische en somatische aandoeningen. De volgende zes 
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aandoeningen, gecodeerd in ICPC hoofdstuk P (Psychologische), werden geïncludeerd: 
affectieve psychose (P73), depressieve stoornis (P76), schizofrenie (P72), mentale retardatie 
(P85), persoonlijkheidsstoornis (P80) en poging tot zelfmoord (P77). De volgende ICPC 
hoofdstukken met somatische aandoeningen werden opgenomen: D (Gastro-intestinaale), 
K (Cardiovasculair), L (Bewegingsapparaat), N (Neurologische), R (Respiratoir) en T 
(Endocriene, metabool en nutritioneel). In totaal werden 166 ziekte combinaties (dwz. een 
medische aandoening uit ICPC hoofdstuk P en een medische aandoening uit een van de zes 
somatische ICPC hoofdstukken) geselecteerd voor verdere evaluatie. We concentreerden 
ons op ziekte combinaties met een prevalentie van ≥10 (geregistreerd in het RegistratieNet 
Huisartspraktijken (RNH); N=87.837) en met een observed/expected ratio van ≥1,5. In 
totaal werden 37 ziektecombinaties met een prevalentie van ≥10 en een observed/expected 
ratio van ≥1,5 geëvalueerd door drie experts. De volgende vijf ziekte combinaties werden 
uitvoerig besproken tijdens een expert bijeenkomst: appendicitis en 
persoonlijkheidsstoornis; ongecompliceerde hypertensie en psychotische affectieve stoornis; 
migraine en persoonlijkheidsstoornis; emfyseem en depressieve stoornis; en 
vetstofwisselingsstoornis en depressieve stoornis. Deze nieuwe en potentiële relevante ziekte 
combinaties dienen te worden bevestigd in onafhankelijke, bij voorkeur 
huisartsgeneeskundige, datasets. Nadien kunnen deze ziekte combinaties worden 
geanalyseerd in cross-sectioneel of longitudinale studies om de plausibiliteit van een 
onderliggende (causale) relatie te onderzoeken. Daarnaast illustreert de toegepaste KDD 
methode het gebruik van innovatieve analyse methodes om frequente ziekte combinaties te 
identificeren. 
ALGEMENE DISCUSSIE 
In de algemene discussie, hoofdstuk 9, worden de belangrijkste bevindingen en conclusies 
van de acht verschillende onderzoekprojecten samenvattend besproken om zo de 
vraagstellingen van dit proefschrift te beantwoorden. De methodologische overwegingen 
van deze studies worden besproken waarin zowel sterktes als zwaktes worden gepresenteerd. 
Daarnaast wordt de operationalisatie van multimorbiditeit beschreven en de mogelijke 
implicaties hiervan. Tevens wordt de kwaliteit van de gebruikte databestanden besproken 
en geëvalueerd evenals de diverse analyse methodes. Ten slotte worden aanbevelingen voor 
klinisch beleid en toekomstig onderzoek geformuleerd. 
 
Hoewel elke afzonderlijke studie in dit proefschrift resulteert in specifieke conclusies, 
kunnen de volgende algemene conclusies worden getrokken: 
 Multimorbiditeit is, in de algemene bevolking, eerder regel dan uitzondering. 
 Vergeleken met gezonde mensen, rapporteren mensen met multimorbiditeit meer 
geheugen klachten. 
 Mensen met multimorbiditeit vertonen ook in afname in cognitief functioneren. 
Echter, deze afname blijkt klinisch weinig relevant. 
 Hoewel multimorbiditeit, ‘disability’ en ‘frailty’ aan elkaar gerelateerde concepten 
zijn, moeten ze wel degelijk als aparte constructen worden beschouwd met ieder 
een eigen risico op opname in een verpleegtehuis en overlijden. 
Samenvatting 
 - 155 -
 Multimorbiditeit lijkt geassocieerd te zijn met een permanente vermindering in 
fysieke gezondheid. De mentale problemen die gerelateerd zijn aan 
multimorbiditeit lijken na verloop van tijd te verminderen. 
 De combinatie van medische data verzameld in de RegistratieNet 
Huisartsenpraktijk leent zich bij uitstek voor verder onderzoek naar multi-
morbiditeit. 
 Knowledge Discovery in Databases kan onderzoekers helpen bij het zoeken naar 
relaties en patronen in grote hoeveelheden medische data. 
 
Gezien de bovenstaande conclusies en problemen worden de volgende aanbevelingen 
gedaan: 
 Onderzoek naar het identificeren van frequent voorkomende ziekte combinaties 
(dwz. patronen van multimorbiditeit) is van belang aangezien dit het diagnostisch 
proces van ziektes kan vergemakkelijken en versnellen. De mate waarin frequent 
voorkomende ziekte combinaties een algemene ziektegevoeligheid weerspiegelen, 
dient ook nader onderzocht te worden. 
 Etiologisch onderzoek gericht op het in kaart brengen van risico factoren van 
multimorbiditeit kan leiden tot een risicoprofiel voor multimorbiditeit. Dit 
risicoprofiel kan richting geven aan adequate interventieprogramma’s die tot doel 
hebben de vermindering in kwaliteit van leven van patiënten met 
multimorbiditeit tegen te gaan. 
 De huidige opzet van zorg die zich voornamelijk richt op specifieke, individuele 
chronische aandoeningen, kan leiden tot versnipperde en gefragmenteerde 
gezondheidszorg voor mensen met multimorbiditeit. Integrale zorg voor de 
individuele zorgvrager met multimorbiditeit is daarom een belangrijk 
aandachtspunt. 
 
Dit proefschrift toont dat multimorbiditeit gerelateerd is aan diverse negatieve 
gezondheidseffecten waaronder een permanente afname in fysieke gezondheid. Daarnaast 
onderstreept dit proefschrift dat multimorbiditeit niet verward dient te worden met andere 
geriatrische constructen zoals frailty en disability. Tot slot toont dit proefschrift aan dat 
innovatieve analyse methodes, nieuwe en potentieel relevante medische patronen en 
verbanden kunnen identificeren in grote hoeveelheden medische data. 
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Aan de totstandkoming van dit proefschrift hebben, zoals bij elke uitdagende en langdurige 
taak het geval is, veel mensen een bijdrage geleverd. Op de komende pagina’s zou ik graag 
van de gelegenheid gebruik maken deze mensen te bedanken die, ieder op hun geheel eigen 
manier, de afgelopen vier jaar een belangrijke rol in mijn leven hebben gespeeld. Ik wil dit 
doen aan de hand van de volgende indeling; promotie project, overige collega’s, familie en 
vrienden. Dit wil echter niet zeggen dat mensen niet tot twee of drie groepen kunnen 
behoren Het behoren tot vier groepen acht ik echter uitgesloten; zover ik weet is geen enkel 
familielid van mij direct betrokken geweest bij mijn PhD project. 
Promotie project 
Ik zou graag willen beginnen met die twee mensen te bedanken die niet alleen een enorm 
grote bijdrage hebben geleverd aan de ontwikkeling van mijn proefschrift, maar ook aan 
mijn ontwikkeling als mens. Beste Marjan van den Akker, jouw vrolijkheid en expertise op 
(zo lijkt het) bijna alle vlakken van wetenschappelijk onderzoek, hebben ervoor gezorgd dat 
ik de afgelopen vier jaar mijn werk met plezier en interesse heb uitgevoerd. Tevens denk ik 
met veel plezier terug aan ons etentje in Dubrovnik waar zowel werkgerelateerde als 
persoonlijke zaken op een leuke, ongedwongen manier besproken werden. Beste Martin 
van Boxtel, jij hebt mij op een prettige en deskundige wijze geleerd wat het is om een 
wetenschappelijk onderzoeker te zijn. Ik kon er altijd op vertrouwen dat je mijn stukken 
rondig en uitermate snel van commentaar voorzag. Dit heeft er voor gezorgd dat het temp 
altijd behouden bleef. Daarnaast leerde je mij, soms onbewust, een aantal persoonlijke 
vaardigheden die mij, zowel op werk als op persoonlijk gebied, een beter mens maken. 
Martin en Marjan, individueel zijn jullie goed, samen zijn jullie uitzonderlijk. Ik voel me 
bevoorrecht om een dergelijk goede begeleiding tijdens mijn promotie traject te hebben 
mogen ervaren. Ik kan alleen maar hopen dat dit voor elke promovendus is weggelegd. 
 
Daarnaast wil ik mijn promotoren, die als overkoepelend orgaan hebben gefungeerd, 
bedanken. Beste Job Metsemakers, jouw visie als praktiserend huisarts heeft mij gewezen op 
de klinische relevantie van mijn promotie traject. Daarnaast denk ik met veel plezier terug 
aan de leuke gesprekken over familie en reizen (m.i. delen we de liefde voor Indonesië). 
Beste Frans Verhey, jouw aanwijzigingen bij het schrijven van artikelen, die voornamelijk 
betrekking had op de klinische relevantie ervan, waren steeds verfrissend. Jelle Jolles, 
ondanks dat je aanwezigheid als mijn promotor slechts van zeer korte duur was, wil ik je 
bedanken voor je bijdrage tijdens de eerste maanden: een goed begin, is het halve werk. 
 
Beste Rein Vos, met behulp van jouw expertise en netwerk heb ik contact kunnen leggen 
met mensen van de afdeling Biomedische Informatica aan de Erasmus Universiteit in 
Rotterdam. Hierdoor is mijn proefschrift geworden wat het nu is; een samensmelting van 
huisartsgeneeskundig onderzoek en knowledge discovery. Beste Hans Bosma, jij was 
wellicht de stille kracht in onze project groep. Jouw kennis van longitudinale analyses heeft 
mij geholpen in het uitvoeren van een aantal onderzoeken. Daarnaast hebben we samen het 
mysterie achter de SF-36 ‘ontrafeld’. Bedankt voor je suggestie om ‘alles simpel te houden’ 
als ik weer eens moeilijke statistische modellen aan het uitdenken was. 
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De volgende mensen die ik wil bedanken zijn Frans Tan en Björn Winkens. Jullie hebben 
mijn statistische vaardigheden naar een hoger niveau getild met behulp van jullie expertise. 
Met groot enthousiasme ontving ik dikwijls een heldere uitleg van ingewikkelde materie. 
Tevens wil ik Nico Rozendaal bedanken voor zijn enorme hulp bij het werken met SPSS. 
Ik heb bewondering voor jouw kennis maar ook voor jou als mens. Jouw vriendelijkheid, 
behulpzaamheid en goede humeur verschaften me altijd enorm veel vreugde. 
 
I would like to thank all American and Icelandic co-authors for their contribution to the 
AGES manuscript. Thank you all for your time and effort. 
 
Euvgeni Smirnov, Irmin Auwerda, Georgi Albinov, Erik van Mulligen, en Jan Kors: 
bedankt voor jullie medewerking aan de data en text mining kant van mijn proefschrift. 
 
Onno van Schayck, Trudy van der Wijden, Hannerieke van der Boom, Rob de Bie, 
Martijn Berger en Gonnie Klabbers. Ik wil jullie allen hartelijk danken voor het verbreden 
van mijn ‘promovendus horizon’. Door mijn werkzaamheden als promovendus 
vertegenwoordigster is mij een kijkje gegund in de ‘keuken van CAPHRI’. Jullie hebben 
mij het gevoel gegeven dat alle ideeën en suggesties van harte welkom waren om zo een 
beter en uitgebreider platform voor promovendi te creëren. Katarina Putnik, Marla 
Woolderink en Laura van Alphen, jullie wil ik bedanken voor de leuke en hechte 
samenwerking tijdens deze periode. Ik heb veel plezier beleefd aan onze 
lunchbijeenkomsten waarin we al etende, brainstormde over workshops, de CAPHRI mail 
en ‘het promovendus zijn’. 
 
Daarnaast zou ik mijn dank willen richten tot alle huisartsen die participeren aan RNH en 
hun patiënten. Zonder hun continue en precieze registratie, zou dit proefschrift niet zijn 
zoals het nu is. Tevens een bedankje voor alle patiënten die het geen problemen vinden dat 
hun gegevens anoniem worden gebruikt voor wetenschappelijk onderzoek. 
Collega’s 
Ten eerste wil ik mijn dank richten tot alle medewerkers van HAG op de tweede en derde 
verdieping van die ik hier niet bij allen bij naam noem aangezien jullie in grote getallen 
aanwezig zijn. Bedankt voor de korte (en lange) praatjes die veelal bij het koffie apparaat of 
in het trappenhuis plaats vonden; ze waren altijd een welkome afleiding. Ik heb jullie 
toegankelijkheid altijd enorm gewaardeerd. Jullie hebben ervoor gezorgd dat ik me vanaf 
dag één welkom voelde! 
 
Daarnaast een bedankje voor het ondersteunend personeel van CAPHRI. Erie, Astrid, Iris, 
Tanja, Nikki en Margareth bedankt dat jullie altijd tijd hadden voor mijn vragen. 
 
Ik wil ook graag van de gelegenheid gebruik maken om een aantal mensen te bedanken die 
mij vooral op sociaal vlak hebben bijgestaan tijdens mijn promotie traject. Ik wil beginnen 
bij Daniel Kotz. Beste Daniel, jij was en bent mijn eerste kamergenoot geweest. Nooit was 
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het je te veel om mij van advies te voorzien of me handige tips toe te fluisteren. Door jouw 
werkervaring te delen met mij, heb je me niet alleen veel geleerd maar ook enorm welkom 
geheten. 
 
Matthijs, ook jou wil ik even apart bedankt voor je opbeurende, leuke, aardige maar ook 
depressieve, vervelende en gemene opmerkingen tijdens de afgelopen vier jaar. Kortom, 
bedankt dat je altijd eerlijk tegen me was en me een spiegel voorhield. 
 
Martine, Tineke, Sander, Viola, Mandy, Joris, Merijn, Mirjam, Francine, Eline, Luc, Eva, 
Jochen (CAPHRI), Lia en Esther (MHeNS), Joep, Pim en Dilana (FdP): ik wil jullie 
bedanken voor jullie vriendelijkheid, hulp, en steun de afgelopen jaren. 
 
Kitty en Marga, vooral de laatste twee jaar van mijn promotie ben ik vaak even bij jullie 
komen kletsen. Ik hoop dat jullie onze gesprekken net zo leuk hebben ervaren dan ik. Ik 
wens jullie alleen nog maar mooie dingen voor de toekomst; jullie verdienen het! 
 
Ine, Kim en Judith, bedankt dat jullie mij altijd van dienst wilde zijn bij het plannen van 
afspraken, het regelen van een buitenlands congres of als ik weer eens ruzie had met de 
faxmachine. 
 
Ik wil hierbij ook de dames van de boekenclub bedanken. Onze boekenclub bestaat uit 
allemaal vrouwen die of bezig zijn met een promotie binnen CAPHRI of de promotie al 
hebben afgerond. Promoveren kan soms al aardig lastig zijn, maar dan ook nog eens elke 
maand een boek voor de boekenclub lezen dat regelmatig wel 500 bladzijdes of meer 
besloeg, was helemaal een uitdaging. En dan ‘vergeten’ we voor het gemak even dat de 
meeste van jullie ook nog mama zijn of zwanger zijn. De mate waarin we elke bijeenkomst 
over baby’tjes praatten hield dikwijls verband met het boek dat we gelezen hadden 
(teleurstellend boek → veel baby praat). Onze bijeenkomsten heb ik altijd erg gewaardeerd, 
mede door het lekkere eten. Hopelijk mogen er nog veel bijeenkomsten volgen! 
 
Ten slotte wil ik twee collega’s bedanken die tevens mijn paranimfen én vriendinnetjes zijn; 
Petra Erkens en Janaica Grispen. Beste Petra, de afgelopen drie jaar hebben we niet alleen 
een werkkamer maar ook lief en leed gedeeld. Verhalen over ons werk, Frank, Sven, onze 
families, onze weekenden, kleren, schoenen en kapsels; ze kwamen allemaal voorbij. Ik heb 
het delen van een kamer met jou als enorm fijn ervaren. Ik kan alleen maar hopen dat dit 
voor jou ook geldt. Beste Janaica, jij was degene die zorgde voor de ‘stimmung’ op tweede 
verdieping. Mocht ik eens geen zin hebben om te werken dan dacht ik gewoon aan het feit 
dat jij er ook zou zijn met je aanstekelijke lach en goede zin. Jouw aanwezigheid brengt een 
vrolijkheid met zich mee die je absoluut nooit moet verliezen! 
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Vrienden 
Als ik wel eens zeurde over mijn promotie traject zag ik mijn familie wel eens denken: 
‘Promoveren? Hoe stressvol kan dat nu werkelijk zijn als je 46 vrije dagen in het jaar hebt 
en een dag in de week thuis werkt’. Eigenlijk hebben jullie daar helemaal gelijk in. 
 
Lieve Daan, misschien is niet alles in ons leven gelopen zoals we hadden verwacht, maar ik 
heb je vriendschap altijd enorm gewaardeerd. 
 
Fieke, bedankt voor alle keren dat je onverwacht op de stoep stond omdat je even wilde 
komen kletsen. Ik hoop dat je dat in de toekomst blijft doen, ook nu je mama bent van een 
geweldig mooie meid. 
 
Geert, vaak belde je Sven om te vragen of je nú een kop koffie kon komen drinken. 
Anderzijds belde Sven je vaker als hij weer hulp in de tuin nodig had. Als je op bezoek 
kwam zorgde je ervoor dat ik even mijn eigen ding kon doen; Sven en jij vermaakten elkaar 
wel. Ik heb in mijn leven nog nooit twee mannen gezien die zo kunnen roddelen! 
 
Kirsten en Roy (en hun 2 honden en 3 katten!), onze gourmette avond zijn altijd lekker 
(gezellig). Ik hoop jullie nog vaak te mogen ontvangen/bezoeken. 
 
Beste Sander (Tasma voor intimi), ik wil jou hier toch ook even bedanken voor alle keren 
dat jij en de rest van de jongens me mee op sleeptouw wilden nemen. Tevens bedankt voor 
alle keren dat je me laat winnen als we Wordfeud spelen! 
Familie 
Ik vind het erg jammer dat mijn beide grootouders mijn promotie niet meer kunnen 
meemaken. Ik had graag gewild dat ze hadden begrepen waar ik aan werkte. Echter, door 
hun harde werken tijdens een, niet altijd aangenaam leven, hebben ze de een goede basis 
gelegd voor hun kinderen en daardoor dus ook voor hun kleinkinderen. Mijn proefschrift 
draag ik dan ook op aan hen. 
 
Martijn (Tinus voor intimi), ik wil je vooral bedanken voor het tweede en derde jaar tijdens 
mijn promotie. Ik keek altijd enorm uit naar vrijdag en zaterdag omdat we dan weer 
gezellig op stap gingen en shoarma konden eten. We zien elkaar nog steeds regelmatig, ook 
al is mijn leven nu iets burgerlijker geworden. Hoewel . . . een wedstrijd van Roda JC 
bezoeken en dan op de west tribune zitten, is mijn inziens alles behalve burgerlijk. Een 
bedankje ook naar de Danielle (mama van Tinus) die haar huis altijd openstelde voor zo 
veel jong volk. 
 
Andy en Sammy, jullie wil ik bedanken voor alle leuke spelletjes avonden! Monopolie, 
Cluedo, Buzz alles was even leuk! Mogen er in de toekomst nog veel van deze avonden 
volgen! 
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Hans, Gina en Joy, wij zijn altijd welkom bij jullie en niets lijkt jullie te veel moeite. 
Bedankt! Joy, wanneer kom je nu eens gezellig bij ons slapen? 
 
Ondanks dat je vaak de wildste verhalen hoort over schoonfamilies en in het bijzonder over 
schoonmoeders, kan ik niet anders dan toegeven dat ik het enorm getroffen heb op dit 
gebied. Lieve schoonmoeder, bedankt voor alle leuke momenten de afgelopen jaren. Jouw 
liefde voor uit eten gecombineerd met mijn liefde voor eten, of dat nu uit of thuis is, heeft 
geleidt tot vele etentjes die altijd een welkome afleiding waren. Moge er nog vele volgen! 
Bedankt ook voor al die uren die je poetsend hebt doorgebracht in ons nieuwe huis toen ik 
in Washington werkte. 
Lieve schone vader (zoals je jezelf vaker noemt) en Martha bedankt voor de keren dat 
we mochten komen eten op vrijdagavond (ondanks dat ik ze altijd op de kop kreeg als ik 
een halve pot mayonaise bij mijn frietjes at). Tevens bedankt voor alle hulp aan ons huis! 
 
Het bezoeken van een festival is bij uitstek het beste middel om niet aan je werk te denken. 
Bennie en Ineke, bedankt voor alle leuke Pinkpop momenten. Ik zie ons nog genieten bij 
Bruce. En dit jaar komt hij weer! Zoë en Evaatje, hoe kun je een weekend beter beginnen 
dan je liefste nichtjes uit te nodigen om te komen logeren? Jullie zijn lieverdjes! 
 
Papa en mama, doordat jullie altijd benadrukten hoe belangrijk (maar zeker niet hét 
allerbelangrijkst) een goede opleiding was, hebben jullie de fundamenten gelegd voor mijn 
opleiding als psycholoog en daardoor dus ook voor mijn promotie. Sanne, ondanks dat de 
inhoud en de vorm anders is, leveren we beiden een bijdrage aan de gezondheidszorg, iets 
dat ons beiden enorm interesseert. 
 
Lieve Sven, ik wil jou bedanken voor je luisterend oor, je altijd aanwezige glimlach, je 
optimisme, de ‘stemmetjes die je doet’ (Sven kan heel goed een kermisattractie na doen!) 
om me op te vrolijken en je aandacht voor mij. Al deze factoren die zo kenmerkend zijn 
voor jou als mens zorgen ervoor dat ik me gesteund, speciaal en geliefd voel. Vriendjes? 
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